Robust pipelines for extensive analyses of large genetic and brain imaging datasets linked to complex human behavior by Petrovska, Jana
Robust pipelines for extensive analyses of large 
genetic and brain imaging datasets linked to 
complex human behavior 
A cumulative dissertation submitted to the Faculty of Psychology, University of Basel, 
in partial fulfillment of the requirements for the degree of Doctor of Philosophy by 
Jana Petrovska 
from Skopje, North Macedonia 
Basel, 2020 
Original document is stored on the document server of the University of Basel 
edoc.unibas.ch 
Approved by the Faculty of Psychology at the request of 
Professor Dr. med. Andreas Papassotiropoulos 
Professor Dr. med. Dominique J.-F. de Quervain 
Date of the doctoral examination: 24.02.2020 
Dean of the Faculty of Psychology 
Declaration of scientific fairness 
I Jana Petrovska hereby declare that the present work was written independently without the help 
of third parties and without the use of any means other than those indicated. Sources used for 
help are marked as such. The manuscripts published or submitted for publication in journals were 
prepared in cooperation with the co-authors and were not published elsewhere by any of the 
participants, submitted for publication, or submitted to any other examination authority as a 
qualification paper. These are the following manuscripts: 
- Petrovska, J., Coynel, D., Fastenrath, M., Milnik, A., Auschra, B., Egli, T., Gschwind, L., Hartmann, F., 
Loos, E., Sifalakis, K., Vogler, C., de Quervain, D. J.-F., Papassotiropoulos, A. & Heck, A. (2017). The 
NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals. 
Journal of Psychiatric Research, 91, 116-123. 
- Petrovska, J., Loos, E., Coynel, D., Egli, T., Papassotiropoulos, A., de Quervain, D. J.-F. & M., Milnik, A. 
Recognition memory performance can be estimated based on few specific brain networks. 
- Heck, A., Milnik, A., Vukojevic, V., Petrovska, J., Egli, T., Singer, J., Escobar, P., Sengstag, T., Coynel, 
D., Freytag, V., & Fastenrath, M., Demougin, P., Loos, E., Hartmann, F., Schicktanz, N., Bizzini, B. D., 
Vogler, C., Kolassa, I.-T., Wilker, S., Elbert, T., Schwede, T., Beisel, C., Beerenwinkel, N., de Quervain, D. 
J.-F. & Papassotiropoulos, A. (2017). Exome sequencing of healthy phenotypic extremes links TROVE2 to 
emotional memory and PTSD. Nature Human Behaviour, 1(4), 1-10.
Jana Petrovska 
Basel, 23.01.2020 
Abstract 
The rapid technological and methodological advances in genetics, molecular 
biology and brain imaging in the last decades have enabled the current wide-spread 
application of brain-wide and genome-wide analyses of potential biological substrates 
of complex behavioral traits, such as psychological processes and psychiatric 
disorders. This thesis addresses methodological and statistical issues emerging from 
the large scale, complexity and explorative nature of brain-wide and genome-wide 
analyses. Furthermore, it points out additional steps for increasing the confidence in 
findings resulting from such extensive analyses. It does so by introducing two studies 
investigating the genetic bases of depressive symptoms and the brain imaging 
underpinnings of recognition memory performance, respectively. In the first study we 
aggregated genome-wide data of genetic variation to groups of genes and used 
inferential statistics to associate them with depressive symptoms. We also replicated 
the results in an independent sample and used imagining genetics to validate and 
extend our findings. In the second study, we decomposed the voxel-wise brain 
activation contrast of looking at previously seen vs. new pictures into 12 brain 
networks, based of which we evaluated recognition memory performance using 
prediction analysis. We used stable and reproducible data-driven decomposition and 
we trained and tested our prediction model in different samples, insuring higher 
generalizability of our findings. These two studies offer additional insight into the 
biological underpinnings of complex behavioral traits. Importantly, the applied 
analyses were carefully tailored to the specific research questions and integrated into 
robust pipelines for replication and validation of the initial results. 
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1 Introduction 
Over the last few decades, there has been substantial progress in the 
investigation of the biological underpinnings of complex human behavior. The rapid 
technological and methodological advances in genetics, molecular biology and brain 
imaging throughout the years have greatly contributed to this endeavor. Innovations 
in high-throughput genotyping have provided the possibility for rapidly generating high-
density datasets of genetic variability throughout the genome (“genomics”) (Brown & 
Botstein, 1999; Bumgarner, 2013; Goodwin et al., 2016; Metzker, 2010). Additional 
high-throughput technologies have been developed, capable of generating extensive 
datasets of distinct molecular information, e.g., deoxyribonucleic acid (DNA) 
methylation or gene expression, on a global scale (“-omics”) (Hasin et al., 2017). 
Furthermore, the development of non-invasive magnetic resonance imaging (MRI) 
technology has enabled the production of large datasets of estimates of brain anatomy 
and neural function with high spatial resolution (Belliveau et al., 1991; Lerch et al., 
2017). These technological advances have been followed by the creation of an 
abundance of analytical software for the utilization of large (gen)omics and brain 
imaging data. Furthermore, there has been an increasing initiative for data and 
technology sharing in these fields, making diverse datasets, as well as state-of-the-art 
analytical tools quickly accessible to the scientific community (Bycroft et al., 2018; 
Craig et al., 2011; Kannan et al., 2016; Nichols et al., 2017; Sullivan, 2010; Thompson 
et al., 2014; Van Essen et al., 2013).  
These developments have enabled the current widespread application of 
extensive brain-wide and genome-wide analyses in search of potential biological 
substrates of complex behavioral traits, such as psychological processes and 
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neuropsychiatric disorders. For example, there are over 20,000 experiments including 
brain-wide analysis of brain function or structure only in the BrainMap database - 
http://brainmap.org/ (Laird et al., 2005; Vanasse et al., 2018) and over 500 publications 
with genome-wide search for genetic background of psychology-related traits only in 
the GWAS Catalog - https://www.ebi.ac.uk/gwas/ (Horwitz et al., 2019). While 
hypothesis-driven studies targeting specific genes or brain regions of interest can 
certainly extend our understanding of the biological underpinnings of complex 
behavior, extensive genome-wide and brain-wide approaches have proven essential 
for many novel discoveries (Horwitz et al., 2019; Papassotiropoulos & de Quervain, 
2011; Poldrack & Farah, 2015).  
However, specific methodological and statistical issues appear due to the large 
scale, complexity and the explorative nature of such extensive approaches, many of 
which are common to both brain imaging and genomics (Lazar, 2016). In this thesis, I 
will present two studies applying extensive analyses of potential genetic and brain 
imaging substrates of complex behavior, respectively, and address some of those 
issues. First, I will provide a brief description of some of the different levels of analyzing 
brain-wide and genome-wide datasets, ranging from single units to pathways and 
networks. Next, I will introduce two distinct types of analysis, i.e., inference and 
prediction, as well as their purpose in the context of neuroscientific research. Finally, 
I will discuss some potential ways in which the initial analyses can be integrated into 
robust analytical pipelines, in order to insure more meaningful, high-confidence 
results. The two studies that will serve as examples are listed below.  
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• Study 1: Petrovska, J., Coynel, D., Fastenrath, M., Milnik, A., Auschra,
B., Egli, T., Gschwind, L., Hartmann, F., Loos, E., Sifalakis, K., Vogler,
C., de Quervain, D. J.-F., Papassotiropoulos, A. & Heck, A. (2017). The
NCAM1 gene set is linked to depressive symptoms and their brain
structural correlates in healthy individuals. Journal of Psychiatric
Research, 91, 116-123.
• Study 2: Petrovska, J., Loos, E., Coynel, D., Egli, T., Papassotiropoulos,
A., de Quervain, D. J.-F. & M., Milnik, A. Recognition memory
performance can be estimated based on few specific brain networks.
In Study 1, we conducted a genome-wide search for groups of genes, i.e., gene 
sets, associated with depressive symptoms in a large sample of healthy young adults 
(N = 2’099). While several gene sets were significantly associated with depressive 
symptoms in this sample, we robustly identified the NCAM1 Interactions gene set as 
relevant for our trait of interest due to its association with depressive symptoms and 
their structural brain correlates in an additional independent sample (N = 1’523 and N 
= 658, respectively). I contributed to designing the experiment, analyzing the data and 
writing the paper for this study.  
In Study 2, we used whole-brain functional MRI (fMRI) data from 1’410 healthy 
young adults that performed a picture-recognition task. We robustly estimated the task 
performance based on the fMRI-derived brain activation. First, we decomposed the 
brain activation contrast of previously seen vs. new pictures from 56’764 voxels, i.e. 
three-dimensional pixels, into 12 robust and replicable brain networks by performing 
data-driven dimensionality reduction in two independent samples of participants (N = 
645, N = 665). Next, we estimated recognition memory performance based on the 12 
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networks in a third independent sample (N = 100). I contributed to designing the 
experiment, analyzing the data and writing the paper for this study.  
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2 Complex behavioral traits 
Common neuropsychiatric disorders and the psychological processes associated with 
them are complex behavioral traits influenced by a combination of interacting genetic 
and environmental factors. As such, they have notable heritability and diverse 
(neuro)biological and behavioral correlates (Assary et al., 2018; Murray et al., 2017; 
Otte et al., 2016; Papassotiropoulos & de Quervain, 2011). In the next paragraphs I 
will briefly introduce two such complex traits, depressive symptoms and recognition 
memory, as their biological underpinnings were the object of investigation in Study 1 
and Study 2 of this PhD thesis, respectively.  
2.1 Depressive symptoms 
Major depressive disorder (MDD) is a highly debilitating psychiatric disorder, with a 
lifetime prevalence of about 20%. It is characterized by experiencing a minimum of 
one depressive episode with a duration of at least two weeks, including notable 
changes in mood, interests, pleasure and cognition, as well as vegetative symptoms 
(Otte et al., 2016). Depressive symptoms are continuously distributed throughout the 
general population and symptoms below the diagnostic threshold for depression are 
related to the same risk factors as full-blown depressive episodes (Ayuso-Mateos et 
al., 2010). Therefore, utilizing the continuous spectrum of depressive symptomatology 
may provide additional insights into the complex underpinnings of depression. 
Depressive symptoms can be measured by standardized psychological instruments, 
such as the Montgomery Asberg Depression Rating Scale (MADRS) (Montgomery & 
Asberg, 1979) or the Beck Depression Inventory (Beck et al., 1996). In Study 1, we 
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obtained MADRS scores of young healthy individuals and used them to investigate 
the genetic basis and the neural correlates of depressive symptoms.  
2.2 Recognition memory 
Recognition memory is a complex psychological process entailing the identification of 
an event and the judgement of its previous occurrence, which has a vital role in our 
daily life (Mandler, 1980). The nature and the neural features of recognition memory 
have been the object of extensive scientific research and debate (Squire et al., 2007; 
Yonelinas, 2002). However, studies on the neural underpinnings of recognition 
memory typically investigate the general neural mechanism associated with 
recognition memory processes (Carlesimo et al., 2015; Frithsen & Miller, 2014; Horn 
et al., 2016; Kim, 2010; Scalici et al., 2017; Skinner & Fernandes, 2007; Spaniol et al., 
2009; Vilberg & Rugg, 2008; Yonelinas et al., 2005). More research is needed on 
neural systems underlying interindividual differences in recognition memory 
performance in healthy individuals (though please see de Chastelaine, Mattson, 
Wang, Donley, & Rugg, 2016). In Study 2 of this PhD thesis, recognition memory 
performance was assessed by subjecting our participants to an image-based memory 
test while recording their brain activation in the MRI scanner, in order to estimate 
interindividual differences in memory performance based on the fMRI signal.       
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3 Extensive analyses of the biological underpinnings of 
complex human behavior 
In the next paragraphs, I will outline some important analytical considerations when 
investigating the neural and genetic underpinnings of complex behavioral traits in an 
extensive manner. Notably, both brain imaging and genetic data can be analyzed on 
multiple levels, ranging from single units to pathways, networks and overall 
measurements. Furthermore, one faces some similar analytical challenges when 
working with these two modalities (Lazar, 2016). First, I will review some of the levels 
of analysis of genomics and brain-wide imaging data, respectively. Second, I will 
discuss the types of analysis that can be applied to each modality.  
3.1 Level of analysis: From single units to pathways and networks 
3.1.1 Genome-wide approaches 
The most widely used contemporary approach for investigating the genetic 
underpinnings of complex traits is conducting a genome-wide association study 
(GWAS). The majority of GWASes conducted to date rely on DNA microarray chip 
technology to rapidly produce data for a large number of predetermined single 
nucleotide polymorphisms (SNPs), i.e., interindividual differences in a single base pair 
of the DNA sequence, throughout the genome (Bumgarner, 2013; Chee et al., 1996). 
Microarray technologies profit from the naturally existing correlational structure 
between DNA variants, termed linkage disequilibrium (LD) (Gibbs et al., 2003). 
Namely, SNPs tagged by the microarray are usually in high LD with additional variants, 
thus capturing information beyond a single base pair. However, array-based 
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technologies are typically limited to tagging common variants, found in over 1% of the 
general population (Visscher et al., 2017). More recently developed whole exome and 
whole genome sequencing technologies can produce extensive exome-wide and 
genome-wide data for both common and rare genetic variants (Kiezun et al., 2012; 
Sanders et al., 2017). Nevertheless, due to the longer use and lower financial cost of 
microarrays compared to sequencing technologies, array-based datasets still remain 
more prevalent. 
An array-based GWAS usually tests the association between a heritable trait 
and each of around one million SNPs throughout the genome (Corvin et al., 2010). 
Furthermore, by applying genotype imputation, i.e., a method of inferring genotypes 
at untagged locations based on LD patterns, the number of tested variants can be 
greatly increased (Das et al., 2016; Marchini et al., 2007). Thus, GWAS is a large-
scale method for investigating the genetic underpinnings of a given trait. This approach 
has proven successful for identification of common SNPs associated with many 
complex traits and diseases, such as type 2 diabetes, height, body mass index, 
memory performance, neuroticism, schizophrenia and MDD (Fuchsberger et al., 2016; 
Lam et al., 2019; Li et al., 2017; Locke et al., 2015; Luciano et al., 2018; Nagel et al., 
2018;  Papassotiropoulos et al., 2011; Papassotiropoulos et al., 2006; Pardinas et al., 
2018; Ripke et al., 2014; Wood et al., 2014; Wray et al., 2018). However, most of the 
identified genetic variants have small effect sizes. This notion can be problematic for 
GWASes considering that their results need to surpass stringent statistical correction 
for false-positive findings due to the large number of association tests conducted 
(Pe’er et al., 2008; Price et al., 2015). Therefore, a very large number of participants 
is typically needed in order to gain sufficient statistical power for GWAS-based 
detection of common variants associated with complex traits (Sullivan et al., 2018). 
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Furthermore, GWAS findings do not offer any information regarding the biological 
mechanisms underlying the identified genetic associations (Visscher et al., 2017). 
Methods for secondary analysis of GWAS summary statistics, such as gene-
level and gene-set analysis (GSA), can increase the statistical power for investigating 
the genetic underpinnings of complex traits and disorders and place association 
findings in a wider biological context (Wojcik et al., 2015). Gene-level analyses 
combine GWAS statistics (or raw genetic variance) per gene, and associate each gene 
with a given trait (e.g. de Leeuw et al., 2015). GSA aggregates single variants to genes 
and genes to groups of genes (also known as gene sets or pathways) based on prior 
knowledge regarding their biological or functional properties and investigates the 
association of each gene set with a trait of interest (de Leeuw et al., 2016; Wang et 
al., 2010). This method has been successfully utilized to identify genetic underpinnings 
of complex behavioral traits and disorders, such as working memory, episodic 
memory, schizophrenia and bipolar disorder (Heck et al., 2014, 2015; Lips et al., 2012; 
Nurnberger et al., 2014). GSA was also used in Study 1 contributing to this PhD thesis, 
in which we aggregated GWAS summary statistics to 1’411 gene sets in search of 
genetic basis of depression scores in healthy young adults (Petrovska et al., 2017).  
3.1.2 Brain-wide approaches 
Within the last few decades, the neural underpinnings of complex human behavior 
have been predominantly investigated using MRI. MRI technology utilizes the 
magnetic properties of the nuclei of hydrogen atoms in order to create images of soft 
tissues in the human body, including the brain (Plewes & Kucharczyk, 2012). A typical 
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MRI scanner produces three-dimensional images with a rather high spatial resolution, 
e.g., 1 mm3 or better for T1-weighted anatomical images (Lusebrink et al., 2017).
Contemporary MRI technology provides diverse possibilities for non-invasive 
large-scale investigation of the human brain. MRI techniques based on the distinct 
structural properties of grey matter (GM) are used for estimation of cortical thickness, 
surface area and volume (Lerch et al., 2017). Importantly, MRI is also used for 
investigating brain function. fMRI technology typically relies on a measure of the 
magnetization difference between oxygenated and deoxygenated hemoglobin in the 
brain, termed blood oxygenation level-dependent (BOLD) signal. The BOLD signal is 
considered to reflect changes in the levels of oxygen consumption within a brain region 
and is used as an estimate of brain activation (Gauthier & Fan, 2019). Since its 
development nearly three decades ago, fMRI has become one of the most prevalent 
brain imaging techniques in neuroscientific research (Roalf & Gur, 2017; Rosen & 
Savoy, 2012). Another widely-used MRI technique is diffusion tensor imaging (DTI). 
DTI relies on the specific nature of the dispersion of water molecules in white matter 
(WM) throughout the brain, in order to make inferences regarding the structural 
properties of WM tracts connecting brain regions (Basser, 1995; Beaulieu, 2002).  
Initially, the majority of quantitative MRI studies investigating the neural 
underpinnings of complex human behavior have estimated to which extent individual 
brain regions are implicated in a specific function or trait (Chen & Glover, 2015). 
However, it has been well-established that interacting brain areas, rather than single 
regions, are enabling cognitive processes and complex behavior (Bressler & Menon, 
2010; Fuster, 2000; Misic & Sporns, 2016). Therefore, additional analytical strategies, 
complementary to the regional approach, have been developed in order to investigate 
the structural connectivity and functional interactions between brain regions. Structural 
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connectivity has been predominantly estimated by DTI analysis. DTI measurements, 
such as fractional anisotropy (FA) and mean diffusivity, have been linked to cognition 
and neuropsychiatric disorders like schizophrenia and MDD (Coynel et al., 2017; Jiang 
et al., 2017; Kelly et al., 2018; Takeuchi et al., 2011). Furthermore, functional 
interactions between brain regions, assessed by connectivity analyses of fMRI data 
(reviewed in Friston, 2011; Reid et al., 2019), have been implicated in cognitive 
processes such as memory, learning, attention, cognitive control, reward processing 
and language (Legon et al., 2016; McIntosh et al., 1999; Salimpoor et al., 2013; 
Spielberg et al., 2015; Stephan et al., 2003; Vossel et al., 2016; Xu et al., 2015). For 
example, an increased connectivity from the amygdala to the hippocampus has been 
found during the encoding of emotional pictures in healthy young adults (Fastenrath 
et al., 2014). Not only individual connections, but large-scale networks including 
connectivity between multiple brain regions are recruited by complex behavioral tasks, 
as well as during rest (Damoiseaux et al., 2006; Fox et al., 2005; Smith et al., 2009). 
Network-level brain activation has also been related to cognitive outcomes, such as 
working memory performance, emotional memory and speed of recollection (Egli et 
al., 2018; Fornito et al., 2012; Loos et al., 2019).  
 In Studies 1 and 2 we investigated structural properties of brain tracts and 
network-level brain activation, respectively, as potential neural underpinnings of 
complex behavioral traits. In Study 1, we identified brain tracts related to depressive 
symptoms using DTI analysis. Specifically, we obtained brain-wide FA values, 
reflecting WM properties (e.g. fiber density), as well as coherence within a voxel 
(Beaulieu, 2002), and associated them with our behavioral trait. Depressive symptoms 
were associated with decreased FA within the forceps minor and the left superior 
temporal longitudinal fasciculus. In Study 2, we decomposed the fMRI contrast of 
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looking at previously seen vs. novel pictures into 12 independent components, 
potentially representing distinct functional brain networks, based on which we 
estimated memory performance. 
3.2 Type of analysis: Inference and prediction 
Traditionally, neuroscientific research has relied on inferential statistical approaches, 
such as null hypothesis significance testing, for data analysis. More recently, predictive 
approaches have been adopted as a popular alternative (Bzdok & Ioannidis, 2019; 
Gabrieli et al., 2015; Woo et al., 2017; Yahata et al., 2017). While contemporary 
prediction analyses can rely on highly complex pattern-learning algorithms, it is 
actually the purpose of the analysis, rather than the applied tool, that makes the key 
distinction between prediction and inference. For example, ordinary linear regression 
can be used for both prediction and inference. Therefore, the decision whether to apply 
inference or prediction should depend on the specific research question and the 
motivation for its investigation (Bzdok & Ioannidis, 2019). Inference can provide 
insight into the importance, and somewhat the nature, of the contribution of given 
variable(s) to a certain outcome. Inferential statistics are suitable for identifying 
genetic variants, genes, gene sets, brain regions or networks related to a given 
(behavioral) trait (e.g. Egli et al., 2018; Heck et al., 2014, 2015;  Papassotiropoulos et 
al., 2006). Prediction approaches evaluate how well can a model built based on the 
relation between given variables and an outcome of interest reproduce that outcome. 
Predictive models have already been successfully used for the estimation of complex 
brain-related behavioral traits, such as emotional arousal, emotional memory 
performance and alcohol misuse (Loos et al., 2019; Whelan et al., 2014). On the one 
hand prediction allows higher 
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generalizability of the results compared to inferential approaches, but on the other 
hand it is typically used in a “black box” manner without explanatory power or insight 
into the contribution of individual predictors (but also see Yarkoni & Westfall, 2017). 
Therefore, inferential and prediction approaches have distinct and complementary 
roles in neuroscientific research. In Study 1 of this PhD thesis, we used an inferential 
approach in order to identify gene sets and brain tracts associated with depressive 
symptoms, while in Study 2 we applied prediction analysis for the estimation of 
memory performance based on brain activity. Of note, in Study 2 we used a linear 
model, rather than a more complex predictive algorithm, in order to maximize the 
transparency and generalizability of our results (Bzdok & Ioannidis, 2019).  
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4 From initial results to robust findings 
4.1 Results replication 
Replication of the initial results in an independent sample is widely accepted as the 
gold standard for confirming the validity of novel discoveries in scientific research and 
(lack of) replicability is a major concern across scientific disciplines, including 
neuroscience and genetics (Boekel et al., 2015; Ioannidis, 2005; Jasny et al., 2011; 
Marigorta et al., 2018; Plomin et al., 2016; Poldrack et al., 2017; Schmidt, 2009). When 
possible, independent replication should be conducted as part of the initial analytical 
pipeline, in order to insure higher robustness of the results before they are shared with 
the scientific community. However, independent replication is not always feasible, 
particularly when working with large and complex datasets that require a lot time, 
financial recourses and scientific expertise to be generated, such as large-scale 
genomics or brain imaging data. When this is the case, one alternative strategy would 
be to use cross-validation in order to investigate the reproducibility of the results when 
limited to a single sample. Cross-validation techniques insure training and testing our 
model on different data within the sample (Yarkoni & Westfall, 2017).   
In Study 1, the identified link between certain gene sets and depressive 
symptoms in a large sample of healthy young adults (N = 2’099) was replicated in an 
independent sample (N = 1’523). In Study 2, we used fMRI and behavioral data of a 
single sample of 1’410 healthy young adults. Although we technically lacked an 
independent replication sample in this study, due to the large sample size we were 
able to split the initial sample into three different samples of 645, 665 and 100 
participants, respectively, while maintaining adequate statistical power for our 
analyses. We trained our prediction model on the first sample and tested it on the 
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second and third sample, respectively, insuring higher generalizability of our findings. 
For achieving the highest independency between our three samples, we created them 
by chronologically ordering the participants of the overall sample by date of study 
participation and then performing the sample split.  
4.2 Study-specific considerations 
While the need for replication of the results is a general requirement for increasing the 
validity of scientific research, many aspects of the robustness of findings are tightly 
related to the particular specificities of the study in question, such as the study aim 
and design, the nature and size of the datasets, the specific tools used for data 
analysis and the number of conducted tests. Therefore, below I will discuss some 
specific considerations regarding the robustness of findings in Study 1 and Study 2, 
respectively.  
4.2.1 Statistical significance and multiple testing correction  
In Study 1, we estimated the statistical significance of the association between 
depressive symptoms and a large number of predefined gene sets (N = 1’411) based 
on an enrichment p-value provided for each gene set. The enrichment p-value was 
calculated based on the observed number of genes associated with the phenotype, 
i.e., depressive symptoms, (above a given enrichment threshold) within the gene set,
compared to the number of phenotype-associated genes expected by chance for a 
gene set of that size (Segre et al., 2010). However, because we repeated the 
enrichment test for each of the 1’411 gene sets, it was necessary to make a statistical 
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adjustment in order avoid “false-positive” results due to multiple testing (Goeman & 
Solari, 2014).  
The classical type of adjustment for multiple testing based on the probability of 
at least one false discovery, i.e., family-wise error rate (FWER), can be overly 
conservative, greatly reducing the power to detect true findings, particularly in the 
context of very large number of tests (Chen et al., 2010). Having over 1’400 tests in 
our discovery sample, we opted for the more lenient false discovery rate (FDR) type 
of multiple testing correction, based on the expected proportion of falsely rejected 
discoveries. Since in the replication sample we ran the analysis for only a few gene 
sets identified as significantly associated with depressive symptoms in the discovery 
sample, here we applied the more stringent FWER correction.  
In order to identify gene sets implicated in depressive symptomatology, we 
have chosen the commonly applied statistical significance level of 0.05 (after multiple-
testing adjustment). While having practical value, such thresholds for the assessment 
of statistical significance are arbitrary and should be taken with critical consideration 
(Amrhein & Greenland, 2018; Benjamin et al., 2018).  
4.2.2 Imaging genetics 
Findings from genetics and (gen)omics studies of complex behavioral traits can be 
further validated and extended by the addition of brain-level information (Bogdan et 
al., 2017; Papassotiropoulos & de Quervain, 2011). The research field of brain imaging 
genetics combines information regarding (epi)genetic variation and brain structure, 
function, connectivity or chemistry in order to contribute to the understanding of the 
impact of genetic and molecular differences on behavioral traits on neural level 
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(Bogdan et al., 2017). While the pioneering brain imaging genetics research conducted 
over two decades ago consisted of candidate gene studies of receptor ligand binding 
measured using positron emission tomography (Laruelle et al., 1998; Pohjalainen et 
al., 1998), today this research field includes studies using a variety of sophisticated 
(f)MRI and (epi)genetic measurements (Bogdan et al., 2017). For example, imaging 
genetics findings from our own research lab include specific memory-related genetic 
variation on single variant and pathway level, as well as epigenetic differences, 
associated with brain activation (de Quervain et al., 2012; Heck et al., 2014, 2015, 
2017; Papassotiropoulos et al., 2013; Vukojevic et al., 2014), a genetic variant related 
to emotional arousal and white matter properties of the brain (Spalek et al., 2016) and 
an epigenetic signature associated with memory and neocortical thickness (Freytag et 
al., 2017).  
In study 1 of this PhD thesis, after identifying two gene sets associated with 
depressive symptoms in two independent samples, we added a level of DTI data and 
were able to a) link depressive symptoms to white matter properties of two different 
brain tracts and b) associate those tracts with one of the depressive symptoms-related 
gene sets.  
4.2.3 Stable and reproducible data-driven dimensionality reduction 
As stated before, the aim of Study 2 was to estimate recognition memory performance 
based on the fMRI contrast of seeing old vs. new images while conducting the memory 
task. We have obtained brain-wide fMRI contrast parameters for over 56’000 voxels 
per participant. The large number of parameters can be problematic for our memory 
estimation due to a phenomenon known as overfitting. Overfitting occurs when the 
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model estimation is too closely tailored to the specific dataset and therefore may poorly 
generalize to new data (Yarkoni & Westfall, 2017).  
To overcome this issue, one can reduce the voxel-level dataset to a smaller 
number of variables. Diverse theory-driven and data-driven approaches can be used 
for this purpose. While theory-driven approaches use models based on previous 
knowledge and/or specific hypotheses concerning the underlying mechanisms of the 
process in question, data-driven approaches are generally agnostic of such 
mechanisms (Huys et al., 2016). Therefore, by using a data-driven approach potential 
biases of prior findings can be avoided. 
One data-driven method for dimensionality reduction, i.e., reduction of the 
number of variables, of a given dataset is independent component analysis (ICA). ICA 
produces a linear representation of non-Gaussian data, by decomposing them into 
components that are as statistically independent as possible, termed independent 
components (ICs) (Hyvarinen & Oja, 2000). ICA can be used to decompose a high-
dimensional voxel-level dataset of brain structure or activation into a relatively small 
number of ICs, which may also be considered as potential independent brain networks 
(Smith et al., 2009; Vanasse et al., 2018).  
The optimal number of ICs resulting from the ICA is a key user-defined 
parameter of this method and certain analytical steps can be taken for its estimation, 
such as assessing the components’ stability and reproducibility (Franco et al., 2013; 
Kairov et al., 2017). Stability, i.e., robustness of the analysis within the initial sample, 
can be assessed by re-running the ICA multiple times in random subsets of the initial 
sample, i.e., resampling, and comparing the results across subsets. The ICA stability 
for a specific number of ICs increases with the similarity of those ICs across subsets. 
The components’ reproducibility refers to the extent to which the dimensionality 
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reduction with the same number of ICs can be replicated in an independent sample 
(Franco et al., 2013).  
In Study 2, we assessed the components’ stability by comparing the ICA results 
across 100 different subsets of the initial, i.e., training sample, each of which contained 
90% of the participants from the overall sample. We repeated this assessment for ICAs 
with different number of components (3-32). We then repeated the five ICAs with best 
stability in another sample of similar size, i.e., replication sample, in order to test their 
reproducibility. The most reproducible ICA was chosen for downstream analysis. By 
carefully choosing the number of ICs for ICA decomposition of our dataset based on 
their stability and reproducibility metrics, we ensured their robustness for estimation of 
behavior.  
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Depressive symptoms exist on a continuum, the far end of which is found in depressive disorders.
Utilizing the continuous spectrum of depressive symptoms may therefore contribute to the under-
standing of the biological underpinnings of depression. Gene set enrichment analysis (GSEA) is an
important tool for the identification of gene groups linked to complex traits, and was applied in the
present study on genome-wide association study (GWAS) data of depression scores and their brain-level
structural correlates in healthy young individuals. On symptom level (i.e. depression scores), robust
enrichment was identified for two gene sets: NCAM1 Interactions and Collagen Formation. Depression
scores were also associated with decreased fractional anisotropy (FA) e a brain white matter property e
within the forceps minor and the left superior temporal longitudinal fasciculus. Within each of these
tracts, mean FA value of depression score-associated voxels was used as a phenotype in a subsequent
GSEA. The NCAM1 Interactions gene set was significantly enriched in these tracts. By linking the NCAM1
Interactions gene set to depression scores and their structural brain correlates in healthy participants, the
current study contributes to the understanding of the molecular underpinnings of depressive
symptomatology.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Depressive symptoms are continuously distributed in the gen-
eral population, as supported by taxometric studies of large com-
munity samples (Hankin et al., 2005; Slade and Andrews, 2005).
Depressive disorders are considered to represent the far end of this
continuum (Ayuso-Mateos et al., 2010; Kendler and Gardner, 1998;
Slade, 2007), and subthreshold depressive symptoms have been
associated with the same risk factors as diagnosable depressivement of Psychology, Division
5 Basel, Switzerland.
vska).episodes worldwide (Ayuso-Mateos et al., 2010). Moreover, higher
depressive symptoms have been associated with higher levels of
psychosocial dysfunction and increased risk for Major Depressive
Disorder (MDD) and substance use disorder in the general adult
population (Lewinsohn et al., 2000).
Furthermore, whilemultiple brain-level structural changes have
been implicated in MDD (LeWinn et al., 2014; Ota et al., 2015; Wu
et al., 2011; Zuo et al., 2012), microstructural changes within
various neuroanatomical tracts have also been associated with
subthreshold depressive symptoms (Hayakawa et al., 2013;
McIntosh et al., 2013; Sprengelmeyer et al., 2014). Therefore, uti-
lizing the continuous spectrum of depressive symptoms may
contribute to the understanding of the biological underpinnings of
depression.
Table 1
Sample descriptives.
Sample N N Females (%) Age range (years) Age mean
Basel_1 2099 1378 (65.6) 18e35 22.47
Basel_2 1523 939 (61.6) 18e35 22.37
Basel_2: DTI 658 393 (59.73) 18e35 22.36
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healthy adults, with heritability estimates of 30e37% (Kendler et al.,
1994; Sham et al., 2000), which approximately equals heritability
estimates for MDD of 31e42% (Sullivan et al., 2000), rendering
them a suitable phenotype for genetic studies.
Gene set enrichment analysis (GSEA) can be used to improve the
detection and the explanatory power of the genetic basis of heri-
table traits (Wang et al., 2010). Importantly, GSEA is particularly
suitable for the study of complex traits, which are characterized by
small genetic effects of multiple genetic variants that contribute to
the trait in question (Lohmueller et al., 2003), as demonstrated by
previous studies (Heck et al., 2014, 2015; Lips et al., 2012;
Nurnberger et al., 2014). Specifically, it tests whether multiple
genes with modest associations with a given complex trait are
enriched in specific biological processes. The objective of the cur-
rent study was to dissect the biological basis of depression scores,
measured as a continuous, quantitative phenotype in healthy par-
ticipants, by applying GSEA to genome-wide association study
(GWAS) data. Notably, the NETRIN1 signaling pathwaywas recently
associated with MDD using a similar approach (Zeng et al., 2017).
Furthermore, the Synaptic transmission pathway was associated
with MDD and several immune-inflammatory pathways with
depressive symptoms, respectively, using genome-wide expression
data (Elovainio et al., 2015; Hori et al., 2016). Therefore, it was
hypothesized that depression scores are related to particular gene
sets in the current study. Replication was performed in an inde-
pendent study, having the identical phenotype. Additionally,
diffusion tensor imaging (DTI) data in individuals of the replication
study were available. Decreases of fractional anisotropy (FA) have
been previously reported in both MDD (LeWinn et al., 2014; Ota
et al., 2015; Wu et al., 2011; Zuo et al., 2012) and subthreshold
depressive symptoms (McIntosh et al., 2013; Sprengelmeyer et al.,
2014). FA is a measure of the directional dependence of diffusion
(Basser, 1995) and reflects white matter tracts properties such as
fiber density, as well as coherence within a voxel (Beaulieu, 2002).
To test the hypothesis of a link between depression scores and FA
values in our sample of healthy young adults, we first identified
brain structural correlates of the depression scores by correlating
them with brain-wide FA measurements. To furthermore check if
depressive symptoms and brain structural correlates of the
depression scores share some genetic background, we ran a GSEA
for each of the identified brain tracts, by extracting the mean FA
values for depression score-associated voxels from the DTI analysis
and using these as a phenotype in a subsequent GSEA.
2. Materials and methods
2.1. Studies
Discovery study (Basel_1): This study was conductedwith 2099
cognitively healthy young adults from the general population,
recruited in Basel, Switzerland, as part of an ongoing behavioral
genetics study (data lock May 2015). Sample characteristics are
presented in Table 1. Participants were free of medication and of
any neurological and psychiatric conditions at the time of the study
as assessed by standard questionnaires. All participants provided
written informed consent prior to participation in the study. Data of
the Montgomery Asberg Depression Rating Scale (MADRS)
(Montgomery and Asberg, 1979), consisting of ten items rated on a
scale from 1 to 6, were available for N ¼ 1651 participants. The
ratings were summed up to a single depression score (0e60) per
participant, ranging from 0 to 46 in this sample, with a mean value
(±SD) of 8.48 (±6.32). For comparison, mean MADRS score (±SD) of
23.4 (±13.2) has been reported for MDD patients (Muller et al.,
2003). Score distributions for our participants are reported inSupplementary Fig. 1. The internal consistency was high (Cron-
bach’s alpha ¼ 0.83), and correlation between the self-reported
MADRS and Beck Depression Inventory (Beck et al., 1996) was
r ¼ 0.62, and thus in line with prior reports comparing both in-
struments in both clinical and healthy samples (Carter et al., 2010;
Kjaergaard et al., 2014; Wikberg et al., 2015).
Replication study (Basel_2): This study was conducted with
1523 cognitively healthy young adults from the general population,
recruited in Basel, Switzerland, as part of an ongoing imaging ge-
netics study (data lock May 2015). Sample characteristics are pre-
sented in Table 1. Participants were free of medication and of any
neurological and psychiatric conditions at the time of the study as
assessed by standard questionnaires. All participants provided
written informed consent prior to participation in the study. 1135
participants completed the MADRS in this sample. MADRS scores
ranged from 0 to 33 in this sample with a mean value (±SD) of 7.29
(±5.40). Score distributions are reported in Supplementary Fig. 2.
Furthermore, a magnetic resonance imaging (MRI) scanning ses-
sion was conducted including a picture recognition task, followed
by an anatomical imaging sequence and a DTI sequence, conducted
for 658 of the participants. Sample characteristics and MADRS
scores distribution for the DTI subsample are provided in Table 1
and Supplementary Fig. 3, respectively. Additional information
regarding the scanning procedure is provided in the Supplemen-
tary Materials.
We used sex and age-corrected depression scores for all ana-
lyses by regressing out the effects of sex and age in both studies.
The ethics committee of the Canton of Basel approved both
protocols.2.2. Array-based SNP genotyping
Array-based SNP genotyping was performed as described in the
Genome-Wide Human SNP Nsp/Sty 6.0 User Guide (Affymetrix).
Briefly, genomic DNA was digested with Nsp I and Sty I restriction
enzymes and ligated to an enzyme-specific adaptor. Adaptor-
ligated DNA fragments were subjected to polymerase chain re-
actions (PCR). PCR amplification products were combined and pu-
rified using Agencourt Magnetic Beads. The amplified DNA was
fragmented, labeled and hybridized onto a Genome - Wide Human
SNP 6.0 Array. The hybridized array was washed, stained and
scanned. Generation of SNP calls and array quality control (QC) was
performed. Contrast QC was chosen as the QC metric, using a
default value  0.4. All samples passing the QC criteria were gen-
otyped using the Birdseed (v2) algorithm. Mean Call Rate averaged
>98.5%. Additional information is provided in the Supplementary
Materials.2.3. Brain imaging
2.3.1. Scanning procedure
Scanning was performed on a Siemens Magnetom Verio 3 T
whole body MR unit equipped with a twelve-channel head coil. For
a detailed description of the scanning procedure please refer to the
Supplementary Materials.
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After visual inspection, 38 participants were excluded due to
corrupted T1-weighted images (movement or anatomical abnor-
malities). Furthermore, two participants were excluded due to
excessive movement during the DTI acquisition. Complete datasets
(behavior and imaging) were available for N ¼ 658 participants.
Diffusion-weighted images were analyzed using FSL (4.1.7). Images
were co-registered to the reference unweighted volume (b ¼ 0)
using an affine transformation for correction of head motion and
eddy currenteinduced image distortion.
2.3.3. DTI: FA statistical analysis
Voxel-wise statistical analysis of FA data was conducted using
Tract-Based Spatial Statistics (TBSS 1.2) (Smith et al., 2006), part of
the FMRIB Software Library (FSL) (Smith et al., 2004). Briefly, in-
dividual FA datawere non-linearly warped to the standard space FA
template (FMRIB58_FA) and projected onto the populationmean FA
skeleton. These data were used as input for voxel-wise between-
subject statistics. GLM analyses, as implemented in the randomize
tool (Winkler et al., 2014), were applied in search of negative voxel-
wise FA associations with depression scores. Statistical significance
was assessed through 5000 permutations and results were
considered significant for p < 0.05, corrected for multiple com-
parisons across space using the 'two-dimensional' parameter set-
tings with threshold-free cluster enhancement (Smith and Nichols,
2009), which avoids using an arbitrary threshold for the initial
cluster-formation.
2.4. Statistical genetics analysis
2.4.1. GWAS
For the input for the GSEA (i.e., association statistics on a
genome-wide level), a standard GWAS was performed on auto-
somal SNPs using the “–assoc” command with asymptotic (Wald
test) significance values, as implemented in the PLINK software
package (Purcell et al., 2007). SNPs with a genotype call-rate < 95%,
minor allele frequency (MAF) < 1%, or a significant deviation from
Hardy-Weinberg Equilibrium (HWE) (p < 0.0001) were excluded
from the analysis.
2.4.2. Genetic heterogeneity
The genomic control inflation factor indicated no notable
admixture in the discovery sample (l ¼ 1.0017) and the replication
sample (l ¼ 1.0000), respectively. Q-Q plots are presented in
Supplementary Figs. 4 and 5, for the discovery and the replication
sample, respectively.
2.4.3. GSEA
GWAS-derived association statistics were entered in a GSEA.
More in detail, SNPs were mapped onto genes and genes were
assigned to gene sets. Information regarding pre-defined gene sets
was obtained from the following databases: Gene Ontology (GO)
(http://geneontology.org/), Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) (http://www.genome.jp/kegg/), BioCarta (http://
www.biocarta.com/) and Reactome (http://www.reactome.org/).
GSEA was conducted using the MAGENTA software package (Segre
et al., 2010). Gene boundaries were set to ±0 kb, thus capturing only
SNPs within transcripts, in order to avoid known potential biases
introduced by overlapping genes (Sedeno-Cortes and Pavlidis,
2014). Consequently, high-effect SNPs in regulatory regions may
be missed. Gene set size was limited to 20 to 200 genes. 1411 gene
sets met this criterion and an enrichment p-value was provided for
each of them. The enrichment p-value is estimated based on the
difference between the observed number of phenotype-associated
genes above a given enrichment cutoff within the gene set and thenumber of phenotype-associated genes that is expected by chance
for a gene set of the same size. In order to correct for multiple
testing within a gene set, false discovery rate (FDR) correction with
a 75th percentile cutoff was used, which is considered the optimal
cutoff for GSEA of complex traits with multiple weak effects (Segre
et al., 2010). The FDR cutoff was computed jointly for all gene-set
databases.
2.5. Workflow
2.5.1. GSEA for depression scores
Gene sets with q75% < 0.05 were identified for depression scores
in the discovery sample. Significantly enriched gene sets in this
sample were checked for association with depression scores in the
replication sample. In case of significant enrichment, defined as
p < 0.05/N(GENE SETS) in the replication sample, the gene set was
considered to be within-phenotype replicated.
2.5.2. From tract-based statistics to GSEA
As a next step, DTI analysis was conducted to investigate the
neural correlates of depression scores, by applying a GLM in search
of voxel-wise FA associations. Age and sex were used as covariates
in the analysis. Voxel-wise FA-depression associations derived from
the DTI statistical analysis were localized to brain tracts using the
JHU White-Matter Tractography Atlas (Hua et al., 2008). The pro-
portion of significant voxels (corrected p < 0.05) belonging to each
of the specific tracts was calculated. We focused on tracts con-
taining a sizable portion (over 20%) of the overall significant voxels
for further analyses. For each participant we extracted an average
FA value for the depression score-associated voxels within each of
the relevant tracts separately, and used them as phenotypes in a
hypothesis-driven GSEA. More specifically, GWAS was run on the
tract-based FA values and GSEA was applied to the genome-wide
association data for these traits.
3. Results
3.1. GSEA for depression scores
Significant enrichment of depression score associations was
identified on a multiple testing-corrected level for three gene sets:
Collagen Formation (Reactome: REACT_120729), q75% ¼ 0.011;
NCAM1 Interactions (Reactome: REACT_18312), q75%¼ 0.021; Acute
Myocardial Infarction (AMI) Pathway (BioCarta: h_amiPathway),
q75% ¼ 0.034. Furthermore, enrichments for the Collagen Formation
and the NCAM1 Interactions gene sets were also significant
(p < 0.01) in the replication sample (Collagen Formation
p ¼ 9.90  105; NCAM1 Interactions p ¼ 1.00  104). FDR cor-
rected (q75%) and nominal (p) GSEA values for each of these gene
sets are reported in Table 2. Of note, including regions 110 kb up-
stream and 40 kb downstream of the gene in the GSEA did not
significantly change the results (Supplementary Table 1).
Notably, there is a substantial genetic overlap between the
NCAM1 Interactions and the Collagen Formation gene set
(p ¼ 1.94  1040). Furthermore, the NCAM1 Interactions and the
Collagen Formation gene set enrichments were due to collagen-
related genes, respectively, as shown by a systematic overview of
genes contributing to the gene set associations with depression
scores, i.e., passing the enrichment cutoff in each sample (Table 3).
Of note, the genetic effects of the NCAM1 Interactions and the
Collagen Formation gene sets on depression scores were signifi-
cantly mediated by trait anxiety (p < 0.001). For more details
regarding this analysis please refer to the Supplementary Infor-
mation and Supplementary Figures 6 and 7. Major depressive dis-
order (MDD) and anxiety disorders share significant amount of
Table 2
Gene set associations with depression scores in A) Basel_1 and B) Basel_2.
Database Gene Set p q75% Gene set size Observed genes above enrichment cutoff Expected genes above enrichment cutoff
2A
REACTOME Collagen Formation 1.00  104 0.011 53 27 13
REACTOME NCAM1 Interactions 3.00  104 0.021 35 19 9
BIOCARTA AMI Pathway 6.00  104 0.034 15 10 4
2B
REACTOME Collagen Formation 9.90  105 0.030 53 26 13
REACTOME NCAM1 Interactions 1.00  104 0.025 35 19 9
BIOCARTA AMI Pathway 0.016 0.44 15 8 4
p, uncorrected values; q75%, FDR corrected values.
Table 3
Genes contributing to the gene set association with depression scores, i.e., passing the enrichment cutoff.
Discovery sample: Basel_1 Replication sample: Basel_2
Collagen Formation NCAM1 Interactions Collagen Formation NCAM1 Interactions
ADAMTS14 CACNA1I ADAMTS3 CACNA1H
ADAMTS2 CACNB2 COL1A1 CACNA1I
BMP1 CACNB4 COL1A2 CACNA1S
COL1A1 CNTN2 COL3A1 CACNB1
COL1A2 COL1A1 COL4A1 COL1A1
COL2A1 COL1A2 COL4A2 COL1A2
COL4A1 COL2A1 COL4A3 COL3A1
COL4A2 COL4A1 COL5A1 COL4A1
COL4A3 COL4A2 COL6A2 COL4A2
COL4A4 COL4A3 COL6A3 COL4A3
COL5A1 COL4A4 COL8A1 COL5A1
COL5A3 COL5A1 COL9A2 COL6A2
COL6A1 COL6A1 COL11A1 COL6A3
COL6A2 COL6A2 COL13A1 COL9A2
COL8A1 GDNF COL14A1 GDNF
COL12A1 GFRA2 COL15A1 NCAM1
COL13A1 NRTN COL19A1 NCAN
COL15A1 ST8SIA2 COL21A1 ST8SIA2
COL22A1 ST8SIA4 COL22A1 ST8SIA4
COL27A1 - COL23A1 -
COL28A1 - COL25A1 -
GLT25D2 - COL27A1 -
LEPREL1 - COL28A1 -
PPIB - LEPREL1 -
SERPINH1 - PCOLCE2 -
TLL1 - TLL2 -
TLL2 - - -
Genes contributing to the gene set association with depression scores, i.e., passing the enrichment cutoff, are listed for each sample, for the Collagen Formation gene set
and the NCAM1 Interactions gene set, respectively. Overlapping genes between the two gene sets per sample are marked in gray color.
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depression and anxiety may also have overlapping genetic bases at
symptom/trait level in healthy participants.
The AMI gene set did not exceed the significance threshold in
the replication sample (p ¼ 0.016). GSEA p-values of the remaining
gene sets that were nominally associated with depression scores
(p < 0.05) are provided in Supplementary Tables 2A and 2B, for the
discovery and the replication sample, respectively.
Of note, no SNP reached genome wide significance
(p < 5  108) in the GWAS of depression scores in the discovery
sample and the replication sample, respectively, demonstrating the
usefulness of GSEA to detect associations of weaker effect sizes. The
GWAS p-values for the best SNP of each gene passing the enrich-
ment cutoff in the GSEA are provided in Supplementary Table 3 and
Supplementary Table 4 for the NCAM1 Interactions and the
Collagen Formation gene set, respectively.3.2. GSEA for MDD
As a next step, we investigated whether the NCAM1 Interactionsand the Collagen Formation gene sets are associated with MDD
diagnosis, by applying the GSEA to publically available summary
statistics of a large MDD case-control GWAS (https://www.med.
unc.edu/pgc/results-and-downloads) (Ripke et al., 2013). While
we identified nominally significant enrichment for the Collagen
Formation gene set in this sample (p ¼ 0.013), the depression as-
sociation with the NCAM1 Interactions gene set did not extend to
MDD patients (p ¼ 0.13). Of note, the MDD analysis was conducted
using case-control data. However, it has been previously demon-
strated that the use of continuous measurements, rather than
clinical cut-offs, can substantially improve the power for detection
of genetic variants associated with polygenic traits (van der Sluis
et al., 2013).3.3. DTI results: FA associations with depression scores
We found whole-brain significant negative associations be-
tween FA and depression scores, as illustrated in Fig. 1. FA re-
ductions have been associated with subclinical depressive
symptoms in two previous studies (Hayakawa et al., 2014;
Fig. 1. Association between FA data and depression scores. Associations are presented using color-coded, multiple testing corrected t values within a display range of 0.95:1
(corresponding to p < 0.05). The mean FA image of the Basel_2 sample is presented in coronal (upper left), sagittal (upper right) and axial (lower left) view. The mean FA skeleton,
overlaid on the mean FA image, is presented in green color. Negative associations are presented in blue color. Abbreviations: FA, Fractional Anisotropy; L, left; R, right. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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The JHU White-Matter Tractography Atlas was used for tract
identification. The proportion of significant voxels allocated to a
particular tract, as well as the proportion of significant voxels
among all the voxels within each tract is provided in Table 4. The
majority of significantly associated voxels was localized within the
forceps minor (FM) (21.86%) and the left superior longitudinal
fasciculus (SLF) (34.08%), mainly confined to its temporal part (tSLF)
(24.38%). FA decreases within these regions have been previously
associated with MDD (LeWinn et al., 2014; Ota et al., 2015; Wu
et al., 2011; Zuo et al., 2012).
3.4. Hypothesis-driven GSEA of depression score-associated FA
within three brain tracts
Average FA values for the voxels significantly associated with
depression scores were calculated for the forcepsminor, the left SLF
and the left tSLF, respectively. To test if there is a shared genetic
basis between depression scores and the respective brain tracts, we
ran a separate GSEA for each brain tract. The GSEAs showed sig-
nificant enrichment for the NCAM1 Interactions gene set on a
nominal level (FM: p ¼ 0.016; SLF: p ¼ 0.033; tSLF: p ¼ 0.007), and
no association with the Collagen Formation gene set (see Table 5).
An overview of the remaining significantly enriched gene sets is
provided in Supplementary Table 5, Supplementary Table 6 and
Supplementary Table 7, for the FM, the left SLF and the left tSLF,
respectively.
We further investigated whether the enrichment of the NCAM1
Interactions gene set for each DTI phenotype is solely dependent ondepression scores. The respective FA values were corrected for
depression scores using linear regression analysis, and the GSEA
was re-run. Removing the depression-related variance reduced the
NCAM1 Interactions FA association for each DTI-derived phenotype
(FM: p¼ 0.14; SLF: p¼ 0.080; tSLF: p¼ 0.016), suggesting that these
associations may be partly mediated by depression scores.
4. Discussion
This study identified two gene sets related to self-reported
depression scores in healthy participants. By applying a GSEA
approach, robust associations were identified for the Collagen
Formation and the NCAM1 Interactions gene sets, respectively.
As a next step, a DTI analysis was conducted in search of brain
structural correlates of depressive symptom scores, resulting in the
identification of depression score-associated FA reductions, local-
izedmainly in the forcepsminor and the left SLF. Although based on
depression score differences in healthy participants, our findings
are in line with previously reported FA decrease in the SLF and
corpus callosum in individuals diagnosed with MDD (LeWinn et al.,
2014; Ota et al., 2015; Wu et al., 2011; Zuo et al., 2012), bipolar
disorder (Saricicek et al., 2016), generalized anxiety disorder (Wang
et al., 2016) and autism spectrum disorders (Fitzgerald et al., 2016).
Additionally, subclinical depressive symptoms have been associ-
ated with widespread FA decrease in healthy female participants,
including corpus callosum and the right anterior cingulum
(Hayakawa et al., 2014), and FA decrease in the bilateral uncinate
fasciculus in healthy individuals over 70 years of age (McIntosh
et al., 2013). An FA decrease was also detected in a small fraction
Table 4
Proportion of depression scores-associated voxels per brain tract.
Tract name Overall associated voxels % Tract's associated voxels %
Anterior_thalamic_radiation_L 5.05 1.68
Anterior_thalamic_radiation_R 0.48 0.18
Cingulum_(cingulate_gyrus)_L 3.28 5.05
Cingulum_(cingulate_gyrus)_R 0 0
Cingulum_(hippocampus)_L 0 0
Cingulum_(hippocampus)_R 0 0
Corticospinal_tract_L 0 0
Corticospinal_tract_R 0 0
Forceps_major 0 0
Forceps_minor 21.86 6.01
Inferior_fronto-occipital_fasciculus_L 0.48 0.13
Inferior_fronto-occipital_fasciculus_R 2.05 0.51
Inferior_longitudinal_fasciculus_L 0 0
Inferior_longitudinal_fasciculus_R 0 0
Superior_longitudinal_fasciculus_L 34.08 10.74
Superior_longitudinal_fasciculus_R 0 0
Superior_longitudinal_fasciculus_(temporal_part)_L 24.38 14.63
Superior_longitudinal_fasciculus_(temporal_part)_R 0 0
Uncinate_fasciculus_L 0 0
Uncinate_fasciculus_R 1.30 1.97
Overall associated voxels %: Proportion (in percent) of all significant voxels belonging to the specific tract; Tract's associated voxels %: the proportion (in percent) of
significant voxels, among all the voxels of the particular tract; Abbreviations: L, left; R, right.
Table 5
Gene set associations with DTI-derived phenotypes.
DTI phenotype Database Gene Set p value Gene set size Genes above enrichment cutoff
Forceps Minor REACTOME Collagen Formation 0.15 53 14
Forceps Minor REACTOME NCAM1 Interactions 0.016 35 12
Left SLF REACTOME Collagen Formation 0.093 53 16
Left SLF REACTOME NCAM1 Interactions 0.033 35 13
Left tSLF REACTOME Collagen Formation 0.093 53 16
Left tSLF REACTOME NCAM1 Interactions 0.007 35 15
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Moreover, in order to further validate our initial genetic find-
ings, DTI-derived measurements of depression score-associated
microstructural properties within the forceps minor and the left
(temporal) SLF were subjected to a hypothesis-driven GSEA. The
NCAM1 Interactions gene set was significantly associated with each
of the three DTI phenotypes, additionally pointing to its possible
involvement in depression-relevant biological pathways.
Genes constituting the neural cell adhesion molecule (NCAM1)
Interactions gene set are implicated in neural development and
synaptic plasticity (Nielsen et al., 2010; Rutishauser, 2008; Walmod
et al., 2004) and code for both intracellular components, e.g. sub-
units of voltage-gated calcium channels, and molecules of the
extracellular matrix, most prominently collagen components
(coded by 17 out of the 39 genes comprising this gene set), asso-
ciated with NCAM activity.
Noteworthy, Collagen Formation, a gene set with substantial
genetic overlap with NCAM1 Interactions (p ¼ 1.94  1040), was
also associated with depression scores in this study (Table 2). Ten
out of the 17 genes shared by these gene sets contributed to the
association with depression scores in the discovery and the repli-
cation sample, respectively (Table 3).
NCAM has been investigated in the context of depression, due to
its modulatory role in intracellular cascades and brain plasticity
(Wainwright and Galea, 2013). NCAM deficits and resulting changes
in neural plasticity have been associated with an increase of
depression-like behavior and reduced efficacy of common antide-
pressants in animal models (Aonurm-Helm et al., 2008; Jürgenson
et al., 2012; Wainwright et al., 2015). Additionally, genetic variants
within or near NCAM1 have been associated with suicidal behavior
(Sokolowski et al., 2016), cannabis use and MDD (Hodgson et al.,2017), as well as other disorders, such as bipolar disorder, (Arai
et al., 2004), schizophrenia (Zhang et al., 2014) and autism (Marui
et al., 2009). According to the references listed above, one may
assume NCAM1 as a general vulnerability factor for neuro-
developmental and psychiatric disorders. Moreover, collagens have
a notable impact on NCAM downstream activity (Monzo et al.,
2013). Our genetic association data are in line with these biolog-
ical observations.
Furthermore, the NCAM1 Interactions gene set was associated
with DTI correlates of depression scores. NCAM-derived polysialic
acid has been implicated in axonal development, myelination and
path finding (Rutishauser, 2008), all of which can impact the
microstructural properties of brain tracts and therefore be reflected
by the DTI (FA) measurement. Moreover, as regressing out the
depression-related variance reduced the association between the
NCAM1 Interactions gene set and each DTI-derived phenotype, the
respective associations are likely to be at least partly mediated by
depression scores.
By linking the NCAM1 Interactions gene set to depression scores
and their structural brain correlates in healthy participants, the
current study contributes to the understanding of the molecular
underpinnings of depressive symptomatology.Funding
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Materials	and	Methods	
Array-based	SNP	genotyping	
Array-based	SNP	genotyping	was	performed	as	described	in	the	Genome-Wide	Human	
SNP	 Nsp/Sty	 6.0	 User	 Guide	 (Affymetrix).	 Briefly,	 genomic	 DNA	 concentration	 was	
determined	and	adjusted	to	50	ng/μl	in	water.	250	ng	of	DNA	was	digested	with	10	units	
of	 Nsp	 I	 and	 Sty	 I	 restriction	 enzymes	 for	 2hr	 at	 37°C.	 Enzyme-specific	 adaptor	
oligonucleotides	 were	 ligated	 onto	 the	 digested	 ends	 with	 T4	 DNA	 Ligase	 for	 3hr	 at	
16°C.	After	adjustment	to	100μl	with	water,	10μl	of	the	diluted	ligation	reactions	were	
subjected	to	polymerase	chain	reactions	(PCR)	of	100μl	(three	for	Sty-digested	products	
and	 four	 for	Nsp).	Reactions	were	 then	verified	 to	migrate	at	an	average	size	between	
200-to	1,100	bps	using	2%	TBE	gel	 electrophoresis.	 PCR	amplification	products	were	
combined	and	purified	using	Agencourt	Magnetic	Beads	(Beckman	Coulter).	4-5μg/μl	of	
purified	PCR	products	was	obtained	on	average	for	each	sample.	The	amplified	DNA	was	
then	 fragmented,	 labeled	and	hybridized	onto	a	Genome-	Wide	Human	SNP	6.0	Array,	
using	the	SNP	Nsp/Sty	5.0/6.0	Assay	Kit	(Affymetrix).	The	hybridized	array	was	washed,	
stained	 and	 scanned.	 Generation	 of	 SNP	 calls	 and	 array	 quality	 control	 (QC)	 were	
performed.	Contrast	QC	was	chosen	as	the	QC	metric,	using	a	default	value	of	≥	0.4.	All	
samples	 passing	 the	 QC	 criteria	 were	 genotyped	 using	 the	 Birdseed	 (v2)	 algorithm.	
Mean	 Call	 Rate	 for	 all	 samples	 (i.e.,	 individuals)	 averaged	 >98.5%	 and	 ranged	 from	
95.1%	to	99.7%.	Thus,	no	individual	with	a	SNP	call	rate	below	95%	was	included.	
3	
Scanning	procedure	
Scanning	 was	 performed	 on	 a	 Siemens	 Magnetom	 Verio	 3	 T	 whole	 body	 MR	 unit	
equipped	with	 a	 twelve-channel	 head	 coil.	 The	 scanning	 session	 consisted	 of	 20	min.	
long	picture	recognition	task	(not	reported),	followed	by	an	anatomical	and	a	diffusion	
imaging	sequence	(10min.	each).			
Sequence	description:		
Anatomical:	 Three-dimensional,	 high-resolution	 T1-weighted	 images	 were	 acquired	
with	 magnetization	 prepared	 rapid	 gradient	 echo	 (MPRAGE)	 sequence.	 Acquisition	
parameters:	 repetition	 time	 (TR)=2000	 ms;	 echo	 time	 (TE)=3.37	 ms;	 inversion	 time	
(TI)=1000	ms;	flip	angle=8°;	176	sagittal	slices;	field	of	view	(FOV)=256	mm;	voxel	size	
=	1	x	1	x	1	mm3.	
DTI:	Diffusion	volumes	were	acquired	using	a	singe-shot	EPI	sequence,	and	consisted	of	
64	diffusion-weighted	volumes	with	b=900s/mm2	and	one	unweighted	volume	(b=0).		
Acquisition	parameters:	TR=9s;	TE=82ms;	 FOV=320	mm;	GRAPPA	R=2.0;	 voxel	 size	=	
2.5	x	2.5	x	2.5mm3.	
4	
Mediation	analyses	
Trait	anxiety	was	measured	with	the	trait	subscale	of	the	State-Trait	Anxiety	Inventory	
(STAI)	(Spielberg	et	al.,	1970).		In	both	samples	depression	scores	and	trait	anxiety	were	
significantly	associated,	showing	large	effect	sizes	(Discovery	Sample	r	=	0.57,	p	<	10e-
16,	Replication	Sample	r	=	0.65,	p	<	10e-16).	Hence,	we	were	interested	in	whether	the	
association	between	the	multilocus	genetic	scores	on	depression	might	at	least	partially	
be	 mediated	 by	 trait	 anxiety.	 For	 doing	 so,	 we	 conducted	 mediation	 analyses	 as	
described	 in	 (Baron	 and	 Kenny,	 1986;	 Shrout	 and	 Bolger,	 2002),	 separately	 for	 the	
NCAM1	 Interactions	 and	 the	 Collagen	 Formation	 gene	 sets	 and	 for	 both	 samples.	 To	
control	 for	confounding	effects	of	sex	and	age,	we	regressed	out	 their	effects	 from	the	
behavioral	phenotypes.		We	used	the	MBESS-package	in	R	to	retrieve	empirical	p-values	
for	the	indirect	effect	(10’000	iterations;	confidence-interval	99.9%).	
For	 both	 genetic	 scores	 the	 indirect	 effect	 of	 trait	 anxiety	 was	 significant	 (discovery	
sample:	NCAM1	r	=	0.078,	p	<	0.001;	Collagen	formation	r	=	0.094,	p	<	0.001;	replication	
sample:	NCAM1	r	=	0.122,	p	<	0.001;	Collagen	formation	r	=	0.122,	p	<	0.001).		
5	
Supplementary	Figures	
Supplementary	Figure	1	A	visual	representation	of	the	distribution	of	depression	
scores	in	the	discovery	sample	(N=1651)	
Abbreviations:	MADRS,	Montgomery	Asberg	Depression	Rating	Scale	
Distribution of MADRS scores: Discovery sample
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Supplementary	Figure	2	A	visual	representation	of	the	distribution	of	depression	
scores	in	the	replication	sample	(N=1135)	
Abbreviations:	MADRS,	Montgomery	Asberg	Depression	Rating	Scale	
Distribution of MADRS scores: Replication sample
Individual MADRS score
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Supplementary	Figure	3	A	visual	representation	of	the	distribution	of	depression	
scores	in	the	DTI	subsample	of	the	replication	sample	(N=658)	
Abbreviations:	MADRS,	Montgomery	Asberg	Depression	Rating	Scale	
Distribution of MADRS scores: DTI sample
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Supplementary	Figure	4	Quantile-quantile	plot	for	genetic	association	in	the	
discovery	sample		
9	
Supplementary	Figure	5	Quantile-quantile	plot	for	genetic	association	in	the	
replication	sample		
10	
Supplementary	Figure	6	Visual	representation	of	the	results	from	the	mediation	
analyses,	testing	if	trait	anxiety	mediates	the	association	between	gene-scores	and	
depression	scores	for	A)	the	NCAM1	Interactions	B)	Collagen	Formation	gene	set,	in	the	
discovery	sample	
Path (a) represents the effect of gene-score on trait anxiety, path (b) the effect of trait anxiety 
on depression scores, path (c) the effect of the gene-scores on depression scores, and path (c’) 
the effect of gene-score on depression scores while controlling for the indirect effect of trait 
anxiety. The indirect effect is computed by multiplying the effects of (a) and (b). Parameters 
(r) show the association strength (+/- 99.9% confidence interval). Ratio indirect/direct 
represents the strength of mediation ((a x b)/c’). Parameters (P) show the significance for 
each path. 
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Supplementary	Figure	7	Visual	representation	of	the	results	from	the	mediation	
analyses,	testing	if	trait	anxiety	mediates	the	association	between	gene-scores	and	
depression	scores	for	A)	the	NCAM1	Interactions	B)	Collagen	Formation	gene	set,	in	the	
replication	sample	
Path (a) represents the effect of gene-score on trait anxiety, path (b) the effect of trait anxiety 
on depression scores, path (c) the effect of the gene-scores on depression scores, and path (c’) 
the effect of gene-score on depression scores while controlling for the indirect effect of trait 
anxiety. The indirect effect is computed by multiplying the effects of (a) and (b). Parameters 
(r) show the association strength (+/- 99.9% confidence interval). Ratio indirect/direct 
represents the strength of mediation ((a x b)/c’). Parameters (P) show the significance for 
each path. 
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Supplementary	Tables	
Supplementary	Table	1	Gene	set	associations	with	depression	scores,	with	110kb	
upstream	of	the	gene	start	site	and	40kb	downstream	of	the	gene	end	site	
included	
Sample	 Gene	Set	 p	value	 q75%	 Gene	set	
size	
Observed	genes	
above	enrichment	
cutoff		
Expected	genes	
above	enrichment	
cutoff	
Basel_1	 Collagen	
Formation	
2.0	x	10-4	 0.040	 53	 26	 13	
Basel_1	 NCAM1	
Interactions	
1.0	x	10-4	 0.024	 35	 19	 9	
Basel_2	 Collagen	
Formation	
1.0	x	10-4	 0.014	 53	 27	 13	
Basel_2	 NCAM1	
Interactions	
0.001	 0.064	 35	 18	 9	
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Supplementary	Table	2	Gene	set	associations	with	depression	scores	A)	in	the	
discovery	sample	(Basel_1);	B)	in	the	replication	sample	(Basel_2)	(only	gene	
sets	with	p	<	0.05	are	listed)	
Supplementary	Table	2A	
Data base Gene set	 p	 q75%	
REACTOME	 REACTOME_COLLAGEN_FORMATION 1.00E-04 1.06E-02	
REACTOME	 REACTOME_NCAM1_INTERACTIONS 3.00E-04 2.12E-02	
REACTOME	 REACTOME_ION_CHANNEL_TRANSPORT 3.00E-04 5.15E-02	
BIOCARTA	 BIOCARTA_AMI_PATHWAY 6.00E-04 3.44E-02	
GO	 INTEGRIN_BINDING 8.00E-04 3.25E-01	
GO	 AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 9.00E-04 2.47E-01	
REACTOME	 REACTOME_SIGNALING_BY_PDGF 1.30E-03 7.51E-02	
REACTOME	 REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH 1.40E-03 9.85E-02	
KEGG	 KEGG_OOCYTE_MEIOSIS 2.30E-03 3.69E-01	
REACTOME	 REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION 2.50E-03 8.86E-02	
BIOCARTA	 BIOCARTA_INTRINSIC_PATHWAY 2.90E-03 6.90E-02	
REACTOME	 REACTOME_DAG_AND_IP3_SIGNALING 2.90E-03 1.10E-01	
GO	 AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 3.10E-03 4.08E-01	
REACTOME	 REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES 3.30E-03 1.07E-01	
REACTOME	 REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION 3.40E-03 1.32E-01	
GO	 NEURON_DEVELOPMENT 3.40E-03 4.40E-01	
REACTOME	 REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES 3.50E-03 1.24E-01	
GO	 POSITIVE_REGULATION_OF_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID 4.50E-03 3.78E-01	
GO	 POSITIVE_REGULATION_OF_TRANSCRIPTION 4.50E-03 4.26E-01	
GO	 CARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.40E-03 4.18E-01	
REACTOME	 REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT 5.60E-03 1.24E-01	
KEGG	 KEGG_COMPLEMENT_AND_COAGULATION_CASCADES 6.00E-03 3.61E-01	
GO	 POSITIVE_REGULATION_OF_TRANSCRIPTIONDNA_DEPENDENT 6.20E-03 3.54E-01	
GO	 NEURITE_DEVELOPMENT 6.20E-03 3.81E-01	
KEGG	 KEGG_CALCIUM_SIGNALING_PATHWAY 6.40E-03 2.78E-01	
KEGG	 KEGG_AXON_GUIDANCE 6.90E-03 1.79E-01	
GO	 ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES 6.90E-03 3.85E-01	
REACTOME	 REACTOME_SIGNALING_BY_ROBO_RECEPTOR 7.20E-03 1.26E-01	
GO	 ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.40E-03 3.83E-01	
REACTOME	 REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION 7.50E-03 1.31E-01	
GO	 ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.70E-03 3.87E-01	
GO	 PROTEIN_TYROSINE_KINASE_ACTIVITY 7.80E-03 3.68E-01	
GO	 POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER 7.90E-03 3.91E-01	
REACTOME	 REACTOME_GABA_RECEPTOR_ACTIVATION 8.10E-03 1.48E-01	
REACTOME	 REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE 8.60E-03 1.30E-01	
KEGG	 KEGG_ECM_RECEPTOR_INTERACTION 8.80E-03 2.18E-01	
GO	 HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDESCATALYZING_TRANSMEMBRANE_MOVEME 1.06E-02 3.33E-01	
GO	 AMINE_TRANSPORT 1.15E-02 3.31E-01	
REACTOME	 REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS 1.17E-02 1.87E-01	
GO	 WOUND_HEALING 1.20E-02 3.27E-01	
GO	 PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 1.24E-02 3.60E-01	
GO	 POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS 1.39E-02 3.58E-01	
GO	 COFACTOR_BINDING 1.43E-02 3.44E-01	
KEGG	 KEGG_ABC_TRANSPORTERS 1.48E-02 2.66E-01	
GO	 ACTIN_FILAMENT_BINDING 1.48E-02 3.20E-01	
REACTOME	 REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA 1.67E-02 2.12E-01	
BIOCARTA	 BIOCARTA_PPARA_PATHWAY 1.67E-02 3.81E-01	
GO	 POSITIVE_REGULATION_OF_TRANSPORT 1.69E-02 3.50E-01	
REACTOME	 REACTOME_CA_DEPENDENT_EVENTS 1.81E-02 2.04E-01	
GO	 KINETOCHORE 1.91E-02 3.53E-01	
REACTOME	 REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE 2.02E-02 2.56E-01	
REACTOME	 REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE 2.06E-02 2.33E-01	
REACTOME	 REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES 2.12E-02 3.22E-01	
GO	 REGULATION_OF_SECRETION 2.14E-02 4.45E-01	
GO	 PROTEIN_COMPLEX_BINDING 2.25E-02 4.79E-01	
REACTOME	 REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS 2.27E-02 2.42E-01	
REACTOME	 REACTOME_PHOSPHORYLATION_OF_THE_APC_C 2.37E-02 2.36E-01	
GO	 TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY 2.45E-02 4.81E-01	
KEGG	 KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES 2.66E-02 3.65E-01	
GO	 LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_ACTIVITY 2.75E-02 4.83E-01	
GO	 DI___TRI_VALENT_INORGANIC_CATION_TRANSPORT 2.84E-02 4.97E-01	
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KEGG	 KEGG_MELANOGENESIS 2.90E-02 4.44E-01	
REACTOME	 REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 2.98E-02 3.87E-01	
REACTOME	 REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION 3.01E-02 3.86E-01	
REACTOME	 REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION 3.10E-02 3.84E-01	
GO	 EXTRINSIC_TO_MEMBRANE 3.10E-02 4.89E-01	
GO	 PEPTIDYL_AMINO_ACID_MODIFICATION 3.12E-02 5.74E-01	
REACTOME	 REACTOME_MITOTIC_PROMETAPHASE 3.13E-02 3.99E-01	
GO	 TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY 3.29E-02 5.56E-01	
KEGG	 KEGG_GLIOMA 3.31E-02 4.95E-01	
REACTOME	 REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS 3.34E-02 3.91E-01	
GO	 METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 3.41E-02 5.37E-01	
GO	 NEURON_DIFFERENTIATION 3.49E-02 5.54E-01	
GO	 PROTEIN_N_TERMINUS_BINDING 3.50E-02 6.05E-01	
REACTOME	 REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION 3.67E-02 3.46E-01	
GO	 CELL_PROJECTION 3.78E-02 5.99E-01	
KEGG	 KEGG_DILATED_CARDIOMYOPATHY 3.91E-02 4.78E-01	
GO	 CALCIUM_ION_TRANSPORT 3.93E-02 5.84E-01	
GO	 CALCIUM_CHANNEL_ACTIVITY 4.11E-02 5.62E-01	
GO	 AMINO_ACID_TRANSPORT 4.13E-02 5.70E-01	
GO	 ADHERENS_JUNCTION 4.17E-02 5.88E-01	
GO	 AXONOGENESIS 4.22E-02 5.42E-01	
GO	 ATPASE_ACTIVITY_COUPLED 4.31E-02 5.72E-01	
BIOCARTA	 BIOCARTA_PGC1A_PATHWAY 4.31E-02 6.38E-01	
KEGG	 KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION 4.36E-02 4.68E-01	
REACTOME	 REACTOME_NETRIN1_SIGNALING 4.46E-02 3.88E-01	
GO	 MEMBRANE_ORGANIZATION_AND_BIOGENESIS 4.47E-02 5.75E-01	
REACTOME	 REACTOME_COMPLEMENT_CASCADE 4.51E-02 3.74E-01	
REACTOME	 REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY 4.52E-02 3.98E-01	
KEGG	 KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC 4.54E-02 4.48E-01	
REACTOME	 REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT 4.70E-02 3.97E-01	
GO	 PERINUCLEAR_REGION_OF_CYTOPLASM 4.74E-02 5.76E-01	
GO	 CALCIUM_ION_BINDING 4.81E-02 5.80E-01	
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Supplementary	Table	2B	
Data base Gene set	 p	 q75%	
KEGG	 KEGG_ECM_RECEPTOR_INTERACTION	 9.90E-05	 1.00E-04	
REACTOME	 REACTOME_COLLAGEN_FORMATION	 9.90E-05	 3.03E-02	
REACTOME	 REACTOME_NCAM1_INTERACTIONS	 1.00E-04	 2.48E-02	
GO	 GLYCOSAMINOGLYCAN_BINDING	 1.00E-04	 6.81E-02	
GO	 POLYSACCHARIDE_BINDING	 1.00E-04	 9.92E-02	
REACTOME	 REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	 3.00E-04	 5.38E-02	
REACTOME	 REACTOME_L1CAM_INTERACTIONS	 5.00E-04	 2.96E-02	
REACTOME	 REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	 6.00E-04	 4.61E-02	
REACTOME	 REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	 1.40E-03	 7.63E-02	
GO	 HEMOSTASIS	 1.50E-03	 1.70E-01	
GO	 PATTERN_BINDING	 1.60E-03	 1.69E-01	
GO	 PROTEIN_OLIGOMERIZATION	 2.80E-03	 1.86E-01	
GO	 GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY	 2.90E-03	 1.91E-01	
GO	 HEPARIN_BINDING	 3.10E-03	 1.92E-01	
GO	 BLOOD_COAGULATION	 3.20E-03	 1.66E-01	
KEGG	 KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	 3.90E-03	 1.43E-01	
GO	 PROTEIN_COMPLEX_ASSEMBLY	 4.50E-03	 2.59E-01	
GO	 COAGULATION	 4.60E-03	 2.12E-01	
GO	 CELL_CORTEX_PART	 4.60E-03	 2.13E-01	
GO	 COLLAGEN	 6.30E-03	 2.21E-01	
BIOCARTA	 BIOCARTA_ECM_PATHWAY	 6.40E-03	 3.63E-01	
GO	 POTASSIUM_CHANNEL_ACTIVITY	 6.60E-03	 2.57E-01	
KEGG	 KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	 6.90E-03	 1.75E-01	
REACTOME	 REACTOME_APOPTOTIC_EXECUTION_PHASE	 6.90E-03	 2.27E-01	
REACTOME	 REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	 7.20E-03	 2.13E-01	
REACTOME	 REACTOME_SIGNALING_BY_RHO_GTPASES	 7.60E-03	 2.15E-01	
GO	 METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	 7.60E-03	 3.63E-01	
REACTOME	 REACTOME_PHOSPHOLIPID_METABOLISM	 8.30E-03	 2.23E-01	
REACTOME	 REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	 8.40E-03	 1.97E-01	
REACTOME	 REACTOME_INTERFERON_GAMMA_SIGNALING	 8.40E-03	 2.07E-01	
GO	 CORTICAL_CYTOSKELETON	 8.50E-03	 2.68E-01	
GO	 PROTEINACEOUS_EXTRACELLULAR_MATRIX	 8.70E-03	 3.47E-01	
REACTOME	 REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	 9.10E-03	 1.96E-01	
GO	 EXTRACELLULAR_MATRIX	 9.30E-03	 3.73E-01	
REACTOME	 REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	 1.10E-02	 2.13E-01	
REACTOME	 REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	 1.17E-02	 2.28E-01	
KEGG	 KEGG_SMALL_CELL_LUNG_CANCER	 1.17E-02	 3.57E-01	
GO	 REGULATION_OF_BODY_FLUID_LEVELS	 1.27E-02	 3.52E-01	
REACTOME	 REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS	 1.30E-02	 2.26E-01	
REACTOME	 REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	 1.31E-02	 2.37E-01	
GO	 SKELETAL_DEVELOPMENT	 1.39E-02	 3.90E-01	
REACTOME	 REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	 1.47E-02	 2.41E-01	
GO	 EXTRACELLULAR_MATRIX_PART	 1.49E-02	 4.03E-01	
BIOCARTA	 BIOCARTA_KERATINOCYTE_PATHWAY	 1.50E-02	 2.57E-01	
REACTOME	 REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	 1.53E-02	 2.24E-01	
BIOCARTA	 BIOCARTA_MYOSIN_PATHWAY	 1.53E-02	 3.09E-01	
BIOCARTA	 BIOCARTA_PAR1_PATHWAY	 1.57E-02	 2.08E-01	
REACTOME	 REACTOME_PURINE_METABOLISM	 1.59E-02	 2.32E-01	
BIOCARTA	 BIOCARTA_AMI_PATHWAY	 1.62E-02	 4.42E-01	
GO	 CARBOHYDRATE_BINDING	 1.65E-02	 4.45E-01	
KEGG	 KEGG_ABC_TRANSPORTERS	 1.80E-02	 3.68E-01	
REACTOME	 REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	 1.94E-02	 2.86E-01	
GO	 PROTEIN_HOMOOLIGOMERIZATION	 1.96E-02	 3.92E-01	
KEGG	 KEGG_TIGHT_JUNCTION	 1.99E-02	 4.41E-01	
REACTOME	 REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	 2.05E-02	 2.85E-01	
REACTOME	 REACTOME_SPHINGOLIPID_METABOLISM	 2.08E-02	 2.74E-01	
GO	 MEMBRANE_LIPID_METABOLIC_PROCESS	 2.12E-02	 5.71E-01	
GO	 SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	 2.23E-02	 5.89E-01	
KEGG	 KEGG_WNT_SIGNALING_PATHWAY	 2.32E-02	 4.66E-01	
REACTOME	 REACTOME_SEMAPHORIN_INTERACTIONS	 2.40E-02	 3.21E-01	
REACTOME	 REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	 2.58E-02	 3.17E-01	
REACTOME	 REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	 2.62E-02	 3.27E-01	
GO	 ION_TRANSPORT	 2.64E-02	 6.41E-01	
GO	 CATION_CHANNEL_ACTIVITY	 2.67E-02	 6.26E-01	
GO	 CARBOHYDRATE_BIOSYNTHETIC_PROCESS	 2.71E-02	 5.62E-01	
GO	 LIPID_TRANSPORTER_ACTIVITY	 2.73E-02	 5.05E-01	
KEGG	 KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	 2.78E-02	 4.37E-01	
GO	 CELL_MIGRATION	 2.78E-02	 6.18E-01	
REACTOME	 REACTOME_GLUCOSE_METABOLISM	 2.98E-02	 3.14E-01	
GO	 CATION_TRANSPORT	 3.03E-02	 6.14E-01	
GO	 ALCOHOL_METABOLIC_PROCESS	 3.18E-02	 6.46E-01	
GO	 ACTIN_CYTOSKELETON	 3.42E-02	 6.06E-01	
16	
KEGG	 KEGG_LONG_TERM_DEPRESSION	 3.43E-02	 4.60E-01	
REACTOME	 REACTOME_POTASSIUM_CHANNELS	 3.47E-02	 3.41E-01	
GO	 PHOSPHOLIPID_METABOLIC_PROCESS	 3.55E-02	 6.23E-01	
GO	 METAL_ION_TRANSPORT	 3.67E-02	 6.11E-01	
GO	 GUANYL_NUCLEOTIDE_BINDING	 3.76E-02	 6.49E-01	
GO	 ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	 3.77E-02	 6.12E-01	
BIOCARTA	 BIOCARTA_BAD_PATHWAY	 3.87E-02	 3.76E-01	
GO	 INORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	 3.89E-02	 6.11E-01	
GO	 DIGESTION	 3.89E-02	 6.35E-01	
BIOCARTA	 BIOCARTA_INTRINSIC_PATHWAY	 3.94E-02	 3.72E-01	
REACTOME	 REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE	 3.96E-02	 3.11E-01	
KEGG	 KEGG_DILATED_CARDIOMYOPATHY	 3.98E-02	 4.65E-01	
REACTOME	 REACTOME_GLYCOSPHINGOLIPID_METABOLISM	 4.03E-02	 3.44E-01	
REACTOME	 REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	 4.03E-02	 3.51E-01	
GO	 ION_CHANNEL_ACTIVITY	 4.08E-02	 6.66E-01	
REACTOME	 REACTOME_CHOLESTEROL_BIOSYNTHESIS	 4.20E-02	 3.28E-01	
REACTOME	 REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	 4.21E-02	 3.01E-01	
GO	 WOUND_HEALING	 4.31E-02	 6.11E-01	
REACTOME	 REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	 4.36E-02	 3.83E-01	
GO	 CYTOSKELETAL_PROTEIN_BINDING	 4.61E-02	 6.97E-01	
GO	 AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	 4.69E-02	 6.08E-01	
REACTOME	 REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	 4.83E-02	 3.85E-01	
GO	 EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT	 4.94E-02	 6.56E-01	
KEGG	 KEGG_ADHERENS_JUNCTION	 4.96E-02	 4.32E-01	
17	
Supplementary	Table	3	GWAS	p-values	for	the	most	significant	i.e.	best	SNP	of	
each	gene	in	the	NCAM1	Interactions	gene	set	A)	in	the	discovery	sample	
(Basel_1);	B)	in	the	replication	sample	(Basel_2)	
Supplementary	Table	3A	
Gene	 Gene	p-value	 Best	SNP	 Best	SNP	p-value	
COL6A1	 1.79E-02	 rs2776407	 6.36E-03	
COL4A1	 4.41E-02	 rs11069830	 3.80E-03	
COL6A2	 4.47E-02	 rs4819203	 1.02E-02	
COL4A3	 4.75E-02	 rs4263106	 4.55E-03	
CNTN2	 6.78E-02	 rs12117194	 1.49E-02	
COL4A4	 8.09E-02	 rs1317770	 8.38E-03	
COL4A2	 8.64E-02	 rs9515203	 4.66E-03	
CACNB4	 8.90E-02	 rs16830513	 4.45E-03	
GFRA2	 9.14E-02	 rs4073433	 1.54E-02	
CACNA1I	 9.18E-02	 rs3788562	 1.36E-02	
COL1A1	 9.78E-02	 rs2696245	 2.52E-02	
COL2A1	 1.31E-01	 rs740024	 3.13E-02	
ST8SIA2	 1.59E-01	 rs8037133	 2.93E-02	
GDNF	 1.74E-01	 rs7731209	 4.41E-02	
CACNB2	 1.82E-01	 rs1106380	 3.54E-03	
COL5A1	 1.93E-01	 rs7044151	 1.66E-02	
ST8SIA4	 2.25E-01	 rs17724833	 4.52E-02	
NRTN	 2.35E-01	 rs3763046	 5.98E-02	
COL1A2	 2.35E-01	 rs10046552	 5.68E-02	
COL5A2	 3.35E-01	 rs10166301	 5.90E-02	
COL3A1	 3.78E-01	 rs3736487	 1.06E-01	
COL6A3	 3.99E-01	 rs3790990	 8.63E-02	
NCAN	 3.99E-01	 rs1064395	 1.28E-01	
CACNA1S	 4.19E-01	 rs3820421	 8.81E-02	
NCAM1	 4.81E-01	 rs644668	 3.50E-02	
CACNA1H	 5.00E-01	 rs11859240	 1.55E-01	
COL9A1	 5.73E-01	 rs9294863	 1.51E-01	
GFRA1	 5.94E-01	 rs17668282	 9.40E-02	
CACNB1	 6.20E-01	 rs17633541	 2.48E-01	
CACNA1G	 6.60E-01	 rs4794166	 2.52E-01	
COL9A3	 7.40E-01	 rs6010757	 3.60E-01	
COL9A2	 7.44E-01	 rs2281399	 3.68E-01	
GFRA4	 7.61E-01	 rs616749	 3.68E-01	
PRNP	 8.25E-01	 rs6107516	 5.05E-01	
AGRN	 9.32E-01	 rs2465136	 7.70E-01	
CACNB3	 NaN	 NaN	 NaN	
PSPN	 NaN	 NaN	 NaN	
ARTN	 NaN	 NaN	 NaN	
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Supplementary	Table	3B	
Gene	 Gene	p-value	 Best	SNP	 Best	SNP	p-value	
COL4A3	 4.84E-03	 rs7608142	 6.26E-04	
ST8SIA4	 1.16E-02	 rs3909452	 2.86E-03	
ST8SIA2	 3.89E-02	 rs3784722	 7.45E-03	
COL4A1	 5.10E-02	 rs7987982	 4.81E-03	
CACNA1S	 6.09E-02	 rs12405259	 9.37E-03	
NCAM1	 6.63E-02	 rs17114760	 2.21E-03	
COL6A3	 6.80E-02	 rs4663723	 1.15E-02	
CACNA1H	 8.16E-02	 rs11859240	 1.96E-02	
CACNB1	 8.60E-02	 rs16537	 2.34E-02	
COL4A2	 9.11E-02	 rs331592	 5.22E-03	
COL6A2	 9.83E-02	 rs9978055	 2.41E-02	
COL9A2	 1.01E-01	 rs2076696	 2.67E-02	
NCAN	 1.33E-01	 rs11672216	 3.79E-02	
COL5A1	 1.51E-01	 rs3922982	 1.34E-02	
COL1A2	 1.56E-01	 rs2023729	 3.64E-02	
CACNA1I	 1.77E-01	 rs136855	 3.08E-02	
COL1A1	 2.15E-01	 rs2075555	 6.35E-02	
COL3A1	 2.28E-01	 rs12693525	 5.97E-02	
GDNF	 2.56E-01	 rs2910797	 7.20E-02	
COL9A1	 3.13E-01	 rs604896	 5.98E-02	
COL4A4	 3.65E-01	 rs16823258	 5.81E-02	
COL2A1	 4.41E-01	 rs12811832	 1.40E-01	
COL9A3	 4.42E-01	 rs4809261	 1.49E-01	
GFRA1	 4.57E-01	 rs10885864	 5.82E-02	
CACNB2	 4.68E-01	 rs10828308	 1.99E-02	
CNTN2	 5.51E-01	 rs4951163	 1.81E-01	
PRNP	 6.73E-01	 rs7274758	 3.25E-01	
CACNA1G	 7.31E-01	 rs198542	 3.21E-01	
GFRA4	 7.48E-01	 rs616749	 3.50E-01	
CACNB4	 7.60E-01	 rs2344734	 1.54E-01	
AGRN	 7.70E-01	 rs2465136	 4.33E-01	
GFRA2	 7.87E-01	 rs4073433	 3.37E-01	
COL6A1	 8.62E-01	 rs9978314	 5.92E-01	
COL5A2	 9.29E-01	 rs7419288	 5.60E-01	
NRTN	 9.71E-01	 rs3763046	 9.20E-01	
CACNB3	 NaN	 NaN	 NaN	
PSPN	 NaN	 NaN	 NaN	
ARTN	 NaN	 NaN	 NaN	
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Supplementary	Table	4	GWAS	p-values	for	the	most	significant	i.e.	best	SNP	of	
each	gene	in	the	Collagen	Formation	gene	set	A)	in	the	discovery	sample	
(Basel_1);	B)	in	the	replication	sample	(Basel_2)	
Supplementary	Table	4A	
Gene	 Gene	p-value	 Best	SNP	 Best	SNP	p-value	
COL27A1	 6.09E-03	 rs1468010	 5.81E-04	
COL15A1	 1.16E-02	 rs4743299	 1.58E-03	
COL6A1	 1.79E-02	 rs2776407	 6.36E-03	
COL8A1	 2.33E-02	 rs12107500	 2.54E-03	
TLL2	 2.66E-02	 rs10882801	 2.74E-03	
ADAMTS14	 3.56E-02	 rs10999487	 5.00E-03	
COL4A1	 4.41E-02	 rs11069830	 3.80E-03	
COL6A2	 4.47E-02	 rs4819203	 1.02E-02	
COL5A3	 4.60E-02	 rs16996952	 1.05E-02	
COL4A3	 4.75E-02	 rs4263106	 4.55E-03	
GLT25D2	 7.29E-02	 rs10752928	 9.97E-03	
COL12A1	 7.39E-02	 rs11966644	 1.03E-02	
COL4A4	 8.09E-02	 rs1317770	 8.38E-03	
COL4A2	 8.64E-02	 rs9515203	 4.66E-03	
BMP1	 9.75E-02	 rs3857979	 2.18E-02	
COL1A1	 9.78E-02	 rs2696245	 2.52E-02	
COL28A1	 1.23E-01	 rs1294627	 1.15E-02	
SERPINH1	 1.25E-01	 rs646474	 3.18E-02	
COL2A1	 1.31E-01	 rs740024	 3.13E-02	
LEPREL1	 1.43E-01	 rs16865025	 1.50E-02	
COL22A1	 1.84E-01	 rs10106218	 6.47E-03	
COL5A1	 1.93E-01	 rs7044151	 1.66E-02	
PPIB	 1.96E-01	 rs7177371	 5.65E-02	
ADAMTS2	 2.10E-01	 rs1530499	 1.37E-02	
TLL1	 2.20E-01	 rs17505658	 1.81E-02	
COL1A2	 2.35E-01	 rs10046552	 5.68E-02	
COL13A1	 2.42E-01	 rs10999049	 2.44E-02	
PLOD2	 2.84E-01	 rs3804664	 6.26E-02	
PLOD3	 2.85E-01	 rs7802724	 9.48E-02	
PCOLCE2	 3.29E-01	 rs9841007	 7.53E-02	
COL5A2	 3.35E-01	 rs10166301	 5.90E-02	
COL3A1	 3.78E-01	 rs3736487	 1.06E-01	
COL6A3	 3.99E-01	 rs3790990	 8.63E-02	
P4HB	 4.23E-01	 rs2070871	 1.55E-01	
COL25A1	 4.38E-01	 rs2198329	 1.04E-02	
COL21A1	 4.46E-01	 rs742497	 6.60E-02	
COL14A1	 5.22E-01	 rs10505377	 6.58E-02	
COL16A1	 5.34E-01	 rs11584199	 1.72E-01	
COL23A1	 5.34E-01	 rs6600941	 3.36E-02	
COL17A1	 5.49E-01	 rs17821926	 1.79E-01	
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LEPREL2	 5.65E-01	 rs4963513	 2.13E-01	
COL9A1	 5.73E-01	 rs9294863	 1.51E-01	
COL24A1	 6.01E-01	 rs17408298	 3.08E-02	
PLOD1	 6.85E-01	 rs2336381	 3.08E-01	
COL19A1	 6.93E-01	 rs12190849	 7.50E-02	
COL9A3	 7.40E-01	 rs6010757	 3.60E-01	
COL9A2	 7.44E-01	 rs2281399	 3.68E-01	
COL11A1	 7.45E-01	 rs2045819	 1.62E-01	
ADAMTS3	 7.52E-01	 rs16847841	 1.38E-01	
CRTAP	 8.13E-01	 rs12054462	 4.44E-01	
COL7A1	 8.29E-01	 rs2228561	 4.97E-01	
GLT25D1	 8.76E-01	 rs10418441	 5.96E-01	
COL10A1	 9.35E-01	 rs1059277	 7.61E-01	
COL4A6	 NaN	 NaN	 NaN	
COL8A2	 NaN	 NaN	 NaN	
PCOLCE	 NaN	 NaN	 NaN	
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Supplementary	Table	4B	
Gene	 Gene	p-value	 Best	SNP	 Best	SNP	p-value	
COL4A3	 4.84E-03	 rs7608142	 6.26E-04	
TLL2	 1.27E-02	 rs3789950	 1.55E-03	
COL19A1	 1.68E-02	 rs3806039	 4.28E-04	
COL8A1	 3.54E-02	 rs17777478	 4.32E-03	
COL22A1	 3.66E-02	 rs10096258	 9.95E-04	
COL4A1	 5.10E-02	 rs7987982	 4.81E-03	
COL6A3	 6.80E-02	 rs4663723	 1.15E-02	
COL4A2	 9.11E-02	 rs331592	 5.22E-03	
COL6A2	 9.83E-02	 rs9978055	 2.41E-02	
COL9A2	 1.01E-01	 rs2076696	 2.67E-02	
PCOLCE2	 1.19E-01	 rs7642969	 2.39E-02	
COL15A1	 1.23E-01	 rs3780621	 1.76E-02	
COL27A1	 1.34E-01	 rs7023208	 1.35E-02	
COL28A1	 1.48E-01	 rs7789187	 1.56E-02	
COL25A1	 1.49E-01	 rs17039914	 1.82E-03	
COL5A1	 1.51E-01	 rs3922982	 1.34E-02	
COL1A2	 1.56E-01	 rs2023729	 3.64E-02	
COL23A1	 1.77E-01	 rs2913787	 5.45E-03	
LEPREL1	 1.80E-01	 rs710551	 2.15E-02	
COL11A1	 2.08E-01	 rs12728397	 1.81E-02	
COL21A1	 2.09E-01	 rs17219382	 2.36E-02	
ADAMTS3	 2.11E-01	 rs10518102	 1.41E-02	
COL1A1	 2.15E-01	 rs2075555	 6.35E-02	
COL14A1	 2.26E-01	 rs7842055	 1.85E-02	
COL3A1	 2.28E-01	 rs12693525	 5.97E-02	
COL13A1	 2.28E-01	 rs1227753	 2.34E-02	
PPIB	 2.76E-01	 rs41434449	 7.86E-02	
PLOD2	 2.87E-01	 rs10935606	 6.82E-02	
COL9A1	 3.13E-01	 rs604896	 5.98E-02	
COL4A4	 3.65E-01	 rs16823258	 5.81E-02	
ADAMTS14	 3.80E-01	 rs7081273	 7.56E-02	
ADAMTS2	 3.94E-01	 rs751546	 3.80E-02	
COL5A3	 4.30E-01	 rs3745597	 1.29E-01	
PLOD1	 4.39E-01	 rs2336381	 1.52E-01	
COL2A1	 4.41E-01	 rs12811832	 1.40E-01	
COL9A3	 4.42E-01	 rs4809261	 1.49E-01	
COL24A1	 4.72E-01	 rs861933	 1.88E-02	
BMP1	 4.98E-01	 rs4072420	 1.62E-01	
GLT25D2	 5.01E-01	 rs2148675	 1.15E-01	
LEPREL2	 5.83E-01	 rs4963513	 2.32E-01	
COL16A1	 5.95E-01	 rs16834652	 2.11E-01	
COL17A1	 6.02E-01	 rs2181833	 2.13E-01	
COL12A1	 6.38E-01	 rs240724	 1.88E-01	
CRTAP	 6.55E-01	 rs4074415	 2.81E-01	
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COL10A1	 7.25E-01	 rs1059277	 3.62E-01	
SERPINH1	 7.83E-01	 rs585821	 4.05E-01	
TLL1	 8.10E-01	 rs2292082	 2.21E-01	
GLT25D1	 8.25E-01	 rs10418441	 5.09E-01	
COL6A1	 8.62E-01	 rs9978314	 5.92E-01	
PLOD3	 8.68E-01	 rs7802724	 6.11E-01	
P4HB	 9.18E-01	 rs2070871	 7.38E-01	
COL5A2	 9.29E-01	 rs7419288	 5.60E-01	
COL7A1	 9.54E-01	 rs2228561	 8.64E-01	
COL4A6	 NaN	 NaN	 NaN	
COL8A2	 NaN	 NaN	 NaN	
PCOLCE	 NaN	 NaN	 NaN	
23	
Supplementary	Table	5	Gene	set	associations	with	the	mean	FA	value	of	the	
depression-associated	voxels	within	the	forceps	minor	(only	gene	sets	with	p	<	
0.05	are	listed)	
Data base Gene set p q75% 
REACTOME REACTOME_SIGNALING_BY_HIPPO 1.00E-04 4.60E-03 
GO LAMELLIPODIUM 5.00E-04 7.42E-02 
GO CELL_PROJECTION_BIOGENESIS 2.10E-03 2.97E-01 
KEGG KEGG_WNT_SIGNALING_PATHWAY 2.30E-03 3.57E-01 
GO RECEPTOR_COMPLEX 2.80E-03 6.17E-01 
GO DNA_HELICASE_ACTIVITY 4.30E-03 4.95E-01 
GO LEADING_EDGE 5.70E-03 6.23E-01 
KEGG KEGG_ABC_TRANSPORTERS 6.70E-03 2.95E-01 
REACTOME REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION 7.10E-03 8.10E-01 
KEGG KEGG_PANCREATIC_CANCER 7.50E-03 2.67E-01 
REACTOME REACTOME_PHOSPHOLIPID_METABOLISM 7.70E-03 7.56E-01 
GO BLOOD_COAGULATION 7.80E-03 5.58E-01 
KEGG KEGG_LONG_TERM_DEPRESSION 8.40E-03 2.09E-01 
KEGG KEGG_ECM_RECEPTOR_INTERACTION 8.50E-03 2.29E-01 
GO HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_ACTIVITY 8.80E-03 5.44E-01 
REACTOME REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX 9.00E-03 9.73E-01 
KEGG KEGG_RENAL_CELL_CARCINOMA 1.07E-02 2.02E-01 
GO COAGULATION 1.13E-02 6.75E-01 
REACTOME REACTOME_G2_M_CHECKPOINTS 1.20E-02 6.28E-01 
KEGG KEGG_COLORECTAL_CANCER 1.26E-02 2.10E-01 
BIOCARTA BIOCARTA_SPPA_PATHWAY 1.27E-02 7.30E-01 
REACTOME REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT 1.30E-02 5.17E-01 
GO ER_GOLGI_INTERMEDIATE_COMPARTMENT 1.35E-02 6.22E-01 
GO CELL_PROJECTION 1.49E-02 8.54E-01 
REACTOME REACTOME_APOPTOTIC_EXECUTION_PHASE 1.51E-02 4.79E-01 
KEGG KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION 1.52E-02 2.73E-01 
REACTOME REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS 1.62E-02 5.93E-01 
REACTOME REACTOME_NCAM1_INTERACTIONS 1.65E-02 4.43E-01 
GO PROTEIN_HOMODIMERIZATION_ACTIVITY 1.76E-02 8.63E-01 
REACTOME REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH 1.91E-02 4.22E-01 
REACTOME REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS 2.00E-02 4.63E-01 
GO BONE_REMODELING 2.04E-02 7.96E-01 
GO TISSUE_REMODELING 2.06E-02 8.74E-01 
REACTOME REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE 2.07E-02 3.93E-01 
GO TRANSFERASE_ACTIVITY_TRANSFERRING_ACYL_GROUPS 2.15E-02 8.80E-01 
REACTOME REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION 2.21E-02 4.28E-01 
REACTOME REACTOME_ACYL_CHAIN_REMODELLING_OF_PC 2.31E-02 3.99E-01 
KEGG KEGG_PROSTATE_CANCER 2.33E-02 3.45E-01 
GO REGULATION_OF_BODY_FLUID_LEVELS 2.39E-02 8.30E-01 
REACTOME REACTOME_SPHINGOLIPID_METABOLISM 2.47E-02 4.37E-01 
GO PHOSPHOLIPID_BINDING 2.61E-02 7.91E-01 
GO HEMOSTASIS 2.71E-02 7.61E-01 
REACTOME REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS 2.72E-02 4.44E-01 
BIOCARTA BIOCARTA_MET_PATHWAY 2.72E-02 5.10E-01 
BIOCARTA BIOCARTA_DEATH_PATHWAY 2.76E-02 6.36E-01 
GO TRANSFERASE_ACTIVITY_TRANSFERRING_GLYCOSYL_GROUPS 2.84E-02 7.87E-01 
KEGG KEGG_VIRAL_MYOCARDITIS 2.85E-02 3.52E-01 
GO CELL_SUBSTRATE_ADHESION 2.85E-02 7.35E-01 
GO CATION_TRANSPORT 2.85E-02 7.87E-01 
BIOCARTA BIOCARTA_CERAMIDE_PATHWAY 2.89E-02 7.93E-01 
REACTOME REACTOME_ACTIVATED_TLR4_SIGNALLING 2.93E-02 4.84E-01 
GO POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION 2.96E-02 8.24E-01 
GO HELICASE_ACTIVITY 2.97E-02 7.40E-01 
REACTOME REACTOME_DOUBLE_STRAND_BREAK_REPAIR 2.98E-02 4.43E-01 
KEGG KEGG_AXON_GUIDANCE 3.00E-02 4.02E-01 
GO RUFFLE 3.05E-02 7.27E-01 
REACTOME REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACID
S_METAL_IONS_AND_AMINE_COMPOUNDS 
3.29E-02 4.59E-01 
GO RECEPTOR_SIGNALING_PROTEIN_ACTIVITY 3.31E-02 7.92E-01 
GO ATPASE_ACTIVITY 3.47E-02 7.80E-01 
GO RECEPTOR_SIGNALING_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY 3.87E-02 8.50E-01 
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REACTOME REACTOME_INWARDLY_RECTIFYING_K_CHANNELS 3.89E-02 4.78E-01 
REACTOME REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE 3.90E-02 5.27E-01 
GO ENDOPLASMIC_RETICULUM_PART 4.11E-02 7.78E-01 
BIOCARTA BIOCARTA_IL12_PATHWAY 4.12E-02 4.76E-01 
GO WOUND_HEALING 4.16E-02 8.08E-01 
REACTOME REACTOME_METAL_ION_SLC_TRANSPORTERS 4.19E-02 5.03E-01 
REACTOME REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ 4.21E-02 5.18E-01 
REACTOME REACTOME_ACYL_CHAIN_REMODELLING_OF_PE 4.25E-02 5.05E-01 
KEGG KEGG_P53_SIGNALING_PATHWAY 4.41E-02 3.70E-01 
GO HUMORAL_IMMUNE_RESPONSE 4.42E-02 8.16E-01 
KEGG KEGG_APOPTOSIS 4.56E-02 3.95E-01 
GO NUCLEAR_ENVELOPE_ENDOPLASMIC_RETICULUM_NETWORK 4.58E-02 7.31E-01 
GO AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 4.65E-02 7.99E-01 
GO CELL_MATRIX_ADHESION 4.70E-02 7.04E-01 
GO ACTIN_BINDING 4.76E-02 7.35E-01 
KEGG KEGG_ACUTE_MYELOID_LEUKEMIA 4.95E-02 3.68E-01 
BIOCARTA BIOCARTA_FCER1_PATHWAY 4.98E-02 5.63E-01 
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Supplementary	Table	6	Gene	set	associations	with	the	mean	FA	value	of	the	
depression-associated	voxels	within	the	left	Superior	Longitudinal	Fasciculus	
(SLF)	(only	gene	sets	with	p	<	0.05	are	listed)	
Data base Gene set p	 q75%	
BIOCARTA BIOCARTA_HDAC_PATHWAY 1.00E-04 4.55E-03 
BIOCARTA BIOCARTA_MEF2D_PATHWAY 1.00E-04 4.90E-03 
KEGG KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC 1.00E-04 3.04E-02 
REACTOME REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS 2.00E-04 4.67E-02 
KEGG KEGG_DILATED_CARDIOMYOPATHY 3.00E-04 2.07E-02 
GO ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 3.00E-04 1.94E-01 
KEGG KEGG_LINOLEIC_ACID_METABOLISM 4.00E-04 1.56E-02 
REACTOME REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS 6.00E-04 9.72E-02 
GO TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY 8.00E-04 2.89E-01 
KEGG KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY 1.00E-03 2.86E-02 
REACTOME REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES 1.50E-03 1.26E-01 
KEGG KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION 1.90E-03 2.64E-02 
GO ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES 1.90E-03 2.73E-01 
KEGG KEGG_WNT_SIGNALING_PATHWAY 2.10E-03 4.85E-02 
REACTOME REACTOME_GLYCOSAMINOGLYCAN_METABOLISM 2.10E-03 1.38E-01 
REACTOME REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_
NLR_SIGNALING_PATHWAYS 
2.40E-03 1.86E-01 
BIOCARTA BIOCARTA_FCER1_PATHWAY 2.50E-03 6.95E-02 
REACTOME REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM 2.70E-03 1.72E-01 
GO AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 2.80E-03 3.33E-01 
GO PROTEIN_IMPORT 3.10E-03 3.02E-01 
BIOCARTA BIOCARTA_VIP_PATHWAY 3.30E-03 5.36E-02 
KEGG KEGG_THYROID_CANCER 3.70E-03 4.58E-02 
KEGG KEGG_LONG_TERM_DEPRESSION 4.10E-03 6.36E-02 
GO HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDESCATALYZING_TRANSMEMBRANE_MOVEM
ENT_OF_SUBSTANCES 
4.10E-03 2.81E-01 
REACTOME REACTOME_GABA_RECEPTOR_ACTIVATION 4.20E-03 1.33E-01 
REACTOME REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM 4.30E-03 1.41E-01 
GO HUMORAL_IMMUNE_RESPONSE 4.50E-03 2.84E-01 
REACTOME REACTOME_ION_CHANNEL_TRANSPORT 4.80E-03 1.36E-01 
REACTOME REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION 4.80E-03 1.62E-01 
BIOCARTA BIOCARTA_NDKDYNAMIN_PATHWAY 5.40E-03 5.32E-02 
KEGG KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY 5.50E-03 7.66E-02 
GO PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 5.50E-03 3.24E-01 
KEGG KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM 5.70E-03 6.46E-02 
GO REGULATION_OF_ANGIOGENESIS 7.20E-03 3.32E-01 
REACTOME REACTOME_GABA_B_RECEPTOR_ACTIVATION 7.90E-03 1.87E-01 
GO METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 7.90E-03 4.70E-01 
KEGG KEGG_LONG_TERM_POTENTIATION 8.10E-03 8.16E-02 
GO PROTEOGLYCAN_METABOLIC_PROCESS 8.40E-03 3.31E-01 
KEGG KEGG_MELANOGENESIS 8.50E-03 8.15E-02 
REACTOME REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS 9.00E-03 2.23E-01 
GO POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY 9.20E-03 4.24E-01 
GO ION_CHANNEL_ACTIVITY 9.30E-03 4.36E-01 
GO SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY 9.40E-03 4.87E-01 
KEGG KEGG_ECM_RECEPTOR_INTERACTION 1.00E-02 8.26E-02 
BIOCARTA BIOCARTA_GPCR_PATHWAY 1.12E-02 1.08E-01 
GO CATION_CHANNEL_ACTIVITY 1.13E-02 4.58E-01 
BIOCARTA BIOCARTA_GCR_PATHWAY 1.14E-02 1.12E-01 
REACTOME REACTOME_OPIOID_SIGNALLING 1.24E-02 2.69E-01 
GO CARBOXYLIC_ACID_METABOLIC_PROCESS 1.24E-02 4.58E-01 
REACTOME REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ 1.25E-02 2.54E-01 
GO PROTEIN_IMPORT_INTO_NUCLEUS 1.27E-02 4.33E-01 
GO ACTIN_CYTOSKELETON 1.39E-02 4.38E-01 
GO PROTEIN_SECRETION 1.41E-02 4.71E-01 
GO TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 1.47E-02 4.25E-01 
KEGG KEGG_CARDIAC_MUSCLE_CONTRACTION 1.54E-02 1.19E-01 
BIOCARTA BIOCARTA_BCR_PATHWAY 1.55E-02 1.24E-01 
REACTOME REACTOME_NOD1_2_SIGNALING_PATHWAY 1.59E-02 2.61E-01 
GO ORGANIC_ACID_METABOLIC_PROCESS 1.63E-02 4.45E-01 
REACTOME REACTOME_IL1_SIGNALING 1.69E-02 2.53E-01 
GO GATED_CHANNEL_ACTIVITY 1.74E-02 4.37E-01 
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GO REGULATION_OF_HYDROLASE_ACTIVITY 1.79E-02 4.46E-01 
KEGG KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY 1.85E-02 1.60E-01 
BIOCARTA BIOCARTA_CALCINEURIN_PATHWAY 1.86E-02 1.21E-01 
GO WOUND_HEALING 1.93E-02 4.54E-01 
GO CYSTEINE_TYPE_PEPTIDASE_ACTIVITY 1.95E-02 4.70E-01 
GO NEGATIVE_REGULATION_OF_CELL_PROLIFERATION 1.98E-02 4.24E-01 
REACTOME REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING 2.01E-02 2.58E-01 
GO NUCLEAR_IMPORT 2.03E-02 4.49E-01 
GO REGULATION_OF_SECRETION 2.09E-02 4.54E-01 
KEGG KEGG_AXON_GUIDANCE 2.10E-02 1.71E-01 
REACTOME REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS 2.12E-02 2.40E-01 
REACTOME REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING 2.19E-02 2.70E-01 
REACTOME REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS 2.20E-02 2.47E-01 
BIOCARTA BIOCARTA_TCR_PATHWAY 2.24E-02 1.82E-01 
REACTOME REACTOME_L1CAM_INTERACTIONS 2.24E-02 3.16E-01 
GO VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX 2.43E-02 4.34E-01 
KEGG KEGG_APOPTOSIS 2.45E-02 1.67E-01 
KEGG KEGG_HEDGEHOG_SIGNALING_PATHWAY 2.47E-02 1.80E-01 
GO POTASSIUM_ION_TRANSPORT 2.51E-02 4.23E-01 
KEGG KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION 2.55E-02 1.77E-01 
REACTOME REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS 2.75E-02 3.14E-01 
GO NITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS 2.76E-02 4.39E-01 
GO PROTEIN_DOMAIN_SPECIFIC_BINDING 2.78E-02 4.50E-01 
GO ION_TRANSPORT 2.79E-02 4.68E-01 
KEGG KEGG_CALCIUM_SIGNALING_PATHWAY 2.82E-02 1.90E-01 
BIOCARTA BIOCARTA_IL1R_PATHWAY 2.86E-02 1.70E-01 
GO LIPID_TRANSPORT 2.87E-02 4.31E-01 
GO CARBOHYDRATE_BIOSYNTHETIC_PROCESS 2.97E-02 4.39E-01 
REACTOME REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES 3.00E-02 3.21E-01 
GO POTASSIUM_CHANNEL_ACTIVITY 3.09E-02 4.60E-01 
GO POSITIVE_REGULATION_OF_CASPASE_ACTIVITY 3.10E-02 4.26E-01 
GO LIPASE_ACTIVITY 3.12E-02 4.47E-01 
REACTOME REACTOME_PLC_BETA_MEDIATED_EVENTS 3.17E-02 3.77E-01 
REACTOME REACTOME_NCAM1_INTERACTIONS 3.33E-02 3.87E-01 
REACTOME REACTOME_SIGNALING_BY_ILS 3.73E-02 4.46E-01 
GO KINASE_INHIBITOR_ACTIVITY 3.74E-02 4.32E-01 
GO AMINE_METABOLIC_PROCESS 3.74E-02 5.07E-01 
GO NITROGEN_COMPOUND_METABOLIC_PROCESS 3.76E-02 5.05E-01 
BIOCARTA BIOCARTA_NOS1_PATHWAY 3.90E-02 1.94E-01 
KEGG KEGG_O_GLYCAN_BIOSYNTHESIS 3.92E-02 1.90E-01 
GO SULFUR_METABOLIC_PROCESS 3.97E-02 4.97E-01 
BIOCARTA BIOCARTA_FMLP_PATHWAY 4.02E-02 1.95E-01 
GO RECEPTOR_COMPLEX 4.07E-02 4.84E-01 
REACTOME REACTOME_HS_GAG_BIOSYNTHESIS 4.11E-02 3.92E-01 
KEGG KEGG_GNRH_SIGNALING_PATHWAY 4.13E-02 2.32E-01 
GO DAMAGED_DNA_BINDING 4.14E-02 4.54E-01 
GO METAL_ION_TRANSPORT 4.23E-02 5.33E-01 
BIOCARTA BIOCARTA_PGC1A_PATHWAY 4.25E-02 2.01E-01 
GO BLOOD_COAGULATION 4.83E-02 5.10E-01 
KEGG KEGG_ALZHEIMERS_DISEASE 4.97E-02 2.78E-01 
GO RESPONSE_TO_WOUNDING 4.97E-02 5.74E-01 
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Supplementary	Table	7	Gene	set	associations	with	the	mean	FA	value	of	the	
depression-associated	voxels	within	the	left	temporal	Superior	Longitudinal	
Fasciculus	(tSLF)	(only	gene	sets	with	p	<	0.05	are	listed)	
Data base Gene set p	 q75%)	
KEGG KEGG_DILATED_CARDIOMYOPATHY 9.90E-05 2.50E-03 
REACTOME REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS 9.90E-05 3.80E-03 
KEGG KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC 9.90E-05 4.00E-03 
GO VOLTAGE_GATED_CATION_CHANNEL_ACTIVITY 5.00E-04 2.20E-01 
GO METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 6.00E-04 1.20E-01 
GO GATED_CHANNEL_ACTIVITY 7.00E-04 1.12E-01 
GO HUMORAL_IMMUNE_RESPONSE 7.00E-04 1.59E-01 
KEGG KEGG_ECM_RECEPTOR_INTERACTION 8.00E-04 5.68E-02 
GO POTASSIUM_ION_TRANSPORT 8.00E-04 3.83E-01 
KEGG KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM 1.10E-03 1.98E-02 
GO CATION_CHANNEL_ACTIVITY 1.20E-03 1.05E-01 
REACTOME REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING 1.20E-03 1.70E-01 
REACTOME REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS 1.40E-03 1.09E-01 
REACTOME REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM 1.40E-03 1.16E-01 
GO SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY 2.00E-03 1.49E-01 
GO POTASSIUM_CHANNEL_ACTIVITY 2.10E-03 1.51E-01 
GO VOLTAGE_GATED_CHANNEL_ACTIVITY 2.50E-03 1.60E-01 
KEGG KEGG_LINOLEIC_ACID_METABOLISM 3.10E-03 4.71E-02 
GO VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY 3.30E-03 1.63E-01 
GO NEGATIVE_REGULATION_OF_CELL_PROLIFERATION 3.60E-03 1.66E-01 
GO CYSTEINE_TYPE_PEPTIDASE_ACTIVITY 3.70E-03 1.49E-01 
GO ION_CHANNEL_ACTIVITY 3.80E-03 1.46E-01 
REACTOME REACTOME_GLYCOSAMINOGLYCAN_METABOLISM 3.90E-03 2.38E-01 
GO TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY 4.10E-03 1.48E-01 
GO VOLTAGE_GATED_POTASSIUM_CHANNEL_COMPLEX 4.20E-03 1.47E-01 
REACTOME REACTOME_L1CAM_INTERACTIONS 4.20E-03 2.07E-01 
GO NUCLEOTIDE_EXCISION_REPAIR 5.30E-03 1.53E-01 
REACTOME REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ 5.80E-03 2.28E-01 
REACTOME REACTOME_POTASSIUM_CHANNELS 6.10E-03 2.07E-01 
GO ATPASE_ACTIVITY_COUPLED_TO_MOVEMENT_OF_SUBSTANCES 6.30E-03 1.64E-01 
REACTOME REACTOME_NCAM1_INTERACTIONS 6.70E-03 2.59E-01 
GO APOPTOTIC_PROGRAM 6.80E-03 1.91E-01 
GO MONOVALENT_INORGANIC_CATION_TRANSPORT 6.90E-03 1.81E-01 
KEGG KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE 7.40E-03 8.94E-02 
KEGG KEGG_CARDIAC_MUSCLE_CONTRACTION 7.50E-03 1.01E-01 
KEGG KEGG_CALCIUM_SIGNALING_PATHWAY 7.60E-03 1.18E-01 
REACTOME REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES 8.20E-03 2.46E-01 
REACTOME REACTOME_GABA_B_RECEPTOR_ACTIVATION 8.40E-03 2.00E-01 
GO HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDESCATALYZING_TRANSMEMBRANE_MOVEME
NT_OF_SUBSTANCES 
8.50E-03 2.10E-01 
REACTOME REACTOME_GABA_RECEPTOR_ACTIVATION 8.60E-03 2.32E-01 
GO POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY 8.80E-03 2.05E-01 
GO LIPID_TRANSPORT 9.00E-03 1.86E-01 
BIOCARTA BIOCARTA_HDAC_PATHWAY 9.40E-03 5.80E-01 
GO ACTIN_CYTOSKELETON 9.50E-03 2.43E-01 
GO REGULATION_OF_MAPKKK_CASCADE 1.06E-02 1.90E-01 
KEGG KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION 1.15E-02 1.34E-01 
REACTOME REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_
THE_POSTSYNAPTIC_CELL 
1.18E-02 2.90E-01 
GO ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 1.18E-02 2.99E-01 
REACTOME REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM 1.43E-02 3.00E-01 
GO PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 1.59E-02 2.83E-01 
GO LIPASE_ACTIVITY 1.62E-02 2.89E-01 
GO PROTEIN_KINASE_BINDING 1.75E-02 3.32E-01 
GO REGULATION_OF_HYDROLASE_ACTIVITY 1.77E-02 3.69E-01 
REACTOME REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS 1.86E-02 3.08E-01 
REACTOME REACTOME_SMOOTH_MUSCLE_CONTRACTION 1.94E-02 2.85E-01 
REACTOME REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS 2.11E-02 3.35E-01 
GO POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY 2.12E-02 4.44E-01 
BIOCARTA BIOCARTA_P38MAPK_PATHWAY 2.15E-02 7.84E-01 
GO METAL_ION_TRANSPORT 2.25E-02 4.57E-01 
GO REGULATION_OF_ANGIOGENESIS 2.37E-02 3.75E-01 
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REACTOME REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 2.60E-02 4.33E-01 
GO SYNAPTIC_TRANSMISSION 2.64E-02 4.74E-01 
GO CARBOXYLIC_ACID_METABOLIC_PROCESS 2.75E-02 4.93E-01 
GO NITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS 2.82E-02 3.67E-01 
KEGG KEGG_MELANOGENESIS 2.85E-02 3.03E-01 
GO PROTEOGLYCAN_METABOLIC_PROCESS 2.85E-02 3.84E-01 
KEGG KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM 2.89E-02 2.67E-01 
KEGG KEGG_HEMATOPOIETIC_CELL_LINEAGE 2.99E-02 2.92E-01 
GO NITROGEN_COMPOUND_METABOLIC_PROCESS 3.04E-02 4.98E-01 
REACTOME REACTOME_APOPTOTIC_EXECUTION_PHASE 3.06E-02 4.18E-01 
BIOCARTA BIOCARTA_IL1R_PATHWAY 3.06E-02 6.98E-01 
REACTOME REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS 3.08E-02 4.11E-01 
KEGG KEGG_THYROID_CANCER 3.10E-02 2.91E-01 
REACTOME REACTOME_SIGNALING_BY_RHO_GTPASES 3.11E-02 4.58E-01 
GO KINASE_BINDING 3.20E-02 4.87E-01 
KEGG KEGG_ALZHEIMERS_DISEASE 3.21E-02 2.79E-01 
REACTOME REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NL
R_SIGNALING_PATHWAYS 
3.39E-02 4.54E-01 
REACTOME REACTOME_MUSCLE_CONTRACTION 3.41E-02 4.37E-01 
GO AMINE_METABOLIC_PROCESS 3.48E-02 4.99E-01 
GO PHOSPHOLIPASE_ACTIVITY 3.50E-02 4.76E-01 
GO ATPASE_ACTIVITY 3.50E-02 4.87E-01 
GO CELL_JUNCTION 3.55E-02 4.84E-01 
KEGG KEGG_WNT_SIGNALING_PATHWAY 3.63E-02 3.01E-01 
GO ORGANIC_ACID_METABOLIC_PROCESS 3.84E-02 5.22E-01 
GO CARBOXYLESTERASE_ACTIVITY 3.88E-02 4.95E-01 
GO KINASE_INHIBITOR_ACTIVITY 3.92E-02 4.47E-01 
BIOCARTA BIOCARTA_PGC1A_PATHWAY 3.97E-02 5.07E-01 
GO TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY 4.01E-02 4.82E-01 
BIOCARTA BIOCARTA_GCR_PATHWAY 4.03E-02 5.86E-01 
REACTOME REACTOME_INWARDLY_RECTIFYING_K_CHANNELS 4.18E-02 4.38E-01 
GO CONTRACTILE_FIBER_PART 4.19E-02 4.68E-01 
BIOCARTA BIOCARTA_VIP_PATHWAY 4.24E-02 4.27E-01 
KEGG KEGG_O_GLYCAN_BIOSYNTHESIS 4.43E-02 2.96E-01 
GO POSITIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER 4.61E-02 4.95E-01 
GO AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY 4.63E-02 5.05E-01 
GO PEPTIDASE_ACTIVITY 4.72E-02 5.36E-01 
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Abstract 
Background 
Recognition memory is an essential ability for functioning in everyday life. Establishing 
robust brain networks linked to recognition memory performance can help in understanding 
the neural basis of recognition memory and thus contribute to the research on this key, 
basic ability. 
Methods 
We analysed behavioural and whole-brain fMRI data from 1’410 healthy young adults 
during a picture-recognition task. Using independent component analysis (ICA), we 
decomposed the fMRI contrast for previously seen vs. new (old-new) pictures into few 
networks of brain activity in two independent samples (training sample: N = 645, replication 
sample: N = 665). Next, we investigated the relationship between the identified brain 
networks and interindividual differences in recognition memory performance by conducting 
prediction analysis. We estimated predication accuracy in a third independent sample (test 
sample: N = 100). 
Results  
We identified 12 robust and replicable brain networks by applying ICA to the old-new fMRI 
contrast. Based on these networks we estimated recognition memory performance with 
high accuracy (r = 0.5).  
Conclusion 
Given the high prediction accuracy, the identified brain networks may be considered as 
potential biomarkers of recognition memory performance in healthy young adults and can 
be further investigated in the context of health and disease. 
3 
Introduction 
Recognition memory describes the ability to judge whether an object or event has 
been previously encountered [1]. This ability is essential for functioning in everyday life and 
has an important role in shaping one’s future behaviour and decision making [2, 3]. Thus, 
recognition memory paradigms are widely used in empirical research on human cognition in 
both health and disease [4-6]. Identifying brain activity related to recognition memory 
performance would contribute to the research on this key, basic ability.  
Based on fMRI studies using task-based contrasts recognition memory has been 
linked to activation in multiple brain regions, such as the (para)hippocampus and perirhinal 
cortex in the medial temporal lobe, parts of the prefrontal cortex (PFC), the thalamus and 
the parietal cortex [7-15] These contrast-based analyses allow the identification of regions 
that are in general more (or less) active during a task or in a specific condition, however, 
they do not enable making inferences about interindividual differences in the behavioural 
outcome. For recognition memory, it has been additionally shown that brain activation of 
specific regions of interest (ROIs) within a core recollection network, including the medial 
PFC and the right hippocampus, is also associated with interindividual differences in task 
performance [16].  
Instead of solely using task-based contrasts and ROIs approaches to investigate the 
link between brain activation and behaviour, more sophisticated network-level analyses can 
be used not only to identify large-scale brain networks but also to investigate their impact 
on individual differences in task performance [17, 18]. These analyses identify brain 
networks as the joint co-dependent activity of different parts of the brain [17]. It has already 
been shown that wide-spread functional brain networks are recruited by diverse 
behavioural tasks, as well as during rest [19-21]. Additionally, recent studies have linked 
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network-level brain activation to memory-related behavioural outcomes, including working 
memory performance, emotional memory and recollection speed of a context memory [22-
24]. 
Utilizing a network-level approach instead of standard contrasts or ROI-approaches 
may therefore lead to a more comprehensive picture of the neural bases of recognition 
memory and their impact on memory performance differences. Therefore, we applied a 
whole-brain, data-driven approach to identify recognition memory-related brain networks 
and investigated their relationship with interindividual differences in recognition memory 
task performance. We used fMRI data from 1’410 healthy young adults who had performed 
a picture-recognition task in the scanner. The large number of participants allowed us to 
identify robust and replicable brain networks. Additionally, it enabled us to perform 
prediction analysis instead of simple association analysis, which allows higher 
generalizability of our results [25, 26].  
Results 
During a picture-recognition task, participants were shown 72 previously seen (old) 
and 72 new pictures and rated each of them as remembered (recollection), familiar 
(familiarity), or new (novelty). We analysed participants’ brain activity when looking at old in 
comparison to new pictures (fMRI contrast old-new). For the behavioural data, we also 
compared the recognition memory performance of old and new pictures, by calculating 
false-alarm corrected performance scores separately for familiarity (familiarity rating of old 
– familiarity rating of new pictures) and for recollection (remembering rating of old –
remembering rating of new pictures). We then calculated the overall recognition memory 
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performance as the sum of false-alarm corrected familiarity ratings and false-alarm 
corrected recollection ratings.  
To achieve a robust estimation of networks of brain activation and of model fit when 
predicting the behavioural outcome, we divided the full sample into three independent 
samples for the following analyses (training sample: N = 645, replication sample: N = 665 
and test sample: N = 100). The training and replication samples were used to determine the 
optimal number of brain networks that can be robustly identified, whereas the test sample 
was used to achieve unbiased estimates for the prediction accuracy. 
Behavioural results 
The mean recognition memory performance of our overall sample was 61.36 (SD = 
7.70). Descriptive statistics for recognition memory performance scores in the training, 
replication and test sample separately are reported in Table 1. Recognition memory 
performance was significantly associated with participants’ sex and age (tsex = 2.48, psex = 
0.013; tage = -2.55, page = 0.011). Therefore, all subsequent analyses using behavioural data 
were corrected for sex and age. 
Descriptive statistics for familiarity and recollection scores separately, as well as the 
separate ratings for old and new pictures, are reported in Suppl. Table 1. Additional 
information regarding the contribution of old and new picture ratings to the familiarity and 
recollection scores is provided in the Supplementary Material and Suppl. Figure 1. Of note, 
familiarity and recollection scores were negatively correlated (r = -0.76, p < 2.2 x 10-16). 
Identification of stable and reproducible brain networks by using ICA decomposition 
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In order to decompose the old-new fMRI contrast estimates into few brain networks 
we conducted independent component analysis (ICA). ICA is an unbiased, data-driven 
method which reduces the dimensionality of the data to a lower number of statistically 
independent components (ICs, also termed brain networks throughout the following text) 
[27]. We determined the optimal number of ICs using a resampling procedure in the training 
sample and using independent validation in the replication sample. Specifically, we 
randomly selected 90% of the participants 100 times from the training sample and 
repeatedly performed IC decomposition with a varying number of ICs (26 different ICA 
solutions: ICA3 … ICA32, see Method section). The stability per number of ICs is depicted in 
Figure 1A. For each of the 5 most stable solutions (5, 10, 12, 14 and 15 ICs) we then 
performed IC decomposition in the entire training and the entire replication sample, 
respectively. The training and replication sample were of similar sample size (training 
N = 645; replication N = 665), which ensured comparable power in both samples for the 
estimation of the ICs. Based on the similarity of the voxel loadings between training and 
replication sample we determined the number of ICs that could be successfully replicated in 
an independent sample. We quantified the reproducibility per ICA solution as the average 
similarity (r2 between voxel loadings) of matched vs. unmatched ICs between the training 
and the replication sample (see Method section), resulting in a reproducibility of 0.69, 0.47, 
0.70, 0.58 and 0.54, for ICA5, ICA10, ICA12, ICA14 and ICA15, respectively (Suppl. Figure 2 and 3). 
As the solution comprising 12 ICs was most accurately reproduced in the replication sample 
(Figure 1B), we used this IC decomposition for the subsequent analyses (also see Figure 2, 
Suppl. Table 2, Suppl. Figure 4 and Suppl. Figure 5).  
Prediction of recognition memory performance based on brain activation 
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We investigated if we could predict a participant’s recognition memory performance based 
on the brain activation strength in these 12 ICs. Since the ICs represent co-activation 
networks resulting from the decomposition of the old-new contrast, the participants’ brain 
activation strength per IC shows the contribution of each participant to the group-level 
network. In the training sample, we built a linear model (LM) including the recognition 
memory performace scores as outcome variable and the participants’ activation of the 12 
ICs as predictors. We then applied the beta weights from this model to the brain activation 
of the 12 ICs in the replication sample. With this procedure, we could successfully predict 
recognition memory performance with high accuracy (r = 0.47, p < 2.2 x 10-16; Figure 3A). 
Importantly, in this analysis the ICs activation was independently estimated in the two 
samples.  
While having an independent estimation of ICs activation in the replication sample 
provides a robust estimate of our prediction model, it does not allow for the prediction 
model to be applied to a single participant. In order to assess if our prediction model can 
also be applied to single-participant level, we conducted an additional analysis. Namely, we 
projected the voxel loadings from the ICs derived from the larger training sample (N=645) 
onto the fMRI data of the smaller test sample (N=100). We then applied the beta weights of 
the training sample onto these projected ICs to predict the memory performance in the test 
sample. Again, we were able to predict the memory performance with a high accuracy 
(r = 0.50, p = 1.29 x 10-07; Figure 3B).  
Prediction of familiarity and recollection separately based on brain activation 
Familiarity-based and recollection-based recognition memory are often considered as 
separate constructs [1, 4]. Therefore, we repeated the prediction analyses for familiarity-
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based and recollection-based recognition memory, separately, using the identical 
procedure. We were able to predict both familiarity and recollection with high accuracy 
(replication sample: familiarity: r = 0.69, p < 2.2 x 10-16, recollection: r = 0.50, p < 2.2 x 10-16; 
test sample: familiarity: r = 0.68, p = 7.13 x 10-15, recollection: r = 0.45, p = 2.07 x 10-06, 
Suppl. Figure 6).   
Discussion 
The aim of the current study was to estimate the recognition memory performance of 
healthy young individuals based on their fMRI activation patterns in a few robust brain 
networks. Therefore, we analysed the fMRI signal of a picture-recognition memory task and 
deconstructed the task-based contrast “old – new pictures” into 12 brain networks using 
ICA. Importantly, we confirmed the robustness of this IC estimation by using an 
independent replication sample. Based on the activation in these 12 brain networks we 
could predict recognition memory performance with high accuracy in a third independent 
sample. These results reveal the close relationship between the fMRI activation pattern 
when processing old compared to new pictures and the corresponding memory-related 
behavioural outcome. 
Focusing on few robust networks and their relation to the behavioral outcome 
improves data reproducibility and interpretability, which is important especially in the 
context of basic clinical-related research [28, 29]. Given the stability of the IC estimation 
confirmed in two independent samples and the high prediction accuracy estimated in a 
third independent sample, the identified brain networks may be considered as potential 
imaging biomarkers of recognition memory performance in healthy young adults.  
9 
Of note, based on our 12 brain networks we could also estimate with high accuracy 
recollection-based recognition memory performance and familiarity-based recognition 
memory performance, when taken as separate constructs. Familiarity is typically defined as 
having a general sense of knowing an object or event while recollection is defined as 
remembering specific details associated with the recognised object or event [1, 4]. An 
alternative view is that familiarity and recollection are not distinct processes but rather 
describe differences in memory strength [30]. Further investigation of potential differences 
in network-level brain activation between familiarity-based and recollection-based memory 
performance is beyond the scope of this paper. 
Recognition memory has an important role in our everyday life and aids efficient 
decision making [3]. Deficits in recognition memory performance have been associated with 
healthy aging, mild cognitive impairment and Alzheimer’s disease, as well as schizophrenia 
[5, 6, 31]. Thus, the here identified networks have potential relevance in the context of both 
health and neuropathology.  
In conclusion, we identified 12 robust functional brain networks, based on which we 
successfully predicted recognition memory performance. Given the high prediction 
accuracy, the identified brain networks may be considered as potential biomarkers of 
recognition memory performance in healthy young adults and can be further investigated in 
health and disease. 
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Materials and Methods 
Study design  
Healthy young adults took part in a large-scale, single-centre fMRI study in Basel, 
Switzerland, conducted between 2008 and 2015. The study has been described elsewhere 
[22, 32, 33]. Participants were free of any medication other than oral contraceptives and of 
any neurological and psychiatric illness at the time of the study. All participants provided 
written informed consent prior to study participation.  The study protocol was approved by 
the ethics committee of the Cantons of Basel-Stadt and Basel-Landschaft.  
Description of picture encoding and picture recognition task 
1’446 participants were shown 72 meaningful pictures of positive, negative and neutral 
valence (24 per emotional valence category), and 24 scrambled pictures. Two additional 
neutral pictures were presented at the beginning and two at the end of the picture-
encoding task, in order to account for potential primacy and recency effects. Each picture 
was presented for 2.5 s in a quasi-randomised order (no more than four consecutive 
pictures per category). A 500 ms fixation-cross appeared before each picture presentation. 
Each picture was rated on two separate three-point Likert scales, measuring subjective 
arousal and valence of positive, negative and neutral pictures and form and size of 
scrambled pictures. Ratings were given via button presses with three fingers of the 
participant’s preferred hand.  
The picture recognition task took place approximately 80 minutes after the picture 
encoding task. Participants were presented with the 72 old pictures shown in the encoding 
task and a set of new pictures comprising again 72 meaningful pictures with positive, 
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negative and neutral valence (24 per emotional valence category). Pictures were presented 
in a quasi-randomised order (no more than 4 consecutive pictures per category). A 500 ms 
fixation-cross appeared before each picture presentation. Participants rated each picture as 
remembered, familiar or new on a three-point Likert scale within 3 s after picture 
presentation via button presses with three fingers of their preferred hand.  
For the encoding and the picture recognition task we used pictures from the 
International Affective Picture System (IAPS) [34]. The neutral pictures were additionally 
complemented by in-house standardised pictures to equate for visual complexity and 
content of the stimuli.   
Subsampling 
In order to obtain independent samples needed for the subsequent analyses (building of 
independent brain networks and prediction analysis), we divided our full sample of N = 
1’446 participants with complete behavioural data in three samples. We created two 
equally sized samples (N = 673 participants) and an additional sample of N = 100 
participants, referred to as training, replication and test sample throughout the paper. The 
samples were created by chronologically ordering the participants of the overall sample and 
then performing the sample split. 
(f)MRI data acquisition, preprocessing and first-level analysis 
 Siemens Magnetom Verio 3 T whole-body MR unit equipped with a twelve-channel head 
coil was used for scanning. (f)MRI data acquisition, preprocessing and the construction of a 
population-based anatomical probabilistic atlas have been described elsewhere [22] and are 
also reported in the Supplementary Information. Preprocessing and first-level analysis of the 
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fMRI data was performed using the software SPM8 (Statistical Parametric Mapping, 
Wellcome Trust Centre for Neuroimaging; http://www.fil.ion.ucl.ac.uk/spm/) in MATLAB 
R2012b (MathWorks) using a standard fMRI pipeline.  
Brain activation during presentation of old (presented during the encoding task) and 
new (not previously presented) pictures during the recognition task was separately 
estimated per participant. 
The difference between the old and the new picture parameter estimates was 
calculated for each participant and voxel (first-level analysis for old-new contrast). 
Performance measurements were not included in the analysis.  
fMRI second-level analysis 
All further analyses were conducted with the statistical software R (3.4.2; 
RRID:SCR_001905).  The old-new contrast parameters were included in a second-level group 
analysis. Only participants with complete fMRI data and behavioral data (training sample: N 
= 648; replication sample: N = 665; test sample: N = 100) were included. Additionally, we 
removed participants with missing values for > 10% of voxels (N = 3 in the training sample) 
and voxels with any missing values (N = 14’458). The final sample included 1’410 
participants (training sample: N = 645; replication sample: N = 665; test sample: N = 100) 
and 56’764 voxels.  
We regressed out the effects of age and sex from the voxel signal separately for the 
training and the replication sample and used the scaled residuals in all subsequent analyses. 
Scanner-related confounding variables (gradient coils and software changes) were present 
in the training sample and were also regressed out. To achieve independence on participant 
level in the test sample for the prediction analysis, we corrected for sex and age by applying 
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the sex and age beta values derived from the training sample to the test sample. Scaling was 
also based on the parameter derived from the training sample.  
Identification of independent brain networks using ICA decomposition 
We used ICA in order to decompose the whole-brain fMRI signal into a set of voxel-wise 
independent components. ICA is a dimensionality reduction method used for linear 
representation of non-Gaussian data by decomposing them into components that are as 
statistically independent as possible [27]. We applied ICA to a matrix X (old-new contrast 
parameters), comprising m observations (participants) and n variables (voxels). ICA 
estimates a matrix of k x n latent sources S that underlie the variables, while holding the 
source estimates (voxel loadings) as independent from each other as possible. Therefore, by 
applying ICA decomposition to old-new contrast parameters (a matrix with participants as 
rows and voxels as columns) our voxel loadings describe statistically independent latent 
sources that underlie the contrast estimates. Additionally, ICA provides a matrix of m x k 
mixing coefficients A (participants scores) for each independent component. The mixing 
coefficients of each component represent the component’s activity strength, per participant 
[35]. Participants with high contrast estimates in voxels that load highly onto a particular 
component in a positive direction are assigned elevated scores for that component by this 
method. Therefore, we interpret the participants’ scores as a measure of coactivation in the 
voxels that load onto the component.  
Determining the optimal number of components 
The number of independent components is a key ICA parameter, and there are several 
methods for its optimisation, such as estimation of component stability and reproducibility 
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for ICA solutions with N number of components (ICAN) [36, 37], described in the following 
section.  
ICA decomposition stability assessment  
As a first step for identifying the optimal number of components for decomposition of the 
old-new fMRI contrast, we investigate the stability of decomposing the voxel signal into N = 
3:24, 26, 28, 30 and 32 ICs (26 different ICA solutions: ICA3 … ICA32). 
Procedure: 1) We used a resampling method with 100 repetitions and 90% of randomly 
selected participants from the training sample, producing 100 similar, but non-identical 
subsamples, in order to prevent overfitting. 2) For each of the 26 ICA solutions: a) We 
performed ICA on each of the 100 subsamples, using the fastICA algorithm (R-package 
“fastICA”; [27]); b) We calculated the stability of each IC by applying Pearson’s correlation to 
its voxel loadings across subsamples. As the direction of IC estimates is arbitrary, we 
squared the correlation coefficients to adjust for directionality (r2); c) ICA solution stability 
was calculated as the mean stability of its ICs.  
ICA decomposition reproducibility assessment 
As a second step for identifying the optimal number of components, we investigated the 
reproducibility of the five most stable ICA solutions: ICA5, ICA10, ICA12, ICA14 and ICA15 
between the training and the replication sample. For each ICA solution, we 1) conducted ICA 
with the complete training and replication sample, respectively (no subsampling), 2) created 
a correlation matrix by calculating Pearson’s correlations between the voxel loadings per IC 
across samples. As the direction of IC estimates is arbitrary, we squared the correlation 
coefficients to adjust for directionality (r2). Since the order of components derived from ICA 
15 
is arbitrary, we reordered the replication sample ICs, so that each IC matches its 
corresponding training sample IC (r2 ≥ 0.6). Furthermore, as the direction of IC estimates is 
also arbitrary, we recoded IC estimates (voxels loadings and participants scores, 
respectively), so that estimates have the same direction in the training and replication 
sample and voxels with the highest absolute loadings have positive loadings.  
From the correlation matrix for each ICA solution we estimated the average 
correlation coefficient on the diagonal, i.e., for matched ICs (X) and off the diagonal, i.e., for 
unmatched ICs (Y), across samples. We used mean(r2X) – mean(r2Y) as a reproducibility 
metric. The most reproducible ICA solution was used for all subsequent analyses.  
Recognition memory prediction  
We built our prediction model based on the training sample (N = 645). Specifically, we 
performed multiple linear regression using the participants IC scores from all 12 ICs as 
predictors and recognition memory performance as the outcome variable. 
We first estimated the model fit based on independently estimated ICs in the 
replication sample (N=665). We applied the regression weights of the predictive model to 
the participants IC scores from the 12 replication sample ICs.   
Next, we estimated the model fit in the test sample (N = 100). Since ICA was not 
applied to the test sample, we projected the voxel loadings from the 12 ICs in the training 
sample onto the old-new contrast parameters from the test sample, using the ‘ginv’ 
function from the R package “MASS” [38]. Using projected values enabled us to apply our 
model on the fMRI data from a new sample without subjecting it to ICA. Therefore, the 
model can also be applied on a single participant. 
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The model’s accuracy for each sample was assessed by comparing the predicted 
behavioural outcome with the observed behaviour using Pearson’s correlation (r). Statistical 
test for significance was done with a t-test (p-value threshold < .05).  
Additionally, the described prediction analyses were conducted two more times, for 
familiarity-based and recollection-based recognition memory scores as the outcome 
variable, separately. The procedure for these analyses was identical to the one using the 
overall recognition memory scores. 
Anatomical labelling of functional brain networks 
Anatomical labelling of grey matter brain regions was based on a population-averaged 
probabilistic atlas. The atlas construction is described in the Supplemental Information. The 
atlas consisted of 87 distinct cortical and subcortical brain regions from both hemispheres. 
To anatomically describe functional brain networks represented by the 12 ICs we used 5% of 
voxels, having most extreme voxel loadings on any of the ICs (considering the full ICA 
solution). For each of these voxels we extracted the probability of belonging to a given brain 
region according to the population-based atlas. We assigned each voxel to the anatomical 
brain region with the highest probability, provided the probability was higher than 25%. In 
case the region with the highest probability was cortical white matter, we report the 
anatomical region with the 2nd highest probability. Next, for each brain region we 
summarized the number of voxels and the percentage of voxels for the respective IC, for the 
left and right hemisphere separately, irrespective of the direction of task activation (task-
positive and task-negative). Only brain regions with a coverage of 20% or higher are 
displayed in the table that describes the ICs (Suppl. Table 2).  
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Table 1: Descriptive statistics (mean and standard deviation) of recognition memory performance scores, 
shown separately for the training, replication and test sample. 
Training sample Replication sample Test sample 
Recognition memory 61.59 (7.12) 61.01 (8.35) 62.20 (6.65) 
Figure 1: ICA stability and reproducibility A) Stability (y-axis) calculated as the mean correlation (r2) of 
voxel loadings across 100 runs from the resampling procedure, averaged across ICs. This was done 
separately for different number of ICs (x-axis). The error bars represent 90% confidence intervals; B) 
Reproducibility, i.e., correlation (r2) between voxel loadings in the training sample and the replication 
sample, of the IC solution with 12 ICs. Abbreviations: train, training sample; repl, replication sample, IC, 
independent component 
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Figure 2: Anatomical localization of the voxel loadings for each of the 12 ICs in the training sample. Only 
voxels with the strongest loadings (overall top 5%) are depicted. Positive and negative voxels loadings are 
presented in red and blue, respectively.  
Figure 3: Scatter plot depicting the observed and predicted recognition memory performance scores in A) 
the replication and B) the test sample. The figure contains scaled behavioural data. 
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Contribution of old and new picture ratings to recognition memory performance 
The separate ratings for old and new pictures exhibited ceiling effects and rather narrow 
distributions especially for the recollection rating of new pictures (see Supplementary Table 
1 and Supplementary Figure 1). Therefore, we tested in how far the separate ratings of the 
old and the new pictures contributed to the false-alarm corrected familiarity and recollection 
scores. While both performance measures contributed to the familiarity score (old and old-
new: r = 0.83, p < 2.2 x 10-16; new and old-new: r = -0.54, p < 2.2 x 10-16), the recollection score 
was almost exclusively based on the performance of the old pictures (old and old-new: r = 
0.99, p < 2.2 x 10-16; new and old-new: r = -0.01, p = 0.57) (Table 1; Figure 1). 
(f)MRI data acquisition 
 Siemens Magnetom Verio 3 T whole-body MR unit equipped with a twelve-channel head coil 
was used for scanning. Blood oxygen level-dependent fMRI was acquired using a single-shot 
echo-planar imaging (EPI) sequence using generalized auto-calibrating partially parallel 
acquisition (GRAPPA). Acquisition parameters: echo time (TE) = 35 ms; field of view (FOV) = 
22 cm; GRAPPA R = 2.0; voxel size = 2.75 x 2.75 x 4 mm3. An ascending interleaved sequence 
with repetition time (TR) of 3000 ms (α = 82°) was used to measure 32 contiguous axial slices 
placed along the anterior-posterior commissure plane based on a midsagittal scout image. A 
three-dimensional, high-resolution T1-weighted image were obtained using magnetization 
prepared rapid gradient echo (MPRAGE) sequence. Acquisition parameters: TR = 2000 ms; TE 
= 3.37 ms; inversion time (TI) = 1000 ms; flip angle = 8°; 176 sagittal slices; FOV = 256 mm; 
voxel size = 1 x 1 x 1 mm3. Based on visual inspection by 3 raters, 38 participants with 
corrupted T1-weighted images (movement or anatomical abnormalities) were excluded from 
all subsequent analyses.  
3 
fMRI preprocessing 
Preprocessing of the fMRI data was performed using the software SPM8 (Statistical 
Parametric Mapping, Wellcome Trust Centre for Neuroimaging; 
http://www.fil.ion.ucl.ac.uk/spm/) in MATLAB R2012b (MathWorks). Functional images were 
slice-time corrected to the first slice, adjusting for inter-voxel time of measurement variability 
and realigned using the ‘register to mean’ option. Individual images were co-registered onto 
high resolution structural images. The coregistered images from all participants were spatially 
normalized to a customized template, using the high dimensional DARTEL approach [1], which 
allows registration to both cortical and subcortical regions and has been shown to perform 
well in volume-based alignment [2]. Normalization incorporated the following four steps: (1) 
Structural images of each subject were segmented using the 'New Segment' procedure in 
SPM8. (2) The resulting gray and white matter images were used to derive a study-specific 
group template. The template was computed from a subgroup of 1’000 subjects, which were 
part of the subjects included in the present study. (3) An affine transformation was applied 
to map the group template to MNI space. (4) Subject-to-template and template-to-MNI 
transformations were combined to map the functional images to MNI space. The functional 
images were smoothed with an isotropic 8 mm full-width at half-maximum (FWHM) Gaussian 
filter. 
First-level analysis 
Separate regressors modelling the presentation of A) old (presented during the 
encoding task) and B) new (not previously presented) pictures during the recognition task 
were convolved with a canonical hemodynamic response function (HRF). Specifically, an 
4 
epoch/boxcar function with duration of 1 s was used for modeling. Intrinsic autocorrelations 
were accounted for by AR (1), and low-frequency drifts were removed via high-pass filter 
(time constant 128 s). Movement parameters were entered as nuisance covariates. The 4 
pictures accounting for potential primacy and recency effects were excluded from the 
analysis.  
The difference between the old and the new picture parameter estimates was 
calculated for each participant and voxel (first-level old-new contrast). Performance 
measurements were not included in the analysis.  
Construction of a population-average anatomical probabilistic atlas 
Automatic segmentation of the subjects’ T1-weighted images was used to build a population-
average probabilistic anatomical atlas. More precisely, each participant’s T1-weighted image 
was first automatically segmented into cortical and subcortical structures using 
FreeSurfer(version 4.5, http://surfer.nmr.mgh.harvard.edu/) [3]. Labeling of the cortical gyri 
was based on the Desikan-Killiany Atlas [4], yielding 35 regions per hemisphere. We also 
labeled 28 subcortical regions in total (11 subcortical bilateral regions, 6 central regions 
comprising corpus callosum and brain stem) following Fischl et al. [3]. The segmented T1 
image was then normalized to the study-specific anatomical template space using the 
subject’s computed warp field and affine-registered to the MNI space. The normalized 
segmentations were finally averaged across subjects, in order to create a population-average 
probabilistic atlas. Each voxel of the template could consequently be assigned a probability 
of belonging to a given anatomical structure, based on the individual information from 1’000 
subjects, which were part of the subjects included in the present study. 
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Supplementary Table 1: Descriptive statistics (mean and standard deviation) of the 
behavioural data, shown separately for old and new pictures and for the familiarity and 
recollection scores. 
Old New Old – New 
Familiarity 10.64 (9.49) 7.11 (6.32) 3.53 (11.29) 
Recollection 58.63 (10.85) 0.80 (1.50) 57.83 (10.77) 
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Supplementary Table 2: Anatomical annotation of the 12 ICs in the training and replication 
sample. Only voxels with the strongest loadings (top 5%) and regions with a coverage ≥ 20% 
in both samples are displayed. The table is sorted by the order of ICs. Abbreviations: IC, 
independent component; Hem., hemisphere.  
IC Lobe Region Hem. Voxels N Coverage % 
Training sample Replication sample 
1 cingulate Rostral anterior cingulate left 134 61 33 
1 cingulate Rostral anterior cingulate right 84 29 23 
1 frontal Pars opercularis right 228 34 32 
1 parietal Inferior parietal left 756 22 23 
1 parietal Inferior parietal right 896 21 29 
1 parietal Superior parietal right 731 31 42 
2 subcortical Amygdala left 83 65 96 
2 subcortical Hippocampus left 203 59 68 
2 subcortical Amygdala right 87 100 99 
2 subcortical Hippocampus right 201 64 56 
2 subcortical Ventral Diencephalon right 219 31 41 
2 temporal Fusiform left 414 23 32 
2 temporal Parahippocampal left 118 58 83 
2 temporal Entorhinal right 87 37 68 
2 temporal Fusiform right 411 32 25 
2 temporal Parahippocampal right 112 65 81 
3 frontal Caudal middle frontal left 367 51 57 
3 frontal Pars opercularis left 279 62 59 
3 frontal Pars orbitalis left 121 51 45 
3 frontal Pars triangularis left 197 77 66 
3 frontal Rostral middle frontal left 972 21 32 
3 frontal Superior frontal left 1356 22 24 
3 parietal Supramarginal right 595 21 28 
4 occipital Pericalcarine left 57 60 21 
4 occipital Cuneus right 146 38 38 
4 occipital Lateral occipital right 558 52 63 
4 occipital Lingual right 345 58 61 
4 occipital Pericalcarine right 66 92 94 
4 temporal Fusiform right 411 36 31 
5 frontal Precentral left 712 36 31 
5 parietal Postcentral left 506 53 57 
6 cerebellum Cerebellum cortex left 1808 45 56 
6 cerebellum Cerebellum cortex right 1725 48 50 
7 cingulate Caudal anterior cingulate left 93 76 57 
7 cingulate Caudal anterior cingulate right 103 86 81 
7 frontal Pars opercularis right 228 29 33 
7 frontal Pars triangularis right 236 23 29 
7 insula Insula left 317 32 25 
7 insula Insula right 314 31 27 
7 subcortical Pallidum right 54 57 22 
8 occipital Cuneus left 121 42 56 
8 occipital Lateral occipital left 610 62 48 
8 occipital Lingual left 321 61 50 
7 
8 occipital Pericalcarine left 57 88 79 
8 occipital Pericalcarine right 66 20 27 
8 temporal Fusiform left 414 23 20 
9 frontal Caudal middle frontal right 329 63 61 
9 frontal Pars orbitalis right 126 79 78 
9 frontal Rostral middle frontal right 921 43 37 
9 frontal Superior frontal right 1304 34 21 
9 parietal Inferior parietal right 896 47 49 
9 temporal Middle temporal right 655 25 23 
10 cingulate Isthmus cingulate left 115 100 94 
10 cingulate Isthmus cingulate right 117 100 100 
10 cingulate Posterior cingulate right 176 28 20 
10 corpus callosum Posterior center 46 52 39 
10 occipital Cuneus left 121 52 54 
10 occipital Cuneus right 146 45 51 
10 parietal Precuneus left 544 62 62 
10 parietal Precuneus right 547 63 66 
11 corpus callosum Central center 30 33 33 
11 subcortical Caudate right 180 23 26 
12 frontal Precentral right 708 41 31 
12 frontoparietal Paracentral left 188 45 35 
12 frontoparietal Paracentral right 222 60 47 
12 insula Insula right 314 22 28 
12 parietal Postcentral left 506 27 26 
12 parietal Postcentral right 466 55 39 
12 temporal Transverse temporal left 55 82 60 
12 temporal Transverse temporal right 42 100 100 
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Supplementary Figure 1: Histograms of the behavioural data, shown for familiarity of  old 
pictures (A), new pictures (B) and familiarity false-alarm corrected scores (C) as well as for 
recollection of old pictures (D), new pictures (E), and recollection false-alarm corrected 
scores (F). 
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Supplementary Figure 2: ICA reproducibility between the training sample and the replication 
sample for the top 5 most stable solutions (5, 10, 12, 14 or 15 ICs). Abbreviations: train, 
training sample; repl, replication sample, IC, independent component  
10 
Supplementary Figure 3: Comparison of the average reproducibility metrics between the 
top 5 most stable ICA solutions. The difference between the mean r2 of matched (in blue) 
and unmatched (in green) ICs between the training and the replication sample, “matched – 
unmatched ICs”, was used as reproducibility metric.  
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Supplementary Figure 4: Anatomical localization of ICA decomposition voxel loadings for 
each IC in the replication sample. Only 5% of voxels, having most extreme voxel loadings, are 
depicted. Positive and negative voxels loadings are presented in red and blue, respectively.  
12 
Supplementary Figure 5: Between-sample comparison of voxel loadings per IC. The overlap 
of voxels with most extreme loadings (top 5%) between the training sample (x-axis) and the 
replication sample (y-axis) is presented in green colour. Non-overlapping voxels, i.e., with IC 
loadings within the top 5% in one sample but not in the other, are presented in black and 
blue, for the training and the replication sample, respectively. Voxels with loadings < 5% in 
both samples are presented in grey. 
13 
14 
Supplementary Figure 6: Scatter plot depicting the observed and predicted familiarity and 
recollection performances in the replication and the test sample. A) familiarity scores and B) 
recollection scores in the replication sample; C) familiarity scores and D) recollection scores 
in the test sample. The figure contains scaled behavioural data. 
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exome sequencing of healthy phenotypic extremes 
links TROVE2 to emotional memory and PtSD
angela Heck1, 2, 3*, annette milnik1, 2, 3, vanja vukojevic1, 2, 4, Jana Petrovska1, 2, tobias egli1, 2, 
Jochen Singer5, 6, Pablo escobar6, 7, 8, thierry Sengstag6, 7, 8, David Coynel2, 9, virginie Freytag1, 2,  
matthias Fastenrath2, 9, Philippe Demougin1, 2, 4, eva Loos2, 9, Francina Hartmann1, 2, Nathalie Schicktanz2, 9,  
Bernardo Delarue Bizzini1, 2, 4, Christian vogler1, 2, 3, iris-tatjana Kolassa10, Sarah Wilker10, thomas elbert11,  
torsten Schwede6, 7, 8, Christian Beisel5, Niko Beerenwinkel5, 6, Dominique J.-F. de Quervain2, 3, 9 † and 
andreas Papassotiropoulos1, 2, 3, 4* †
Many mental disorders represent the extremes of the normal distribution of traits, which are related to multiple cognitive 
and emotional dimensions. By performing whole-exome sequencing of healthy, young subjects with extremely high versus 
extremely low aversive memory performance, we identified TROVE2 as a gene implicated in emotional memory in health and 
disease. TROVE2 encodes Ro60, a broadly expressed RNA-binding protein implicated in the regulation of inflammatory gene 
expression and autoimmunity. A regulatory TROVE2 variant was linked to higher emotional memory capacity and higher emo-
tional memory-related brain activation in healthy subjects. In addition, TROVE2 was associated with traumatic memory and the 
frequency of post-traumatic stress disorder in genocide survivors.
Enhanced memory for emotional events, a common observa-tion in animals and humans, is an evolutionary important trait, because it helps remembering both dangerous and favor-
able situations1. On the other hand, strong sensory and emotional 
memories of various life-threatening and aversive experiences may 
contribute to the development and symptoms of post-traumatic 
stress disorder (PTSD)2,3, especially when such memories loose 
their association with the original contextual system4,5. In healthy 
humans, emotionally charged memory (that is, enhanced memory 
for emotional events) shows large phenotypic variability6 and has 
been linked to genetic variants of well-established neuromodulatory 
systems and molecules in candidate gene studies6–13. Similarly, there 
is substantial variability in the individual vulnerability to develop 
PTSD, particularly at lower levels of trauma exposure, which can be 
partially explained by genetic factors14.
Next-generation sequencing coupled with efficient DNA cap-
ture has recently enabled the use of whole-exome sequencing 
(WES) for the study of the genetics of human phenotypes15. Indeed, 
WES studies have been particularly successful at identifying func-
tional variants related to complex traits15–17. Such variants can be 
identified through extreme-phenotype sampling followed by deep 
WES17–20. In extreme-phenotype sampling, samples from a care-
fully selected population at one or both ends of the extremes of a 
phenotype, which have been adjusted for known covariates, are 
subjected to sequencing. In these populations, causal variants 
are expected to be enriched. Thus, even small sample sizes may be 
sufficient to suggest candidate variants that can subsequently be 
genotyped in a larger group of phenotyped individuals, as has also 
been shown recently by empirical research21.
Here we performed WES in healthy, young subjects with extreme 
high or extreme low emotionally charged memory performance, fol-
lowed by targeted genotyping in a larger population, which showed 
a normal distribution of the phenotype of interest (n  =   2,684). 
Genotype-dependent differences in emotional memory-related 
brain activation were studied in a homogenous sub-sample of 1,258 
subjects. In addition, we assessed the effect of the identified variants 
on gene expression in the post-mortem human brain and on symp-
toms and frequency of PTSD in genocide survivors.
results
Exome sequencing in phenotypic extremes. WES was performed 
in 88 healthy, young participants with extreme high or extreme low 
aversive memory performance carefully matched for sex (1-to-1 
matching), genetic background, age and smoking behaviour (see 
Methods, Fig. 1, Supplementary Fig. 1 and Supplementary Table 1). 
Aversive memory was quantified by means of a picture delayed free-
recall task. High and low extremes were defined on the basis of the 
distribution of aversive memory performance in n =  3,418 healthy, 
young subjects (see Methods).
WES was performed with the SureSelectXT human all exon 
V5+ UTR target-enrichment kit (Agilent), which allows sequencing 
of exonic and near-gene regulatory variants. To avoid discarding 
1Division of Molecular Neuroscience, Department of Psychology, University of Basel, CH-4055 Basel, Switzerland. 2Transfaculty Research Platform 
Molecular and Cognitive Neurosciences, University of Basel, CH-4055 Basel, Switzerland. 3Psychiatric University Clinics, University of Basel, CH-4055 
Basel, Switzerland. 4Department Biozentrum, Life Sciences Training Facility, University of Basel, CH-4056 Basel, Switzerland. 5Department of Biosystems 
Science and Engineering, ETH Zurich, CH-4058 Basel, Switzerland. 6SIB Swiss Institute of Bioinformatics, CH-4056 Basel, Switzerland. 7Department 
Biozentrum, University of Basel, CH-4056 Basel, Switzerland. 8sciCORE Center for Scientific Computing, University of Basel, CH-4056 Basel, Switzerland. 
9Division of Cognitive Neuroscience, Department of Psychology, University of Basel, CH-4055 Basel, Switzerland. 10Clinical & Biological Psychology, 
Institute of Psychology & Education, Ulm University, D-89069 Ulm, Germany. 11Department of Psychology, University of Konstanz, D-78457 Konstanz, 
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variants that were enriched at high frequencies in the extremes21, 
the empirical minor allele frequency (MAF) in the extreme dataset 
of n =  88 subjects was set to ≤ 0.125 (see Methods). Given that no 
prior information is available regarding putative differences in effect 
sizes of variants associated with the phenotype of interest, gene-
based analyses were done using both burden and adaptive burden 
tests (see Methods). After adjustment for multiple testing, TROVE2 
(encoding TROVE domain family member 2; also known as Sjögren 
syndrome type A antigen; Ro60 KDa autoantigen), PKD2L2 (encod-
ing polycystin 2 like 2, also known as transient receptor potential 
cation channel), and CFAP57 (also known as WDR65; encoding 
cilia and flagella associated protein 57) were significantly associated 
with group membership, which reflected extreme aversive memory 
performance (Table 1). We investigated TROVE2 further, because 
this gene exceeded the adjusted significance threshold in both 
the burden and adaptive burden test (Table 1). In the burden test, 
TROVE2 remained significant after Bonferroni correction for the 
entire number of genes (n =  21,175) that were analysed in the bur-
den test (Pnominal =  2 ×  10−6, PBonferroni =  0.042; Supplementary Fig. 2). 
Moreover, TROVE2 was the best hit (Pnominal =  0.0002) in the opti-
mized sequence kernel association test (SKAT-O)22 (Supplementary 
Table 2). A detailed view of the sequencing data for TROVE2 (Fig. 2) 
showed that the variant, which is mainly responsible for the results 
of the gene burden tests, was a 3′ -UTR (untranslated region) single-
nucleotide polymorphism (SNP) (rs72740218; C/T transition on 
chr1:193054088 according to GRCh37/hg19 coordinates). Notably, 
10 of the 44 high-extreme individuals were heterozygous minor T 
allele carriers, whereas this was only the case for 2 of the 44 low-
extreme individuals. Pyrosequencing-based genotyping confirmed 
this result (see Methods). According to the Exome Aggregation 
Consortium (ExAC) browser (version 0.3.1), rs72740218 MAF is 
0.08 in European (non-Finnish) populations.
Free-recall performance for positive material relative to neutral 
material (termed positive memory, in analogy to aversive memory) 
was also significantly higher in high-extreme subjects. However, 
this was entirely owing to this group’s lower free-recall performance 
for neutral pictures (Supplementary Table 1). The genetic associa-
tion findings were unrelated to the difference in positive memory 
between extreme groups. Firstly, TROVE2 was not significant 
(P  =   0.6) when tested at the gene level (SKAT-O with positive 
memory as the quantitative phenotype). Secondly, TROVE2-variant 
rs6692342 was not significantly associated with positive memory 
(P =  0.2) or with free recall for positive pictures (P =  0.9).
Next, we tested whether the association of the T allele with 
increased aversive memory performance could also be detected in 
the entire population of healthy young subjects (n =  2,684 success-
fully genotyped for rs72740218, including the n  =   88 sequenced 
subjects, see Methods). We identified 19 minor allele homozygotes, 
369 heterozygotes, and 2,296 major allele homozygotes (empirical 
MAF =  0.075, Hardy–Weinberg P >  0.1). The T allele was signifi-
cantly correlated (P =  0.005) with increased aversive memory per-
formance, also after exclusion of the n  =   88 sequenced extremes 
(P =  0.035, n =  2,596). This sample of n =  2,596 participants con-
sisted of n  =   217 subjects that had not been selected for exome 
sequencing, but nonetheless fullfilled the performance criteria for 
extreme high or extreme low aversive memory (Supplementary 
Table 3), and of 2,379 non-extreme individuals. Notably, the signifi-
cant association between rs72740218 and aversive memory perfor-
mance in this population of n =  2,596 participants was attributable 
to subjects that exhibited extreme aversive memory performance 
(P =  0.0008 for the interaction ‘genotype X extreme/non-extreme 
group membership’; r =  0.11 in n =  217 non-sequenced extremes; 
r =  0.016 in n =  2,379 non-extremes).
Functional brain imaging. In the next step, we used functional 
brain imaging (functional magnetic resonance imaging, fMRI) to 
identify TROVE2 rs72740218-dependent differences in brain activ-
ity related to memory encoding of aversive stimuli in n  =   1,258 
subjects, a sub-sample of the population of n =  2,596 healthy sub-
jects (sequenced extremes were excluded), who participated in the 
behavioural genetic study. All neuroimaging data were acquired in 
the same MRI scanner, thereby reducing hard- and software-related 
methodological variance.
We first investigated encoding-related brain activation inde-
pendently of whether the information was later recalled or not (see 
Methods). We found significant (P <  0.05, two-sided test, family-
wise error (FWE) corrected for the whole brain (PFWE)) gene dose-
dependent (that is, with increasing number of the minor T allele) 
activity increases in the middle frontal gyrus, Brodmann area 9 
(peak at ((− 33, 36, 48), t =  5.39; PFWE =  0.0015)) (Supplementary 
Fig. 3). Because these activation differences may be independent 
of memory processes, we then investigated brain activation that 
was related to successful memory encoding, that is, activation that 
was specifically related to information that was later recalled (see 
Methods). We observed significant positive associations between 
the TROVE2 genotype (with increasing number of the minor T 
allele) and aversive memory-related activity in the left medial pre-
frontal cortex (peak at (− 5.5, 38.5, 36), superior frontal gyrus/para-
cingulate gyrus, Brodmann area 32, t =  5.80; PFWE =  0.0003; with 
FWE-corrected voxels extending to the dorsal anterior cingulate) 
(Fig. 3 and Supplementary Fig. 4). Even after excluding the 6 minor 
allele homozygotes from the analysis, we still found significant 
TROVE2-dependent differences in activation between the major 
allele homozygotes and the heterozygotes with the peak at the same 
coordinate (((− 5.5, 38.5, 36), t =  5.25; PFWE =  0.0125)). There were 
no significant increases in activity with increasing number of major 
alleles. Additionally, we tested whether the reported association was 
specific for the negative valence. An analysis of TROVE2-dependent 
differences in brain activity, which were related to successful 
memory encoding of positive stimuli compared to neutral stimuli 
(see Methods), did not show significant FWE-corrected results; 
nevertheless the corresponding uncorrected significance level was 
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Figure 1 | Frequency histogram of aversive memory performance in 
3,418 healthy, young adults. Dotted vertical blue and red lines at the 
right distribution tail represent the lower and upper performance margins 
of subjects, respectively, defined as high extremes. Dotted vertical blue 
and red lines at the left distribution tail represent the upper and lower 
performance margins of subjects, respectively, defined as low extremes.
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high (((− 5.5, 38.5, 36), t =  3.44; Puncorrected =  0.0006; PFWE =  0.97)). 
Accordingly, we did not observe significant (P  <   0.05, two-sided 
test, FWE-corrected for the whole brain) associations between the 
number of minor TROVE2 alleles and contrast testing for differ-
ences in brain activity between successful memory encoding of 
aversive compared to positive stimuli (see Methods), suggesting 
that, although the observed association was strongest for aversive 
stimuli, it was also observable for the positive valence.
In summary, the fMRI experiment showed that the minor allele 
of TROVE2 SNP rs72740218, which was associated with increased 
memory for aversive information, was also related to increased brain 
activity in the medial prefrontal cortex during successful memory 
encoding of emotional pictures, whereby the strongest association 
was observed for aversive ones.
TROVE2 expression in human frontal cortex. Given the effect of 
the TROVE2 minor allele on brain activation that is related to suc-
cessful memory encoding in the prefrontal cortex, we further inves-
tigated possible minor-allele effects on TROVE2 expression in this 
part of the human brain. For this analysis, we used the BRAINEAC 
data, a publicly available resource for the exploration of the regu-
latory significance of genetic variants in the human brain (http://
www.braineac.org/)23. Brain samples specified as frontal cortex 
probes in the BRAINEAC database were taken from the prefrontal 
cortex24, mostly Brodmann area 9/46, a region well-known for its 
involvement in emotional processing and emotional memory25,26. 
The 3′ -UTR variant rs72740218 was significantly associated with 
expression of the adjacent TROVE2 terminal coding exon (exon-
specific probeset 2372955; chr1:193053788–193053828, GRCh37/
hg19 coordinates) in the prefrontal cortex of 125 deceased subjects. 
The minor T allele predisposed to significantly higher expression 
values (P =  0.005, Fig. 4a), possibly suggesting a local effect of this 
variant on expression of the corresponding exon. No significance 
was observed at the full-transcript level (that is, the Winsorized 
means over all exon-specific probesets) (Supplementary Table 4).
TROVE2 genetic variability in traumatized survivors of the 
Rwandan genocide. Extremely aversive, in particular life-threatening, 
incidents can lead to an excessive and persisting emotional memory 
of the traumatic events, which can result in intrusive and distress-
ing re-experiencing (traumatic memory), a core PTSD symptom. 
The heritability of re-experiencing traumatic events ranges from 
23% to 51%, suggesting that naturally occurring genetic variations 
have an important effect on this trait27. Given the association of 
TROVE2 with aversive memory and aversive memory-related brain 
activation in healthy subjects, we hypothesized that TROVE2 would 
also be associated with emotional memory for traumatic events 
reflected in increased re-experiencing symptoms. We tested this 
hypothesis in 271 refugees who have fled from the Rwandan civil 
war, who have been living in the Nakivale refugee camp in Uganda 
during the time of investigation, and from whom lifetime data on 
the prevalence of PTSD were available (137  females; 134  males; 
mean age, 35 years; range, 18–68 years; see Methods). All subjects 
had experienced highly aversive situations and were examined 
Table 1 |  results of gene-based analyses in phenotypic extremes.
Gene symbol Gene name Burden test P value adaptive burden test P value
Nominal adjusted* Nominal adjusted*
TROVE2 TROVE domain family member 2 (also known as Sjögren syndrome type A 
antigen, Ro60 KDa autoantigen)
2 ×  10−6 0.0004 4 ×  10−5 0.004
PKD2L2 Polycystin 2 like 2, transient receptor potential cation channel 0.00022 0.045 0.00288 0.317
CFAP57 Cilia and flagella associated protein 57 0.00026 0.053 0.00035 0.038
*Corrected for the number of genes reaching i-stat <  0.001 in the respective test (burden test: 203 genes; adaptive burden test: 110 genes).
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Figure 2 | Sequencing results of TROVE2 (positions according to the GrCh37/hg19 coordinates). Blue dots indicate variants with MAF ≤  0.125 detected 
in the sample of 88 individuals with extreme aversive memory performance. Solidus-separated numbers accompanying each dot indicate the frequency 
of the occurrence of the respective minor allele in subjects with extremely high and extremely low performance (high/low). The minor allele of variant 
rs72740218 was observed in 10 high extremes and in 2 low extremes. The y axis indicates − log10 of the P value of genetic association tests that were 
performed separately for each variant. For illustration purposes, two TROVE2 transcript variants (see also Fig. 4) are shown in the lower part of the figure. 
Blue filled rectangles represent coding exons, empty rectangles represent non-coding exons and UTRs.
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by trained experts with a structured interview based on the Post-
traumatic Diagnostic Scale28 with the help of trained interview-
ers chosen from the refugee community. Traumatic events were 
assessed using a checklist of 36 reported war- and non-war-related 
traumatic event types (such as, injury by a weapon, rape, acci-
dents) (Supplementary Table 5). In sub-Saharan African samples, 
the rs72740218 variant is rare (MAF <  0.01, according to dbSNP). 
Therefore, we analysed all TROVE2–spanning common SNPs 
that were present on the Human SNP Array 6.0 with an empirical 
MAF ≥  0.05 in the Rwandan sample (n =  5 tagging SNPs, Table 2). 
None of these variants was significantly associated with age, sex, 
the number of experienced traumatic event types, or with the 
occurrence of any of the 36 distinct traumatic event types (Table 2 
and Supplementary Table 5). TROVE2 SNPs were significantly 
associated with traumatic memory (that is, lifetime symptoms of 
re-experiencing the traumatic event) and with frequency of life-
time PTSD (Table 2). Variant rs6692342, which is located 555 and 
1,007 bases upstream of the respective TROVE2 transcript variants 
(Fig. 5), showed the strongest association: the minor allele G was 
associated with increased traumatic memory (P =  0.007) and with 
increased PTSD frequency (P  =   0.0004). Linkage disequilibrium 
between variants rs6692342 and rs72740218 was not calculated in 
the PTSD sample, given the very low frequency of rs72740218 in the 
Rwandan population. In the healthy, young population sample, vari-
ants rs72740218 and rs6692342 were unlinked (r2 =  0.02). Because 
the occurrence of some of the traumatic event types was unevenly 
distributed between rs6692342 genotype groups (albeit without 
reaching corrected statistical significance; Supplementary Table 5), 
we reran the analyses by controlling for such uneven distributions 
and obtained nearly identical results (Supplementary Table 6). 
The minor allele G of variant rs6692342 was also moderately associ-
ated with increased expression of the adjacent TROVE2 non-coding 
exon 1 of transcript variants NM_004600, NM_001173525, 
NM_001042369 and NM_001042370 (exon-specific probeset 
2372928, chr1:193028950–193029112, GRCh37/hg19 coordinates) 
in the prefrontal cortex of 123 deceased subjects of the BRAINEAC 
study (P =  0.045, Fig. 4b), possibly suggesting a local effect of this 
variant on expression of the corresponding exon. No significance 
was observed at the full-transcript level (that is, the Winsorized 
means over all exon-specific probesets) (Supplementary Table 4). 
The frequency of the minor G allele of rs6692342 was nearly iden-
tical in the BRAINEAC and Rwandan samples (25.6% and 24.6%, 
respectively). Accordingly, genotype frequencies of rs6692342 did 
not differ between these samples (P =  0.5, χ2 test). Notably, genotype 
and allele frequencies in the BRAINEAC and Rwandan samples for 
rs6692342 were in close agreement with the reported values for 
European and Sub-Saharan populations, respectively, in the 1000 
genomes project (Phase 3).
Discussion
The present study suggests that variants related to increased expres-
sion of TROVE2 transcripts in the human frontal cortex are linked 
to emotional memory capacity and emotional memory-related 
brain activation in healthy subjects, and to traumatic memory and 
risk for PTSD in traumatized genocide survivors.
TROVE2 is widely expressed in human tissues, including the 
brain and its frontal cortex23,29. TROVE2 undergoes complex tran-
scriptional regulation, such as alternative splicing with several 
coding transcript variants and a range of 8–11 coding and non-
coding exons30,31 (Fig.  5). SNP rs72740218 was associated with 
emotional memory performance and brain activation related to 
successful memory encoding of emotionally charged informa-
tion in the medial prefrontal cortex, one of the key brain regions 
related to emotional processing32, although it does not belong 
to one of the typical localizations found to be activated by emo-
tional memory encoding in genotype-independent studies33. It is 
important to note, however, that genotype-independent analyses 
may not reveal brain regions for which different genotype groups 
show opposite activation patterns, for example when major-allele 
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Figure 4 | association of TROVE2 SNPs rs72740218 and rs6692342 in 
the human frontal cortex.  a,b, Association of TROVE2 SNPs rs72740218 
(a) and rs6692342 (b) with gene expression. a, Expression values of exon-
specific probeset 2372955 (chr1:193053788–193053828). b, Expression 
values of exon-specific probeset 2372928 (chr1:193028950–193029112; 
GRCh37/hg19 coordinates). Data and box plots were retrieved from the 
BRAINEAC project server23 (http://www.braineac.org/, accessed on  
7 October 2016). Box plots demarcate the 25th and 75th percentile (middle 
line is median), and bars represent the minimum and maximum values. 
Filled circles represent outliers. eQTL, expression quantitative trait locus.
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Figure 3 | TROVE2 rs72740218 genotype-dependent differences in 
brain activity related to successful memory encoding of aversive stimuli 
compared with neutral stimuli in 1,258 healthy young subjects. Displayed 
are positive associations between genotype (the number of minor T 
alleles) and activity. The blue cross indicates the peak genotype-dependent 
activation (t =  5.80; PFWE =  0.0003) in the left medial prefrontal cortex 
at (− 5.5, 38.5, 36). Activations are overlaid on coronal, sagittal and axial 
sections of brain images, displayed at t ≥  3.1 (Pnominal <  0.001) and using 
colour-coded t values. L, left side of the brain; R, right side of the brain.
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homozygotes show a deactivation, whereas the other genotype 
groups show an activation, as was the case with SNP rs72740218 
(Supplementary Fig. 5). Notably, it has been shown that PTSD 
patients, when compared to controls, have an increased response 
in the left dorsal anterior cingulate/medial prefrontal cortex at 
almost identical coordinate positions (peak at − 3, 39, 39) during 
encoding of later remembered negative verbal information34. Of 
note, there is evidence for a dissociative subtype of PTSD patients, 
who typically show increased activation in the anterior cingulate/
medial prefrontal cortex35.
Table 2 |  associations between common TROVE2 SNPs and traumatic memory (Pmemory), lifetime PtSD (PPtSD), sex (Psex), age (Page), 
and the number of traumatic event types (Pevents).
SNP iD Localization maF Psex Page Pevents Pmemory PPtSD
rs6692342 Upstream 0.25 0.868 0.952 0.712 0.007 0.0004
rs4657842 Upstream 0.35 0.895 0.328 0.652 0.191 0.023
rs7554496 Intronic 0.15 0.323 0.800 0.318 0.169 0.581
rs10801173 3′ -UTR; intronic 0.47 0.235 0.316 0.746 0.186 0.024
rs41520747 Downstream; intronic 0.18 0.360 0.669 0.791 0.587 0.017
Chromosome 1
5´
3´
193.03 Mb 193.05 Mb
193.06 Mb193.04 Mb
193,028,007 193,054,007
rs72740218
193,054,098193,027,986
rs6692342
NM_001173524
uc001gss.3
NM_004600
uc001gsv.2
NM_001173525
uc008wyp.3
NM_001042369
uc008gsw.3
NM_001042370
uc001wyq.3
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Figure 5 | Schematic representation of selected TROVE2 refSeq transcript variants (positions according to GrCh37/hg19 coordinates). UCSC 
(University of California Santa-Cruz) identifiers are also given beneath each RefSeq identifier. Blue filled rectangles represent coding exons, empty 
rectangles represent non-coding exons and UTRs. SNPs rs6692342 and rs72740218 are zoomed in with 10 bases up- and downstream; + 1: first coding 
base in the first coding exon.
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SNP rs72740218 is located within the 3′ -UTR of transcripts 
NM_001173524 and NM_004600 (Fig. 5), and is significantly asso-
ciated with expression levels of the terminal coding exon of these 
variants in the prefrontal cortex (Fig. 4). SNP rs6692342, which was 
associated with traumatic memory and PTSD frequency, is located 
555 bases upstream of transcript variant NM_001173524 and 1,007 
bases upstream of transcript variants NM_004600, NM_001173525, 
NM_001042369, and NM_001042370, and is moderately, albeit 
significantly associated with expression levels of the adjacent non- 
coding exon 1 of the latter four variants in the prefrontal cortex 
(Fig. 4). Taken together, the minor alleles of these TROVE2 SNPs 
were associated with increased expression of adjacent exons and 
with gain of emotional (in the case of rs72740218) and traumatic 
(in the case of rs6692342) memory-related phenotypes. Given that 
free recall was assessed shortly after encoding in this study, further 
research will be needed to study the role of this gene on emotional 
memory capacity related to the longer-term (such as, hours, days) 
consolidation processes.
TROVE2 encodes Ro60, an RNA-binding protein that binds to 
misfolded, non-coding RNAs, pre-5S rRNA (ribosomal RNA) and 
Y RNA (small non-coding RNA)31. Autoantibodies to Ro60 are 
prevalent in autoimmune disorders including Sjögren’s syndrome 
and systemic lupus erythematosus36–38, and recent research supports 
the idea of a direct link between Ro60 autoantibody production, 
type I interferon, and autoimmunity39. The findings of the pres-
ent study support a genetic link between TROVE2 and emotional 
memory-related traits, possibly by regulation of specific transcripts. 
Although speculative, one might hypothesize that TROVE2 has a 
role in a possible link between the regulation of immune-related 
processes and the regulation of emotional memory-related traits, 
given the crucial involvement of TROVE2 in autoimmunity. Notably, 
recent genetic and epidemiological data point to a link between 
autoimmunity and PTSD: a retrospective cohort study of 666,269 
Iraq and Afghanistan veterans revealed significant associations 
between PTSD and risk for autoimmune disorders, whereby shared 
etiology was one of the possible explanations for this observation40. 
Recently, a large genome-wide association study (GWAS) of PTSD 
has shown a significantly increased enrichment ratio for immune-
related expression quantitative trait loci in PTSD41. In addition, 
abnormal cytokine regulation and a proinflammatory milieu are 
present in PTSD42–45. Thus, a link between the regulation of immune 
functions and emotional memory-related neuropsychiatric phe-
notypes probably exists. Despite the known, direct connection 
between the human brain and peripheral tissues relevant to the 
function of the immune system46, it is not yet possible to draw any 
causal inferences about the mechanistic nature of this link and about 
a putative involvement of TROVE2. Notably, recent animal research 
identified meningeal immunity as a direct player in the regula-
tion of complex brain functions, such as learning, memory and 
social behaviour47,48.
A number of—mostly small—PTSD GWAS in civilian and mili-
tary or veteran samples have been published41,49–55. TROVE2 has not 
been reported as one of the top hits in these GWAS. Of note, the pub-
lished GWAS results do not converge so far. It is widely acknowledged 
that substantial within- and between-sample differences in trau-
matic event type, duration and rate, time of trauma onset, ancestry, 
sociodemographic factors and social support render comparability 
of GWAS results in the PTSD field inherently difficult56. The pos-
sibility exists that some of the reported findings might prove specific 
to a certain population. Therefore, the replication issue of genetic 
studies of PTSD will remain challenging and might be resolved by 
future large collaborative efforts, which should include different sub-
groups of large homogenous samples. Notably, a recent study that has 
reported on combined genetic and transcriptomic findings in human 
and C. elegans identified TROVE2 as one of the top scoring genes 
involved in mood regulation and stress response57.
In the present study, we used exome sequencing in healthy phe-
notypic extremes to detect genes that were linked to emotionally 
charged memory capacity. Notably, the extreme phenotype design 
proved to be essential for the identification of TROVE2, because 
the effect size of the minor allele T of rs72740218 was considerably 
higher in the extremes, also in the non-sequenced samples, com-
pared to the largest, middle part of the phenotypic distribution. 
It is important to stress that the success of the genetic search pre-
sented herein is not necessarily generalizable to every genetically 
complex cognitive and/or emotional trait. A synergy of factors, such 
as meticulous matching of phenotypic extremes with a particular 
focus on genetic background15, a relatively high MAF for the impli-
cated variant and the specific genetic architecture of the phenotype 
of interest, gave rise to the identification of TROVE2. Nevertheless, 
our experience with this approach and the statistical features of our 
findings are in close analogy to the observations of a recent study, 
which identified a genetic modifier of a Mendelian trait (cystic 
fibrosis) by means of exome sequencing in phenotypic extremes21.
In conclusion, TROVE2, a gene implicated in autoimmunity, is 
linked to emotionally charged memory in health and psychiatric 
disease, particularly in PTSD. Specifically, the present findings sug-
gest that the drawback of the TROVE2 variant-related enhancement 
of emotional memory is increased enhancement of intrusive and 
distressing memory for traumatic events. Given that many mental 
disorders represent the extremes of a normal distribution of traits 
on multiple cognitive and emotional dimensions58, we believe that 
appropriate genetic methodologies in healthy phenotypic extremes 
may help uncover disease dimensions with different symptom pat-
terns, a subtyping that may be necessary to improve understanding 
and treatment of psychopathology.
methods
Definition of phenotypic extremes. Aversive memory was assessed in n =  3,418 
subjects who participated in ongoing behavioural and imaging genetics studies  
of healthy, young adults in the city of Basel, Switzerland (data lock April 2015).  
The ethics committee of the Cantons of Basel-Stadt and Basel-Landschaft approved 
the experiments. All participants received general information about the study  
and gave their written, informed consent for participation. Participants were  
free of any neurological or psychiatric illness, and did not take any medication  
at the time of the experiment (except hormonal contraceptives).
Aversive memory was quantified by means of a picture delayed free-recall 
task. Stimuli consisted of 72 pictures that were selected from the International 
Affective Picture System59, as well as from in-house standardized picture sets 
that allowed us to equate the pictures for visual complexity and content (such as 
human presence). On the basis of normative valence scores (from 1 to 9), pictures 
were assigned to emotionally negative (2.3 ±  0.6), emotionally neutral (5.0 ±  0.3), 
and emotionally positive (7.6 ±  0.4) conditions, resulting in 24 pictures for each 
emotional valence. Four additional pictures that showed neutral objects were 
used to control for primacy and recency effects in memory. Two of these pictures 
were presented at the beginning and two at the end of the picture task. These 
pictures were not included in the analysis. The pictures were presented for 2.5 s 
in a quasi-randomized order. To ensure that the ratio between valence categories 
was kept constant across consecutive parts of the entire picture sequence, each 
twelfth part of the sequence contained exactly two positive, two negative and two 
neutral pictures. Thus, maximally four pictures of the same category occurred 
consecutively. Ten minutes after picture presentation, memory performance was 
tested using a free-recall task, which required participants to write down a short 
description (a few words) of the previously seen pictures. Remembered primacy 
and recency pictures as well as training pictures were excluded from the analysis. 
No time limit was set for this task. A picture was scored as correctly recalled, if the 
rater could identify the presented picture on the basis of the subject’s description. 
Two trained investigators rated the descriptions independently for recall success 
(inter-rater reliability > 99%). A third independent rater decided on those pictures 
that had been rated differently7. For the purpose of selecting phenotypic extremes, 
aversive memory performance was calculated by subtracting the number of 
the freely recalled neutral pictures from the number of freely recalled negative 
pictures. In a sub-sample of 1,900 subjects with data on a second assessment of 
free-recall performance 24 h after the first presentation of the identical picture set, 
both phenotypes showed high levels of inter-trial correlation (Pearson’s r =  0.73 
and r =  0.78 for free recall of negative and neutral pictures, respectively). On the 
basis of the observed phenotypic distribution, subjects with aversive memory 
performance ≥ 10 and ≤ 13 were classified as high-extreme subjects (HES), and 
subjects with aversive memory performance ≥ − 5 and ≤ − 1 were classified as 
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low-extreme subjects (LES). We adopted an almost-extreme sampling approach, 
because the very extremes of cognitive phenotypes are vulnerable to potential 
measurement errors and phenotype heterogeneity18. For example, performance 
at the very extreme low end of the distribution might be related to erroneous 
understanding of task instructions or to gross errors in task execution. Moreover, 
the additive polygenic mode of inheritance of common phenotypes breaks down  
at the very extremes of the distribution tails60,61. Thus, subjects at the very  
extreme ends, as identified upon visual inspection of the frequency histogram  
(that is, aversive memory performance < − 5, n =  6; aversive memory  
performance > 13, n =  8), were not considered for further analysis (Fig. 1).
Next, we selected all subjects who had been genotyped on the Genome-Wide 
Human SNP Array 6.0 (Affymetrix) and performed standard quality control  
with PLINK (https://atgu.mgh.harvard.edu/plinkseq/) including sex check and 
identity by descent analysis as described in ref. 62, resulting in n =  2,991 subjects 
with quality-controlled SNP array data.
The next steps were performed to calculate each subject’s genetic background, 
to select a homogeneous group of participants of European ancestry, and to 
compute an individual parameter in order to match the to-be-sequenced  
extremes for genetic similarity. Thus, we analysed the SNP array data of seven 
Swiss and German samples62–64 (total n =  5,172) including our target sample. 
Genetic data of these subjects was projected onto the first two principal 
components (PCs) of genetic variation in the HapMap3 reference sample 
(consisting of African, Asian and European samples) using SMARTPCA65. 
Participants scoring for PC1 <  0.012 and for PC2 <  0.065 were then filtered  
out to obtain a cluster of broad European ancestry (Supplementary Fig. 1a, b). 
Genetic data of the subjects composing this cluster was also checked for the 
presence of duplicates and cryptic relatedness (identity by descent: p̂ <  0.2). Before 
performing the final principal component analysis within this European sample, genetic 
quality control (MAF >  0.02, call rate >  0.95, Hardy–Weinberg P >  0.001) was 
applied within each of the seven sub-samples separately. We also excluded SNPs 
within regions of long-range linkage disequilibrium as has been suggested in ref. 66. 
The remaining autosomal SNPs of the combined sample were then pruned using 
PLINK (indep-pairwise command; window-size 200 SNPs, 5 SNP steps, r2 <  0.2).  
We next used SMARTPCA65 to estimate the PCs of genetic variation within  
this broad European cluster (Supplementary Fig. 1a, b). The resulting first  
two PCs were used as parameters for genetic similarity.
After these steps, n =  2,739 subjects of European ancestry remained for  
further selection of pairs of subjects from the high- and low extreme groups  
that: (1) have a similar genetic background; (2) have the same sex; (3) were 
investigated at a similar time point; (4) are of similar age; (5) have similar smoking 
behaviour. The latter matching criterion was included given the borderline 
significant correlation between smoking status and being a member of the 
high or low extreme performance group (P =  0.08 before matching). Matching 
was done separately for females and males with the library Matching (Version 
4.8–3.4) in R67. Membership in the low or high extreme group was used as 
treatment vector. Matching was done without replacement, the sequence of the 
subjects entering the matching procedure was chosen randomly. Time point of 
investigation, age, smoking behaviour and the two results of the first two PCs 
from the genetic similarity analysis were used as variables to match on. For each 
HES, the best-matching LES was identified, separately for females and males. 
Finally, these high extreme–low extreme pairs were randomly assigned on the 
plate for subsequent exome sequencing. In line with the circumstance that 
emotionally arousing information is often remembered at the expense of neutral 
background information68, HES had significantly increased mean free-recall 
performance for aversive pictures (P =  3 ×  10−17) and significantly, albeit orders of 
magnitude weaker, decreased mean free-recall performance for neutral pictures 
(P =  1 ×  10−12) than LES (Supplementary Table 1). No difference in mean free-
recall performance for positive pictures (P =  0.6) was observed between HES and 
LES. Overall memory capacity was very similar between extreme groups (P =  0.5). 
No significant group difference in arousal and valence ratings for any of the 3 
picture categories was observed (all comparisons: P >  0.05).
Exome sequencing: blood sampling, DNA isolation and related quality  
controls. Blood samples were collected between midday and evening (mean 
time of day: 14:30, range 13:00–20.00) using BD Vacutainer Push Button blood 
collection sets and 10.0-mL BD Vacutainer Plus plastic whole blood tubes,  
BD Hemogard closure with spray-coated K2EDTA (Becton, Dickinson and 
Company, New Jersey, USA). Standard haematological analysis, including  
blood-cell counting, was performed with a Sysmex pocH-100i Automated 
Hematology Analyzer (Sysmex Co, Kobe, Japan.) DNA was isolated from the 
remaining fraction, upon plasma removal. The isolation was performed with the 
QIAmp Blood Maxi Kit (Qiagen AG, Hilden, Germany), using the recommended 
spin protocol. In order to obtain high purity DNA, isolated DNA samples were 
additionally re-purified. For this purpose, 2 μ g of DNA isolated with the QIAmp/
Oragene procedure, was incubated overnight at 50 °C with proteinase K (lysis 
buffer: 30 mM TrisCl, 10 mM EDTA, 1% SDS pH 8.0, 150 ng μ l−1 Proteinase K), 
agitated by gentle orbital shaking. Next, DNA was purified using the Genomic 
DNA Clean & Concentrate Kit (Zymo Research, Irvine, California, USA). The 
quality and concentration of DNA were assessed using gel electrophoresis, 
NanoDrop ND-1000 (Thermo Scientific, Waltham, Massachusetts, USA) and 
fluorometry measurements (Qubit dsDNA BR Assay Kit; Invitrogen, Carlsbad, 
California, USA), respectively. DNA samples of high integrity and purity were 
further normalized to 24 ng μ l−1 and randomly assigned to a 96-well plate for 
library preparation.
Exome sequencing: library preparation. Quality checks of the genomic DNA 
samples and intermediate products of the library preparation (efficiency of DNA 
fragmentation, pre- and post-capture libraries) were done with the Fragment 
Analyzer, using the DNF-467 Genomic DNA 50 kb Analysis Kit and  
DNF-473 Standard Sensitivity NGS Fragment Analysis Kit, respectively  
(Advanced Analytical Technologies, Ankeny, Iowa, USA). Library preparation  
for WES was performed with the Agilent SureSelectXT Human All Exon  
V5+ UTR kit using the SureSelectXT automated target enrichment for Illumina 
paired-end multiplexed sequencing protocol on the Agilent NGS workstation, 
option B (Agilent Technologies Inc, Santa Clara, California, USA). In brief,  
200 ng of genomic DNA was fragmented with the Covaris E220 focused-
ultrasonicator (Covaris Inc, Woburn, Massachusetts, USA), with the following 
settings: duty factor: 10%; peak incident power: 175; cycles per burst: 200; 
treatment time: 360 s; bath temperature: 4–8 °C. The target DNA fragment size 
was 150–200 bp. After quality assessment the libraries were further prepared 
by using the SureSelect XT Library Prep Kit ILM (Agilent, USA; SureSelectXT 
target enrichment system for Illumina paired-end multiplexed sequencing library 
protocol version B3). AMPure XP bead purification was always implemented 
between the library preparation steps. First, the 3′ ends of the DNA fragments  
were adenylated, followed by paired-end adaptor ligation and adaptor-ligated 
library amplification. After library quality assessment, samples were hybridized  
to the target-specific capture library and the hybridized DNA was captured  
with streptavidin-coated beads. The libraries with 8-bp indexing primers  
were then amplified, assayed for quality and quantity and finally pooled for 
multiplexed sequencing.
Whole-exome sequencing. Libraries were clustered on the Illumina cBot cluster 
station (HiSeq PE Cluster Kit v4). WES was done on an Illumina HiSeq 2500 
machine (paired-end reads, 101 bp per read). The libraries were mixed in 4 pools 
(3 ×  24 +  1 ×  22). Each pool was sequenced in 6 lanes. A fifth pool was mixed  
with 27 of the samples and this Pool 5 was sequenced in an extra lane. For each 
sample, over 12 Gb of sequence were generated.
The SureSelectXT Human All Exon V5+ UTR kit (Agilent) used in this  
study targets 359,555 exons in 21,522 genes (that is, 75 Mb of sequence) included 
in the following databases: CCDS, RefSeq, GENCODE, miRBase, TCGA  
and UCSC. The sequence of each sample was mapped to the hg19 human  
reference genome, downloaded from http://genome.ucsc.edu, using BWA 0.7.12 
(Burrow–Wheeler Alignment)69. Duplicates were flagged with Picard 1.135 
(http://picard.sourceforge.net). Analysis of coverage was done with Picard 
CalculateHSmetrics and Bedtools70 version 2.18.1. Finally, 98% of the target 
bases had a coverage equal or greater than 20× and approximately 50% of target 
bases had 100× coverage (Bedtools; Supplementary Fig. 6). Base quality score 
recalibration and local realignment around indels was done with GATK71 version 
3.4-0 following the standard GATK protocol72. Single nucleotide variants (SNVs) 
were called with the Haplotype Caller. No padding was used for variant calling 
outside non-target regions to prevent false-positive SNV calls. Following the 
recommendation of ref. 73, variant quality score recalibration was used. We chose 
99% sensitivity for a variant to be ‘true’ on the basis of an adaptive error model  
and filtered out false-positive variants using this threshold.
Exome sequencing: callset quality control. The final callset was evaluated using 
variant-level concordance (that is, the percentage of variants in the study sample 
that matched a defined gold standard) and genotype concordance (that is, the 
percentage of variants that matched the genotypes derived from the same samples 
using a different genotyping technique). After defining dbSNP 138.b37 as the gold 
standard, we ran the VariantEval toolkit of GATK. The variant-level concordance 
rate between our callset and dbSNP was high (98.33%). Two genotype concordance 
measures can be derived from comparing sequencing data with array data: non-
reference sensitivity (NRS, that is, the rate at which non-reference alleles in the 
array data are also identified in the sequenced genotypes) and the non-reference 
discrepancy (NRD; that is, the rate at which sequenced genotypes differ from  
array genotypes) rate. We used the GATK toolkit GenotypeConcordance for  
these calculations. 18,709 bi-allelic overlapping variants were identified for  
both WES data and array genotype data of the Affymetrix 6.0 human SNP array.  
NRS was 97.5%, suggesting a high sensitivity for common variants, and NRD  
was 2.4%. The ratio between transitions to transversions (Ti/Tv ratio) was 2.61, 
which matched the expected value of 2.5–2.8 well, for sequences covering  
both exonic and non-exonic 3′ and 5′ UTRs74, like the SureSelectXT Human  
All Exon V5+ UTR kit (Agilent), which targets 75 Mb of the human genome. 
We furthermore checked the rate of novel missense SNPs (that is, not included 
in dbSNP 138.b37) in our callset. The mean over all samples was low (n =  57.8), 
suggesting a low number of false-positive calls. Another quality indicator is  
the het/hom ratio (that is, the ratio between heterozygous and homozygous  
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non-reference variants). In our callset, the het/hom ratio, which is expected  
to be approximately 1.5 for European populations75,76, was 1.57 for all SNPs  
and 1.54 for known SNPs (that is, dbSNP SNPs). Variant call format data  
were annotated with the reference genome GRCh37.75 using SnpEff software 
version 4.1l (build 2015-10-03)77.
Pyrosequencing. Targeted genotyping of TROVE2 SNP rs72740218 was done  
with pyrosequencing on a PyroMark ID System. The following primers were  
used: 5′ -TACTAAACTAGCTCTTGGGGAAAT-3′ (forward primer,  
5′ -biotinylated), 5′ -CAAAGCAAAACTATTTTACAGTGT-3′ (reverse primer), 
5′ -CAAAAAGTTCTCTATTAGAT-3′ (sequencing primer). n =  2,684 subjects 
were successfully genotyped for rs72740218. One-sided genetic-association testing 
(additive model) was used for hypothesis confirmation purposes. Researcher  
team members involved in genotyping were blinded to group allocation.
Burden testing. Genotype–phenotype associations were calculated with PLINK/
SEQ version 0.10 (https://atgu.mgh.harvard.edu/plinkseq/). We calculated gene-
based tests falling into two categories: burden tests78 and adaptive burden tests 
(variable threshold test)79. Burden tests perform optimally when assuming that a 
large proportion of variants are causal and the effects are in the same direction. 
Adaptive burden tests, which use data-adaptive weights or thresholds, are thought 
to be more robust than burden tests that use fixed weights or thresholds80. 
Following power analyses done in studies of phenotypic extremes with similar 
sample size as in the present one, we set the empirical MAF as MAF ≤  0.125 
to avoid eliminating variants enriched to high frequency in the extremes21. To 
correct for multiple testing we used the i-stat statistic (that is, the smallest possible 
empirical P value of a gene), which is implemented in PLINKSeq. According to 
previous recommendations15, the i-stat threshold was set to < 0.001. Burden-test-
derived significances were then Bonferroni-corrected for the number of genes with 
an i-stat below this threshold.
fMRI experiment. Subjects were right-handed, free of any lifetime neurological 
or psychiatric illness, and did not take any medication (except hormonal 
contraceptives) at the time of the experiment, which was approved by the ethics 
committee of the Cantons of Basel-Stadt and Basel-Landschaft. Written, informed 
consent was obtained from all subjects before participation. After receiving general 
information about the study and giving their informed consent, participants were 
instructed and then trained on the picture task they later performed in the scanner. 
After training, they were positioned in the scanner. The participants received 
earplugs and headphones to reduce scanner noise. Their head was fixated in  
the coil using small cushions, and they were told not to move their heads. 
Functional magnetic resonance images were acquired during the performance 
of the picture task in two separate sessions (total scanning time, approximately 
30 min). After finishing the tasks, participants left the scanner and were taken  
to a separate room for free recall of the pictures. Finally, participants filled  
out questionnaires, gave saliva for genotype analysis and were debriefed.  
The total length of the experimental procedure was approximately 3 hours.  
We excluded 54 subjects from the fMRI experiment. Reasons for exclusion  
were defined as follows: corrupted or missing data (n =  40), subjects recalling  
less than one picture in one of the valence categories (n =  10), failed  
co-registration (n =  4).
Measurements were performed on a Siemens Magnetom Verio 3 T 
wholebody MR unit equipped with a twelve-channel head coil. Functional time 
series were acquired with a single-shot echo-planar sequence using parallel 
imaging (GRAPPA). We used the following acquisition parameters: TE (echo 
time) =  35 ms, FOV (field of view) =  22 cm, acquisition matrix =  80 ×  80, 
interpolated to 128 ×  128, voxel size: 2.75 ×  2.75 ×  4 mm3, GRAPPA acceleration 
factor R =  2.0. Using a midsagittal scout image, 32 contiguous axial slices were 
placed along the anterior–posterior commissure (AC–PC) plane covering the 
entire brain with a TR =  3,000 ms (α =  82°). The first two acquisitions were 
discarded owing to T1 saturation effects. A high-resolution T1-weighted anatomical 
image was acquired using a magnetization prepared gradient echo sequence 
(MPRAGE, TR =  2,000 ms; TE =  3.37 ms; TI =  1,000 ms; flip angle =  8; 176 slices; 
FOV =  256 mm; voxel size =  1 ×  1 ×  1 mm3).
Preprocessing and data analysis was performed using SPM8 (Statistical 
Parametric Mapping, Wellcome Department of Cognitive Neurology, London, 
UK; http://www.fil.ion.ucl.ac.uk/spm/) implemented in Matlab (Mathworks Inc., 
Natick, Massachusetts, USA). Volumes were slice-time corrected to the first slice 
and realigned to the first acquired volume. Both functional and structural images 
were spatially normalized by applying DARTEL, which leads to an improved 
registration between subjects. Normalization incorporated the following steps: 
(1) Structural images of each subject were segmented using the ‘New Segment’ 
procedure in SPM8. (2) The resulting gray- and white-matter images were used 
to derive a study-specific group template. The template was computed from a 
subpopulation of 1,000 subjects from this study. (3) An affine transformation was 
applied to map the group template to MNI space. (4) Subject-to-template and 
template-to-MNI transformations were combined to map the functional images  
to MNI space. The functional images were smoothed with an isotropic 8 mm  
full width at half maximum Gaussian filter. Serial correlations were removed  
using a first-order autoregressive model. A high-pass filter (128 s) was applied  
to remove low-frequency noise.
Normalized functional images were masked using information from their 
respective T1 anatomical file as follows: a partial volume effect file obtained from 
the SPM-VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm8/) was used as a 
starting point to define the brain mask. This volume represents the three-tissue 
classification results of the segmentation process (GM, WM, CSF), with two 
additional mixed classes (GM–WM, GM–CSF). It was binarized, dilated and 
eroded with a 3 ×  3 ×  3 voxels kernel using fslmaths (FSL) to fill in potential  
small holes in the mask. The previously computed DARTEL flowfield was used  
to normalize the brain mask to MNI space, at the spatial resolution of the 
functional images. The mask was finally thresholded at 10% and applied to the 
normalized functional images. Consequently, the implicit intensity-based masking 
threshold usually that was employed to compute a brain mask from the functional 
data during the first level specification (by default fixed at mask.thresh =  0.8)  
was not needed any longer and set to a lower value of 0.05.
For each subject, analyses were conducted in the framework of the general 
linear model. Regressors, which modelled the onset and duration of stimulus 
events, were convolved with a canonical haemodynamic response function.  
More precisely, the model comprised regressors for button presses that were 
modelled as stick/delta functions, picture presentations that were modelled  
with an epoch/boxcar function (duration: 2.5 s), and rating scales that were 
modelled with an epoch/boxcar function of variable duration (depending on  
when the subsequent button press occured). Six movement parameters were also 
entered as nuisance covariates. Pictures accounting for possible primacy and 
recency effects were modelled separately.
Brain activity contrasts were calculated individually using a fixed-effects  
model (first level analysis). The following contrasts were specified: (1) brain 
activity related to memory encoding of aversive stimuli compared to neutral 
stimuli, independent of whether the information was later recalled or not  
(aversive pictures − neutral pictures); (2) brain activity related to successful 
memory encoding of aversive stimuli compared to neutral stimuli (aversive 
pictures recalled − aversive pictures not recalled) − (neutral pictures recalled − 
neutral pictures not recalled); (3) differences in brain activity between successful 
memory encoding of aversive compared to positive stimuli (aversive pictures 
recalled − aversive pictures not recalled) − (positive pictures recalled − positive 
pictures not recalled); (4) brain activity related to successful memory encoding of 
positive stimuli compared to neutral stimuli (positive pictures recalled − positive 
pictures not recalled) − (neutral pictures recalled − neutral pictures not recalled). 
The resulting contrast parameters were then used for genotype-dependent  
analyses in a random-effects model (second level analysis). Specifically, we used 
a regression model to analyse differences in brain activity, whereas the number 
of alleles served as covariate in our analysis. We controlled for the effects of 
sex and age by including them as covariates. Significance peaks were assigned 
to anatomical labels based on the Harvard–Oxford Cortical Structural Atlas81. 
Brodmann areas are given based on ref. 82.
Rwanda sample. Study participants were survivors of the Rwandan genocide 
who were living as refugees in the Nakivale refugee settlement. As the Nakivale 
refugee settlement has grown over the last decade and is spread over a large area, 
participants were sampled proportionally to the population size from each zone. 
To exclude genetic relatives in the samples, only one person per household was 
interviewed. Interviewers had been trained to detect current alcohol abuse and 
acute psychotic symptoms; candidates exhibiting these signs were excluded.  
All subjects had experienced highly aversive traumatic situations (including  
life-threatening situations) and were examined in 2006/2007 by psychologists of 
the University of Konstanz with the help of trained interpreters, or by intensely 
trained local interviewers using a structured interview that was based on the  
Post-traumatic Diagnostic Scale28 with the help of trained interpreters. This 
procedure has been validated for implementation in East-African crisis regions83. 
Traumatic events were assessed with a checklist of 36 war- and non-war-related 
traumatic event types, such as, injury by weapon, rape, accident, which have also 
been employed in previous studies7. Traumatic load was estimated by assessing the 
number of different traumatic event types experienced or witnessed. This measure 
has been shown to be more reliable than assessing the frequency of traumatic 
events84. The procedures and study protocols were approved by the Ethics 
Committees of the University of Konstanz, Germany, and the Mbarara  
University of Science and Technology (MUST), Mbarara, Uganda.
Instruments were translated into Kinyarwanda using several steps of 
translations, blind back-translations, and subsequent corrections by independent 
groups of translators. Following the translations, the psychometric properties of the 
translated scales were investigated in a validation study including a retest spanning 
a two-week period and a cross-validation with expert rating85. To avoid known 
ceiling effects (that is, the phenomenon that almost everybody will develop PTSD 
at extreme levels of trauma load)86,87, subjects were selected to have experienced 
no more than 16 different traumatic event types. Subjects that lacked sufficient 
data for the estimation of the prevalence of lifetime PTSD were excluded from this 
study. The significance level of genetic associations with traumatic memory and 
PTSD risk was calculated by performing forward and backward linear and logistic 
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regressions, respectively, under inclusion of age, sex, trauma load, and—wherever 
indicated—occurrence of specific traumatic event types. The significance level of 
genetic associations with trauma load and the occurrence of specific traumatic 
events was calculated by performing forward and backward linear and logistic 
regressions, respectively, under inclusion of age and sex. The significance level 
of genetic associations with age and sex was calculated by performing linear 
regressions and χ2 tests, respectively. Saliva samples were obtained from each 
person using the Oragen DNA Self-Collection Kit (DNA Genotek, Ottawa, 
Ontario, Canada). DNA was extracted from saliva using standard protocols.
Data availability. The data that support the findings of this study are available 
from the corresponding author upon request.
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6 Discussion 
Large datasets of genetic variability, brain structure and brain function hold great 
potential for investigating the biological substrates of complex human behavior. There 
is an ever-growing expansion of diverse approaches for analyzing such datasets. In 
this PhD thesis, some of those approaches were discussed in the context of specific 
research questions. It was also illustrated that the initial analyses need to be 
incorporated into comprehensive analytical pipelines including multiple additional 
steps for insuring the robustness of findings, such as results replication and study-
specific validation procedures. To this end, I presented two studies investigating the 
biological underpinnings of complex behavioral traits in healthy young adults using 
extensive genomics and brain imaging data, respectively. In both studies, the initial 
analyses were placed in the context of robust analytical pipelines for obtaining high-
confidence findings.  
In Study 1, we aggregated genome-wide SNP data to predefined gene sets and 
used inferential statistics to associate each gene set with depressive symptoms. 
Furthermore, we applied an appropriate correction for multiple testing, replicated the 
results in an independent sample and used imagining genetics to validate and extend 
our initial findings. Taking these steps, we found that the NCAM1 Interactions gene 
set is related to depressive symptoms and their structural brain correlates in healthy 
young individuals.  
In Study 2, we decomposed the brain-wide voxel-wise brain activation contrast 
of looking at previously seen vs. new pictures into 12 independent components, which 
can also be considered as functional brain networks. Next, we evaluated recognition 
memory performance based on our 12 components using prediction analysis. Of note, 
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we used stable and reproducible data decomposition, insuring the robustness of the 
resulting components. Furthermore, we trained and tested our prediction model in 
different samples, avoiding overfitting and thus increasing the generalizability of our 
results. We found that recognition memory performance can be estimated with high 
accuracy based on our 12 robust components of brain activation.  
In both studies, we substantially reduced the initial number of variables by 
restructuring our respective genome-wide and brain-wide datasets, but using different 
approaches. Namely, in Study 1 we relied on previous biological knowledge regarding 
the gene sets to which we aggregated our SNP data, while in Study 2 we obtained our 
brain activation components in a data-driven manner. The knowledge-guided creation 
of gene sets in Study 1 goes in line with the aim of the analysis, i.e., identifying 
biologically meaningful groups of genes relevant to our behavioral trait, and aids the 
interpretation of the results. Inevitably, it also makes the results dependent on the 
particular gene set annotations used (Wadi et al., 2016). In contrast, the 
decomposition of voxel-wise brain activation in Study 2 was driven by patterns found 
within our dataset, without being directed by previous findings. 
Importantly, in Study 2 we also applied prediction, rather than the traditional 
inferential approach, increasing the generalizability of our findings. While predictive 
models are often associated with complex machine learning algorithms, e.g., deep 
neural networks, in Study 2 we opted for a linear model, having higher transparency 
and interpretability (Bzdok & Ioannidis, 2019). Interestingly, more complex pattern-
learning algorithms do not necessarily outperform simpler predictive models in brain 
imaging research of complex cognitive traits (e.g. He et al., 2018). This may be due to 
the low signal-to-noise ratio intrinsic to brain imagining and cognitive measurements 
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and/or insufficient sample sizes for the application of highly complex algorithms 
(Arbabshirani et al., 2017; Bzdok & Ioannidis, 2019).  
After establishing our analytical model, we took further steps to reduce the 
likelihood of false positive findings in each study. Unfortunately, false positive findings, 
reflected in failed replication of the results, are commonly encountered across 
scientific disciplines (Begley & Ellis, 2012; Ioannidis, 2005; Open Science 
Collaboration, 2015; Prinz et al., 2011). Some common issues contributing to false 
positive findings, such as overfitting and multiple testing, have been discussed in this 
PhD thesis, along with examples of how to overcome them.  
Of note, the analytical pipelines presented in this thesis can also be further 
validated and extended upon. For example, it can be investigated to which extent 
certain findings depend on the specific analytical algorithms used. In Study 1, we 
conducted GSA using the Meta-Analysis Gene-set Enrichment of variaNT 
Associations (MAGENTA) software package (Segre et al., 2010). MAGENTA has 
been previously used for identification of robust gene set associations with complex 
behavioral traits in our samples (Heck et al., 2014, 2015). Nevertheless, one can also 
investigate if GSA results replicate with algorithms provided by different software 
packages such as INterval enRICHment analysis (INRICH) (Lee et al., 2012), Multi-
marker Analysis of GenoMic Annotation (MAGMA) (de Leeuw et al., 2015) or Versatile 
Gene-based Association Study (VEGAS) 2 (Mishra & MacGregor, 2017). In Study 2, 
the dimensionality reduction of our brain imaging data was performed by ICA, which 
deconstructs the brain-wide fMRI signal into statistically independent components and 
has been used for identification of distinct brain networks in previous studies (Smith et 
al., 2009; Vanasse et al., 2018). However, alternative data-driven dimensionality 
reduction techniques can also be applied when working with highly dimensional 
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neuroscientific data. Some of them can be used prior to the prediction analysis, such 
as principal component analysis and factor analysis, and others as part of the 
prediction algorithm, like in the case of penalized regression (Huys et al., 2016). Given 
the variety of algorithms for utilization of large genomics and brain imaging data, 
repeating the initial analysis with well-chosen alternative analytical tools may further 
validate and/or add additional insight into the findings.  
The generalizability of findings to more diverse populations and settings can 
also be further investigated. In Study 1, while we replicated our initial results in an 
independent sample with similar demographic characteristics, one could further test if 
our findings extend beyond healthy young adults of European ancestry. Although we 
did not find an association between the NCAM1 Interactions gene set and MDD 
diagnosis in a large case-control sample (Ripke et al., 2013), its association with 
continuously measured depressive symptoms in MDD and other (clinical) samples 
remains to be investigated. Using continuous measurements, rather than clinical 
cutoffs, can increase the power for identifying genetic variants implicated in polygenic 
traits (van der Sluis et al., 2013) and thus impact the GSA. Importantly, it remains to 
be seen if the identified genetic associations can be generalized to populations of non-
European ancestry. While non-European samples have been mostly 
underrepresented in genomics studies, large GWASes including samples of diverse 
ancestry are becoming increasingly available (Hindorff et al., 2018; Popejoy & 
Fullerton, 2016; Wojcik et al., 2019). In Study 2, the prediction model remains to be 
externally validated. For example, one can investigate if the estimation of our model 
can be generalized to brain activation data obtained by a different scanner, while 
performing a comparable, but not identical task, in samples with different demographic 
characteristics or in clinical samples.  
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In summary, this PhD thesis has presented two studies in which large genomics 
and brain imaging datasets were successfully utilized for investigating the biological 
underpinnings of complex behavioral traits using genome-wide and brain-wide 
analyses. Importantly, the applied analyses were carefully tailored to the specific 
research question and integrated into robust pipelines for replication and validation of 
the initial results. These pipelines can also be further extended upon.  
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